data_1ctd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ctd _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -69.26 -55.48 10.41 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.418 1.087 . . . . 0.0 113.9 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.13 -9.95 36.24 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -72.86 -68.0 0.52 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.13 161.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -65.31 -25.34 67.58 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 118.625 2.824 . . . . 0.0 118.625 -169.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 56.3 mt -66.43 -49.94 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-O 123.445 1.593 . . . . 0.0 112.648 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -81.21 -38.06 27.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 111.618 -2.537 . . . . 0.0 113.699 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.63 86.15 6.88 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 127.953 2.501 . . . . 0.0 113.104 -171.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -62.89 -71.67 0.16 Allowed 'General case' 0 N--CA 1.485 1.285 1 CA-C-N 107.405 -4.452 . . . . 0.0 114.518 171.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -85.84 133.39 33.97 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -174.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 41.9 43.76 2.7 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 124.755 2.217 . . . . 0.0 116.583 164.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.49 ' CA ' ' H ' ' A' ' 20' ' ' TYR 0.577 1.5 p30 -94.73 67.28 3.24 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 109.895 -3.321 . . . . 0.0 119.612 -172.024 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.47 -4.44 89.29 Favored Glycine 0 CA--C 1.556 2.623 1 CA-C-N 94.818 -10.174 . . . . 0.0 116.41 112.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.49 ' H ' ' CA ' ' A' ' 18' ' ' ASP . 17.3 m-85 -137.99 157.26 46.73 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.14 142.97 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 129.576 3.15 . . . . 0.0 109.879 172.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.29 -176.56 2.93 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.93 1.292 . . . . 0.0 112.87 173.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 tp -52.61 -45.87 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 117.503 2.409 . . . . 0.0 117.503 -175.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -66.78 -43.31 84.31 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -62.79 -40.78 98.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 111.983 -2.371 . . . . 0.0 112.392 172.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 tp -59.45 -48.08 83.01 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.32 1.048 . . . . 0.0 111.554 170.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.73 -50.39 31.67 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.315 0.96 . . . . 0.0 111.652 171.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -54.84 -43.83 73.37 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.5 mt -61.46 -47.77 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.029 0.532 . . . . 0.0 110.198 175.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 174.68 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 6.1 tp . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.77 -47.07 59.74 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.824 1.25 . . . . 0.0 112.241 171.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -60.31 -49.95 75.56 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 171.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.79 -41.28 63.98 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 174.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -57.31 -47.96 80.16 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.054 -1.885 . . . . 0.0 111.932 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -38.52 91.37 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 112.179 -2.282 . . . . 0.0 114.915 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 46.7 mt -61.94 -41.98 92.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 112.985 -1.916 . . . . 0.0 113.016 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -77.99 -38.69 44.44 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 112.339 -2.21 . . . . 0.0 114.802 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -75.13 59.4 0.97 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.489 2.315 . . . . 0.0 111.299 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -46.75 -50.1 18.64 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 111.864 -2.425 . . . . 0.0 114.627 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -84.71 16.82 3.04 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 54.16 28.95 9.67 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 117.869 2.544 . . . . 0.0 117.869 166.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -89.28 4.59 48.26 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 -174.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.32 21.84 66.78 Favored Glycine 0 CA--C 1.546 2.029 0 C-N-CA 124.829 1.204 . . . . 0.0 113.758 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -140.54 172.25 12.98 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.285 1.434 . . . . 0.0 108.931 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -124.21 146.08 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-N 114.427 -1.261 . . . . 0.0 108.512 161.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.57 178.53 4.43 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.594 1.158 . . . . 0.0 114.059 175.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.2 tp -44.43 -45.46 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 118.671 2.841 . . . . 0.0 118.671 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -73.13 -46.76 49.23 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -51.65 -40.84 60.73 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 112.117 -2.311 . . . . 0.0 112.559 167.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 tp -54.93 -40.36 69.81 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 173.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.7 -52.12 21.25 Favored Glycine 0 N--CA 1.477 1.372 0 C-N-CA 124.717 1.151 . . . . 0.0 112.951 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -55.3 -44.59 75.91 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 113.93 -1.135 . . . . 0.0 113.025 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 13.2 mt -65.59 -48.91 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.735 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 177.956 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.644 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -69.48 -44.45 71.13 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.286 1.588 . . . . 0.0 115.286 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.07 -42.73 77.12 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -53.77 -51.85 62.09 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 112.525 -2.125 . . . . 0.0 111.617 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -73.84 -18.57 60.92 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 111.228 -2.715 . . . . 0.0 116.551 -177.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . 0.274 60.7 mt -70.97 -48.99 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.52 170.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -67.72 -44.26 78.05 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 112.508 -2.133 . . . . 0.0 111.645 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -67.07 62.64 0.05 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 127.72 2.408 . . . . 0.0 112.484 177.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -62.12 -37.48 85.3 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 110.692 -2.958 . . . . 0.0 115.293 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -79.27 -2.53 41.71 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.85 37.99 21.52 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.353 1.861 . . . . 0.0 115.944 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.0 p-10 -87.95 -9.72 52.7 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.96 26.91 71.5 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.182 0.896 . . . . 0.0 113.012 -167.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -145.91 178.85 7.87 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.265 1.426 . . . . 0.0 109.614 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.2 mt -128.73 138.53 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 C-N-CA 125.615 1.566 . . . . 0.0 109.29 167.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.7 176.42 5.06 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.344 1.858 . . . . 0.0 115.836 173.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 tp -43.62 -49.81 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 117.645 2.461 . . . . 0.0 117.645 -171.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -38.4 85.73 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -68.72 -38.71 80.41 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 128.487 2.715 . . . . 0.0 113.276 171.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.6 tp -56.13 -41.85 75.97 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.062 165.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.48 -50.9 6.72 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 125.345 1.45 . . . . 0.0 112.68 167.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -51.45 -53.19 39.57 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 172.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 mt -63.34 -44.38 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 124.555 1.142 . . . . 0.0 109.234 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.29 -39.31 63.86 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.916 1.286 . . . . 0.0 113.419 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -73.82 -49.43 25.25 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.8 -42.65 68.6 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -51.16 -52.68 41.77 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 112.466 -2.152 . . . . 0.0 111.28 173.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -71.43 -25.37 62.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 111.061 -2.791 . . . . 0.0 117.723 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 30.5 mt -69.09 -41.68 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-O 122.827 1.299 . . . . 0.0 111.858 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -68.48 -44.77 74.04 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 112.966 -1.924 . . . . 0.0 111.225 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -69.85 65.6 0.23 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 128.706 2.802 . . . . 0.0 113.36 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -49.38 -53.64 21.44 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 109.904 -3.317 . . . . 0.0 114.071 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -85.35 17.92 2.9 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 53.68 33.79 17.42 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 162.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -93.75 1.75 56.43 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.77 28.72 73.9 Favored Glycine 0 N--CA 1.486 1.993 0 C-N-CA 123.906 0.765 . . . . 0.0 112.674 -169.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -143.76 176.64 9.09 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.502 1.121 . . . . 0.0 111.877 -175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 30.4 mm -123.38 128.41 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 168.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.38 173.36 7.01 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 168.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.4 tp -49.98 -49.98 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 -173.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.95 -38.35 90.69 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -61.83 -42.25 98.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.714 -2.039 . . . . 0.0 113.613 171.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 47.9 tp -54.89 -40.57 69.9 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 167.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.23 -47.42 68.01 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 124.354 0.978 . . . . 0.0 112.485 170.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.09 -35.1 66.63 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 175.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 17.2 mt -71.84 -59.33 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 -177.236 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.852 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -65.47 -47.62 75.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 114.395 1.258 . . . . 0.0 114.395 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.75 -46.17 67.38 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -55.14 -49.37 71.97 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.772 175.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -67.41 -35.61 79.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 111.855 -2.43 . . . . 0.0 117.297 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 38.2 mt -60.62 -51.87 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 123.496 1.617 . . . . 0.0 110.111 175.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -76.77 -36.19 57.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 111.061 -2.79 . . . . 0.0 115.272 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -78.36 53.18 1.23 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.986 2.114 . . . . 0.0 112.672 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -48.55 -54.11 15.71 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 111.174 -2.739 . . . . 0.0 114.396 -173.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -82.19 12.69 4.05 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 53.93 32.65 15.68 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 170.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -82.92 0.73 42.99 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 112.769 -2.014 . . . . 0.0 112.874 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.02 18.81 60.58 Favored Glycine 0 N--CA 1.484 1.894 0 C-N-CA 125.562 1.553 . . . . 0.0 112.295 -172.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -132.1 163.43 28.5 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.872 1.269 . . . . 0.0 109.365 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.5 mt -116.31 133.33 63.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 123.732 0.813 . . . . 0.0 109.887 170.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.24 175.96 5.35 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.058 174.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.8 tp -49.48 -45.35 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 118.132 2.641 . . . . 0.0 118.132 -174.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -66.85 -46.79 73.94 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.664 1.221 . . . . 0.0 114.252 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -56.63 -44.17 80.96 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 111.517 -2.583 . . . . 0.0 111.185 171.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tp -63.99 -47.22 81.21 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.723 1.209 . . . . 0.0 112.509 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.98 -45.67 50.58 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.606 1.098 . . . . 0.0 111.735 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -54.25 -50.57 66.91 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.3 mt -59.76 -48.55 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 123.22 0.608 . . . . 0.0 109.582 175.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 21.2 mt . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.15 -40.19 61.06 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.773 1.229 . . . . 0.0 113.05 174.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -71.51 -49.36 41.81 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.16 -35.9 67.72 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 173.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -56.24 -51.72 67.06 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.572 1.949 . . . . 0.0 110.969 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -63.62 -30.43 71.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 112.429 -2.168 . . . . 0.0 116.13 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 37.6 mm -62.53 -46.31 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 123.67 1.7 . . . . 0.0 111.279 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -78.33 -39.97 37.95 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 128.368 2.667 . . . . 0.0 112.795 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -75.69 64.61 1.74 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.415 2.286 . . . . 0.0 109.717 174.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -39.96 -51.0 2.53 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 110.862 -2.881 . . . . 0.0 114.158 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -77.79 -17.2 57.74 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 62.96 54.9 2.09 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.441 2.296 . . . . 0.0 113.724 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 31.2 p30 -88.74 -18.43 27.83 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 116.582 2.067 . . . . 0.0 116.582 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.52 15.18 44.57 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 124.44 1.019 . . . . 0.0 113.286 -170.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -149.38 168.87 22.2 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.348 1.059 . . . . 0.0 110.93 -171.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 28.2 mm -118.29 132.37 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.776 169.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.71 173.73 6.19 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.125 -1.398 . . . . 0.0 114.627 171.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 tp -48.57 -48.48 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 -170.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . 0.254 0.0 OUTLIER -67.02 -40.79 87.32 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 177.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -61.34 -43.95 98.02 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 112.35 -2.205 . . . . 0.0 111.224 170.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.1 -43.21 99.24 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 169.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -45.02 -54.54 6.9 Favored Glycine 0 N--CA 1.479 1.538 0 C-N-CA 124.134 0.873 . . . . 0.0 112.823 169.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -53.44 -52.02 60.78 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 112.295 -1.952 . . . . 0.0 113.195 171.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 49.6 mt -54.82 -50.68 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.41 0.684 . . . . 0.0 110.093 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.467 0.4 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -60.66 -52.79 63.65 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 117.928 -1.034 . . . . 0.0 113.459 169.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.34 -45.11 24.44 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -52.58 -53.88 40.52 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.061 -1.882 . . . . 0.0 111.254 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -66.99 -30.72 70.92 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 111.649 -2.523 . . . . 0.0 117.095 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 35.1 mm -65.83 -44.97 92.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 122.912 1.339 . . . . 0.0 111.009 176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -70.61 -44.88 66.35 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 112.201 -2.272 . . . . 0.0 111.908 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -73.25 52.54 0.36 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 128.294 2.638 . . . . 0.0 113.27 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.68 -42.59 64.9 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 113.563 -1.653 . . . . 0.0 115.066 174.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -79.06 12.8 2.05 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 116.909 2.188 . . . . 0.0 116.909 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 57.72 24.93 11.19 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 119.686 3.217 . . . . 0.0 119.686 161.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -93.19 4.0 54.73 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -175.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.38 25.83 70.23 Favored Glycine 0 CA--C 1.54 1.634 0 O-C-N 123.695 0.622 . . . . 0.0 112.694 -170.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -139.85 167.12 22.85 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.676 1.19 . . . . 0.0 112.321 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -117.79 127.76 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-N 112.495 -2.139 . . . . 0.0 109.818 170.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.57 177.31 4.88 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 113.195 -1.821 . . . . 0.0 113.471 172.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.6 tp -48.47 -47.63 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -66.26 -38.57 88.16 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -67.05 -40.28 87.1 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 127.027 2.131 . . . . 0.0 113.119 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.1 tp -64.8 -41.75 95.55 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.569 168.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.36 -29.07 59.93 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 124.635 1.112 . . . . 0.0 114.331 170.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -73.13 -39.05 66.04 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 169.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.4 mt -62.67 -71.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 168.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 C--O 1.239 0.527 0 CA-C-O 124.922 2.296 . . . . 0.0 112.576 174.827 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.549 0.904 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.57 -50.93 30.25 Favored 'General case' 0 CA--C 1.554 1.123 0 O-C-N 125.386 1.679 . . . . 0.0 113.063 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -63.9 -48.72 75.52 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 175.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.48 -40.87 65.68 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -52.63 -55.27 23.57 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 112.926 -1.943 . . . . 0.0 112.411 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -68.54 -20.34 64.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 110.108 -3.224 . . . . 0.0 115.962 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 51.8 mt -69.35 -52.37 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 122.856 1.312 . . . . 0.0 112.12 174.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -63.63 -35.57 80.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 112.049 -2.341 . . . . 0.0 114.317 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -65.85 46.21 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 128.961 2.904 . . . . 0.0 114.842 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -53.65 -41.68 67.03 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.903 2.081 . . . . 0.0 115.666 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -80.52 14.65 1.95 Allowed 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 56.58 23.17 7.38 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 119.757 3.243 . . . . 0.0 119.757 161.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -88.41 -8.71 54.54 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 113.096 -1.865 . . . . 0.0 115.61 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.86 27.38 73.24 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 123.953 0.787 . . . . 0.0 112.09 -167.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -140.95 170.81 15.03 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.356 1.462 . . . . 0.0 109.409 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -118.72 140.25 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.204 169.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.43 -176.41 2.91 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.036 0.934 . . . . 0.0 112.506 172.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 tp -53.57 -40.49 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -65.01 -46.58 80.75 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 122.548 1.166 . . . . 0.0 113.638 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -62.94 -44.44 96.07 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 112.06 -2.336 . . . . 0.0 112.424 173.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.82 -40.42 84.08 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.53 1.132 . . . . 0.0 111.706 170.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.67 -49.26 62.08 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 124.492 1.044 . . . . 0.0 111.847 172.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.08 -37.17 73.97 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 21.2 mt -70.99 -59.41 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.269 1.028 . . . . 0.0 109.392 175.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 mp . . . . . 0 CA--C 1.543 0.69 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 -170.59 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -71.97 -49.59 35.96 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.902 1.281 . . . . 0.0 113.838 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.89 -39.49 26.17 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -51.98 -56.29 15.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.541 173.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.36 -35.12 77.25 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 110.721 -2.945 . . . . 0.0 116.451 -177.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 53.5 mt -56.3 -58.58 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 112.975 -1.921 . . . . 0.0 111.267 175.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -67.59 -39.03 84.82 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 111.803 -2.453 . . . . 0.0 113.268 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -77.38 61.12 2.14 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 127.13 2.172 . . . . 0.0 110.07 170.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -49.5 -41.69 41.5 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 112.667 -2.06 . . . . 0.0 115.094 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 44.5 p30 -72.49 -19.43 61.54 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 64.99 55.01 1.19 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 127.194 2.197 . . . . 0.0 114.433 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -104.14 0.24 29.37 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.55 17.78 79.62 Favored Glycine 0 N--CA 1.478 1.472 0 N-CA-C 114.987 0.755 . . . . 0.0 114.987 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -133.96 164.57 27.01 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.595 1.188 . . . . 0.0 109.176 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . 0.25 5.2 mt -124.08 121.06 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 113.121 -1.854 . . . . 0.0 109.163 165.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.7 173.67 7.36 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.514 -1.676 . . . . 0.0 114.256 171.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.0 tp -48.33 -47.71 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 -171.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.43 -38.67 87.99 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 175.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -69.41 -43.2 73.9 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 111.836 -2.438 . . . . 0.0 112.776 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.9 tp -68.18 -36.0 78.91 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 124.165 0.916 . . . . 0.0 111.756 170.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -47.79 -55.31 9.9 Favored Glycine 0 N--CA 1.477 1.427 0 C-N-CA 124.305 0.955 . . . . 0.0 112.087 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -62.41 -24.51 67.44 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.3 mt -72.55 -75.59 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 165.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 118.553 2.797 . . . . 0.0 118.553 -163.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 30.6 tp . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.27 -62.56 1.57 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.876 1.27 . . . . 0.0 111.102 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . 0.551 ' ND2' ' H ' ' B' ' 8' ' ' ASN . 5.6 m-80 -46.33 -53.12 11.44 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 167.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.52 -40.68 62.71 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 176.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -57.98 -48.85 78.77 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.866 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.89 -24.28 61.63 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 41.3 mm -70.23 -52.0 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 113.67 -1.605 . . . . 0.0 112.283 171.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -71.35 -36.3 71.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 112.63 -2.077 . . . . 0.0 114.918 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -80.38 68.14 6.46 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 127.099 2.16 . . . . 0.0 110.033 171.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -44.12 -55.41 4.77 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 111.69 -2.504 . . . . 0.0 113.724 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -85.33 16.19 3.85 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 50.82 42.15 27.41 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 166.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 38.8 p30 -98.65 3.52 47.82 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.06 -1.882 . . . . 0.0 114.486 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.07 23.63 69.76 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.442 1.496 . . . . 0.0 114.073 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -137.46 171.58 14.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.033 0.933 . . . . 0.0 111.563 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.21 133.52 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.635 163.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.35 172.92 6.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 169.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . 0.264 9.0 tp -43.16 -35.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -170.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . 0.303 0.0 OUTLIER -74.5 -44.03 53.26 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 174.252 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -58.03 -46.23 85.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 128.074 2.55 . . . . 0.0 110.404 169.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -68.32 -38.58 81.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.675 1.59 . . . . 0.0 112.425 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.19 -62.44 5.7 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 125.745 1.64 . . . . 0.0 110.953 170.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -47.98 -41.14 24.42 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 12.2 mt -66.23 -72.36 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 172.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mt . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 119.124 3.009 . . . . 0.0 119.124 -168.575 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . 0.761 . . . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 119.812 3.264 . . . . 0.0 119.812 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -56.11 -45.8 79.34 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 111.038 -2.801 . . . . 0.0 112.293 169.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.36 -37.98 62.9 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 169.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -53.47 -51.37 62.93 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 112.781 -2.009 . . . . 0.0 112.056 173.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -66.85 -42.68 85.33 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 111.759 -2.473 . . . . 0.0 115.303 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 44.0 mt -60.43 -42.91 92.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.331 -1.758 . . . . 0.0 112.168 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -78.88 -32.48 45.91 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 111.969 -2.378 . . . . 0.0 115.388 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -69.45 52.27 0.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.725 2.01 . . . . 0.0 113.325 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.1 mttm -49.55 -52.54 29.25 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 112.222 -2.263 . . . . 0.0 112.219 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -85.21 20.26 2.0 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 52.83 34.93 17.52 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 163.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -96.09 -3.1 45.28 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.95 31.72 81.78 Favored Glycine 0 CA--C 1.538 1.471 0 O-C-N 124.164 0.915 . . . . 0.0 112.107 -168.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -146.7 169.69 18.52 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.563 1.145 . . . . 0.0 110.456 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 mp -120.33 128.02 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.647 169.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.19 172.93 6.56 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.929 -1.487 . . . . 0.0 114.752 178.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.284 10.0 tt -52.47 -44.06 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 -171.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -43.52 82.33 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 175.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -56.59 -43.79 80.42 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.205 1.802 . . . . 0.0 110.917 169.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 tp -59.96 -44.67 94.28 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.67 -55.81 21.18 Favored Glycine 0 N--CA 1.48 1.613 0 O-C-N 124.057 0.848 . . . . 0.0 111.965 170.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -55.9 -41.65 74.84 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.6 pp -72.96 -42.12 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.377 0.671 . . . . 0.0 110.573 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.3 mt . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 176.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 20.6 tp . . . . . 0 CA--C 1.542 0.64 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.55 -41.59 66.61 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.275 1.03 . . . . 0.0 113.056 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -66.34 -45.5 80.0 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 174.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.03 -36.21 65.27 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -56.69 -58.76 6.71 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.881 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -68.12 -18.83 64.74 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 111.657 -2.52 . . . . 0.0 116.739 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 55.4 mt -72.86 -49.19 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 114.319 -1.31 . . . . 0.0 112.809 171.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -77.03 -36.93 55.79 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 112.823 -1.99 . . . . 0.0 113.9 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -72.8 51.92 0.29 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 128.093 2.557 . . . . 0.0 110.501 169.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -47.33 -47.53 25.7 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 112.34 -2.209 . . . . 0.0 112.93 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -85.27 19.86 2.14 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 52.29 31.27 9.09 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 163.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -98.4 8.62 44.61 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.491 1.664 . . . . 0.0 115.491 -174.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.92 19.8 63.75 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.419 1.009 . . . . 0.0 113.413 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -136.57 169.53 17.55 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.676 1.19 . . . . 0.0 109.209 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 8.3 mt -123.07 127.02 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 113.73 -1.577 . . . . 0.0 107.241 162.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.88 176.19 5.22 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 113.269 -1.787 . . . . 0.0 113.521 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . 0.303 5.9 tp -49.08 -54.37 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 113.056 -1.884 . . . . 0.0 116.035 -174.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.91 -41.5 95.53 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -174.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -51.63 -59.72 3.96 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 110.998 -2.819 . . . . 0.0 110.721 164.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.16 -37.81 86.58 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 117.513 -1.232 . . . . 0.0 114.243 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.29 -56.44 17.19 Favored Glycine 0 N--CA 1.482 1.747 0 CA-C-N 118.951 0.796 . . . . 0.0 112.273 166.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -56.62 -42.68 79.23 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 32.9 mt -58.86 -76.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 173.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 125.94 2.781 . . . . 0.0 115.346 -178.936 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 116.52 2.045 . . . . 0.0 116.52 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -53.18 -47.88 68.48 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 174.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.47 -40.2 71.34 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -57.47 -50.98 71.28 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.254 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -63.06 -35.16 79.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 112.496 -2.138 . . . . 0.0 114.267 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 56.7 mt -61.16 -43.29 96.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 113.039 -1.891 . . . . 0.0 112.191 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -77.02 -40.82 45.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.833 2.053 . . . . 0.0 114.929 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -69.2 51.72 0.09 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 128.535 2.734 . . . . 0.0 114.738 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -44.44 -59.09 2.59 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 112.221 -2.263 . . . . 0.0 113.804 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -80.29 24.44 0.44 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 -176.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 50.75 33.98 9.29 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 161.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -100.07 4.56 44.72 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 112.927 -1.942 . . . . 0.0 114.181 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.26 26.11 63.43 Favored Glycine 0 N--CA 1.479 1.529 0 C-N-CA 124.772 1.177 . . . . 0.0 112.382 -171.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -139.02 167.03 22.96 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.572 1.149 . . . . 0.0 110.296 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -112.68 127.33 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.036 168.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.08 179.27 4.67 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.384 169.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.277 5.0 tt -55.14 -40.56 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 117.071 2.248 . . . . 0.0 117.071 -171.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -67.65 -39.54 84.56 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -65.27 -43.21 91.95 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 127.208 2.203 . . . . 0.0 111.979 174.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tp -61.58 -45.38 94.35 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.561 0.744 . . . . 0.0 111.191 168.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -47.01 -50.24 16.03 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 125.684 1.611 . . . . 0.0 112.404 170.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -52.86 -52.35 57.66 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.691 0.796 . . . . 0.0 112.55 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.8 mt -58.17 -50.45 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 123.881 0.872 . . . . 0.0 109.362 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 CA--C 1.544 0.717 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -178.217 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.7 mt . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.72 -57.11 6.81 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.584 1.153 . . . . 0.0 112.113 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . 0.277 13.5 m-80 -85.26 149.67 25.32 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 147.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.87 4.34 4.26 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 118.849 2.907 . . . . 0.0 118.849 -13.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -49.93 -53.26 27.28 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.218 1.009 . . . . 0.0 112.662 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -31.17 72.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 110.863 -2.88 . . . . 0.0 114.623 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 22.0 mt -69.51 -39.54 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.897 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -74.18 -39.96 62.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 112.513 -2.131 . . . . 0.0 113.066 171.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -70.13 47.91 0.09 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 128.682 2.793 . . . . 0.0 114.099 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -46.04 -47.09 17.03 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 113.375 -1.739 . . . . 0.0 114.126 175.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -82.15 27.99 0.46 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 51.71 34.74 13.52 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 118.077 2.621 . . . . 0.0 118.077 156.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -107.9 -1.32 20.83 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.03 28.9 74.04 Favored Glycine 0 N--CA 1.475 1.241 0 C-N-CA 123.617 0.627 . . . . 0.0 112.678 -170.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -142.35 168.31 20.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.209 1.003 . . . . 0.0 111.065 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -117.11 129.76 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.492 1.517 . . . . 0.0 109.956 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.93 176.85 5.07 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.056 -1.429 . . . . 0.0 113.674 172.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.9 tp -48.56 -48.86 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -67.23 -41.05 86.33 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -59.33 -42.41 91.41 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 112.477 -2.147 . . . . 0.0 112.306 171.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 tp -64.2 -43.99 93.36 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.007 0.523 . . . . 0.0 111.804 172.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.08 -45.67 56.68 Favored Glycine 0 N--CA 1.483 1.806 0 C-N-CA 124.093 0.854 . . . . 0.0 112.453 170.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -56.88 -38.04 72.2 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.909 1.283 . . . . 0.0 113.647 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 12.8 mt -69.58 -63.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 118.34 2.719 . . . . 0.0 118.34 -173.72 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.436 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -44.47 -76.8 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.147 1 C-N-CA 139.926 7.29 . . . . 0.0 112.793 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m -49.38 -47.29 47.79 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.522 1.929 . . . . 0.0 113.978 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -63.32 -50.13 71.24 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.053 0.941 . . . . 0.0 111.585 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -58.85 -51.2 71.03 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.504 1.122 . . . . 0.0 111.494 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -49.93 -48.82 51.58 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.991 1.316 . . . . 0.0 112.362 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 29.3 tp -53.8 -55.43 26.62 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.31 -39.64 60.85 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -69.26 -55.48 10.41 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.418 1.087 . . . . 0.0 113.9 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.13 -9.95 36.24 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -72.86 -68.0 0.52 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.13 161.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -65.31 -25.34 67.58 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 118.625 2.824 . . . . 0.0 118.625 -169.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 56.3 mt -66.43 -49.94 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-O 123.445 1.593 . . . . 0.0 112.648 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -81.21 -38.06 27.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 111.618 -2.537 . . . . 0.0 113.699 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.63 86.15 6.88 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 127.953 2.501 . . . . 0.0 113.104 -171.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -62.89 -71.67 0.16 Allowed 'General case' 0 N--CA 1.485 1.285 1 CA-C-N 107.405 -4.452 . . . . 0.0 114.518 171.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -85.84 133.39 33.97 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -174.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 41.9 43.76 2.7 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 124.755 2.217 . . . . 0.0 116.583 164.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.49 ' CA ' ' H ' ' A' ' 20' ' ' TYR 0.577 1.5 p30 -94.73 67.28 3.24 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 109.895 -3.321 . . . . 0.0 119.612 -172.024 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.47 -4.44 89.29 Favored Glycine 0 CA--C 1.556 2.623 1 CA-C-N 94.818 -10.174 . . . . 0.0 116.41 112.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.49 ' H ' ' CA ' ' A' ' 18' ' ' ASP . 17.3 m-85 -137.99 157.26 46.73 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.14 142.97 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 129.576 3.15 . . . . 0.0 109.879 172.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.29 -176.56 2.93 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.93 1.292 . . . . 0.0 112.87 173.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 tp -52.61 -45.87 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 117.503 2.409 . . . . 0.0 117.503 -175.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -66.78 -43.31 84.31 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -62.79 -40.78 98.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 111.983 -2.371 . . . . 0.0 112.392 172.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 tp -59.45 -48.08 83.01 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.32 1.048 . . . . 0.0 111.554 170.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.73 -50.39 31.67 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.315 0.96 . . . . 0.0 111.652 171.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -54.84 -43.83 73.37 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 8.5 mt -61.46 -47.77 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.029 0.532 . . . . 0.0 110.198 175.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 mp -55.27 -43.92 75.15 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 67.8 mtt180 -59.62 -39.76 85.35 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.425 -1.261 . . . . 0.0 112.859 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.38 -43.45 81.34 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.4 p -101.65 -45.02 5.39 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 116.315 1.968 . . . . 0.0 116.315 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.57 -77.98 0.13 Allowed Glycine 0 N--CA 1.487 2.069 0 CA-C-O 123.116 1.398 . . . . 0.0 113.048 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' NH2 . . . . . 0.642 ' N ' ' H ' ' B' ' 33' ' ' THR . . . . . . . . 0 C--N 1.31 -1.15 0 O-C-N 120.422 -1.634 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.211 -0.935 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -57.92 125.26 22.33 Favored 'General case' 0 C--N 1.306 -1.321 1 C-N-CA 135.933 5.693 . . . . 0.0 113.403 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 81.6 p -156.52 161.56 40.0 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 112.477 -2.147 . . . . 0.0 108.703 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -50.06 -43.94 51.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 123.799 0.687 . . . . 0.0 112.329 171.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -58.31 -51.08 71.29 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.158 1.383 . . . . 0.0 112.688 175.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.43 -42.34 98.6 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 6.1 tp -65.33 -33.32 75.7 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.77 -47.07 59.74 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.824 1.25 . . . . 0.0 112.241 171.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -60.31 -49.95 75.56 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 171.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.79 -41.28 63.98 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 174.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 20.5 t80 -57.31 -47.96 80.16 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.054 -1.885 . . . . 0.0 111.932 174.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -38.52 91.37 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 112.179 -2.282 . . . . 0.0 114.915 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 46.7 mt -61.94 -41.98 92.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 112.985 -1.916 . . . . 0.0 113.016 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -77.99 -38.69 44.44 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 112.339 -2.21 . . . . 0.0 114.802 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -75.13 59.4 0.97 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.489 2.315 . . . . 0.0 111.299 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -46.75 -50.1 18.64 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 111.864 -2.425 . . . . 0.0 114.627 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -84.71 16.82 3.04 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 54.16 28.95 9.67 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 117.869 2.544 . . . . 0.0 117.869 166.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -89.28 4.59 48.26 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 -174.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.32 21.84 66.78 Favored Glycine 0 CA--C 1.546 2.029 0 C-N-CA 124.829 1.204 . . . . 0.0 113.758 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -140.54 172.25 12.98 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.285 1.434 . . . . 0.0 108.931 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -124.21 146.08 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-N 114.427 -1.261 . . . . 0.0 108.512 161.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.57 178.53 4.43 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.594 1.158 . . . . 0.0 114.059 175.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.2 tp -44.43 -45.46 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 118.671 2.841 . . . . 0.0 118.671 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -73.13 -46.76 49.23 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 65.3 mt-10 -51.65 -40.84 60.73 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 112.117 -2.311 . . . . 0.0 112.559 167.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 tp -54.93 -40.36 69.81 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 173.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.7 -52.12 21.25 Favored Glycine 0 N--CA 1.477 1.372 0 C-N-CA 124.717 1.151 . . . . 0.0 112.951 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -55.3 -44.59 75.91 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 113.93 -1.135 . . . . 0.0 113.025 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 13.2 mt -65.59 -48.91 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.735 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 77.5 mt -54.46 -41.36 69.37 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 46.2 mmt-85 -59.48 -34.21 72.28 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.08 -1.418 . . . . 0.0 112.514 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.76 126.32 33.31 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' THR . . . . . 0.642 ' H ' ' N ' ' A' ' 35' ' ' NH2 . 1.7 p -118.17 91.72 3.64 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.876 2.47 . . . . 0.0 109.895 -10.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.52 -149.55 5.29 Favored Glycine 0 N--CA 1.481 1.672 0 CA-C-N 113.599 -1.637 . . . . 0.0 113.222 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.074 0 O-C-N 119.946 -1.914 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.209 -1.029 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -75.75 131.6 39.92 Favored 'General case' 0 C--N 1.31 -1.121 1 C-N-CA 135.469 5.508 . . . . 0.0 113.529 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.8 m -61.43 153.37 27.23 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.257 1.023 . . . . 0.0 112.551 173.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 75.44 -41.72 0.45 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 126.492 1.917 . . . . 0.0 112.19 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.0 -51.61 63.45 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.702 1.201 . . . . 0.0 109.17 160.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -84.65 134.67 34.36 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.216 1.406 . . . . 0.0 110.089 162.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.0 mt -78.43 -18.01 55.55 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 120.587 3.551 . . . . 0.0 120.587 6.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -41.88 -49.3 4.5 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -172.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -69.48 -44.45 71.13 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.286 1.588 . . . . 0.0 115.286 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.07 -42.73 77.12 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -53.77 -51.85 62.09 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 112.525 -2.125 . . . . 0.0 111.617 174.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -73.84 -18.57 60.92 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 111.228 -2.715 . . . . 0.0 116.551 -177.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . 0.274 60.7 mt -70.97 -48.99 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.52 170.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -67.72 -44.26 78.05 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 112.508 -2.133 . . . . 0.0 111.645 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -67.07 62.64 0.05 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 127.72 2.408 . . . . 0.0 112.484 177.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -62.12 -37.48 85.3 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 110.692 -2.958 . . . . 0.0 115.293 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -79.27 -2.53 41.71 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.85 37.99 21.52 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.353 1.861 . . . . 0.0 115.944 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.0 p-10 -87.95 -9.72 52.7 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.96 26.91 71.5 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.182 0.896 . . . . 0.0 113.012 -167.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -145.91 178.85 7.87 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.265 1.426 . . . . 0.0 109.614 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 15.2 mt -128.73 138.53 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 C-N-CA 125.615 1.566 . . . . 0.0 109.29 167.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.7 176.42 5.06 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.344 1.858 . . . . 0.0 115.836 173.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 tp -43.62 -49.81 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 117.645 2.461 . . . . 0.0 117.645 -171.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -38.4 85.73 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -68.72 -38.71 80.41 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 128.487 2.715 . . . . 0.0 113.276 171.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.6 tp -56.13 -41.85 75.97 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.062 165.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.48 -50.9 6.72 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 125.345 1.45 . . . . 0.0 112.68 167.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -51.45 -53.19 39.57 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 172.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 mt -63.34 -44.38 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 124.555 1.142 . . . . 0.0 109.234 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.01 -9.72 32.96 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 177.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 -78.98 89.07 4.74 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.295 0.569 . . . . 0.0 109.65 174.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.74 83.38 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 112.94 -1.936 . . . . 0.0 112.311 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.2 p -77.15 69.22 3.4 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 113.528 -1.669 . . . . 0.0 112.541 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -141.37 -107.88 0.69 Allowed Glycine 0 N--CA 1.482 1.703 0 CA-C-N 112.333 -2.212 . . . . 0.0 109.661 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.737 0 O-C-N 119.994 -1.886 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.682 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -42.08 126.95 3.39 Favored 'General case' 0 C--N 1.304 -1.377 1 C-N-CA 134.92 5.288 . . . . 0.0 111.635 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 34.8 t -138.17 143.88 40.46 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.038 177.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -40.39 -52.56 2.72 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.738 1.215 . . . . 0.0 114.151 168.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -60.04 -44.06 94.92 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.938 0.895 . . . . 0.0 112.16 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -53.37 -57.38 10.8 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.831 1.252 . . . . 0.0 111.04 170.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.96 -40.93 73.96 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 176.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.29 -39.31 63.86 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.916 1.286 . . . . 0.0 113.419 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -73.82 -49.43 25.25 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.8 -42.65 68.6 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -51.16 -52.68 41.77 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 112.466 -2.152 . . . . 0.0 111.28 173.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 8.3 mmt180 -71.43 -25.37 62.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 111.061 -2.791 . . . . 0.0 117.723 -177.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 30.5 mt -69.09 -41.68 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-O 122.827 1.299 . . . . 0.0 111.858 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -68.48 -44.77 74.04 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 112.966 -1.924 . . . . 0.0 111.225 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -69.85 65.6 0.23 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 128.706 2.802 . . . . 0.0 113.36 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 63.3 mttp -49.38 -53.64 21.44 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 109.904 -3.317 . . . . 0.0 114.071 174.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -85.35 17.92 2.9 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 53.68 33.79 17.42 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 162.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -93.75 1.75 56.43 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.77 28.72 73.9 Favored Glycine 0 N--CA 1.486 1.993 0 C-N-CA 123.906 0.765 . . . . 0.0 112.674 -169.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -143.76 176.64 9.09 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.502 1.121 . . . . 0.0 111.877 -175.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 30.4 mm -123.38 128.41 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 168.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.38 173.36 7.01 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 168.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.4 tp -49.98 -49.98 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 -173.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.95 -38.35 90.69 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 62.7 mt-10 -61.83 -42.25 98.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.714 -2.039 . . . . 0.0 113.613 171.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 47.9 tp -54.89 -40.57 69.9 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 167.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.23 -47.42 68.01 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 124.354 0.978 . . . . 0.0 112.485 170.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.09 -35.1 66.63 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 175.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 17.2 mt -71.84 -59.33 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 66.5 mt -63.53 -10.35 17.54 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 65.2 mtt180 -40.64 -45.63 2.39 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 126.005 1.722 . . . . 0.0 115.313 172.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.77 -41.17 68.69 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 2.2 p -78.39 28.75 0.19 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -175.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.69 -116.68 4.92 Favored Glycine 0 N--CA 1.48 1.593 0 CA-C-O 122.489 1.05 . . . . 0.0 113.236 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.128 0 O-C-N 119.861 -1.964 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.2 -1.517 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -66.74 161.46 23.54 Favored 'General case' 0 C--N 1.308 -1.22 1 C-N-CA 139.701 7.2 . . . . 0.0 112.817 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 t 57.35 -149.6 0.46 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.151 1.781 . . . . 0.0 112.397 173.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -54.12 -25.74 23.76 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -64.34 -32.74 74.47 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -54.21 -37.54 64.69 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.802 0.841 . . . . 0.0 112.218 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 tp -59.37 -50.56 73.48 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.174 1.39 . . . . 0.0 114.063 174.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.89 -48.05 70.48 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.674 1.19 . . . . 0.0 111.965 176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -65.47 -47.62 75.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 114.395 1.258 . . . . 0.0 114.395 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.75 -46.17 67.38 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -55.14 -49.37 71.97 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.772 175.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -67.41 -35.61 79.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 111.855 -2.43 . . . . 0.0 117.297 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 38.2 mt -60.62 -51.87 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 123.496 1.617 . . . . 0.0 110.111 175.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -76.77 -36.19 57.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 111.061 -2.79 . . . . 0.0 115.272 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -78.36 53.18 1.23 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.986 2.114 . . . . 0.0 112.672 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -48.55 -54.11 15.71 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 111.174 -2.739 . . . . 0.0 114.396 -173.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -82.19 12.69 4.05 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 53.93 32.65 15.68 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 170.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -82.92 0.73 42.99 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 112.769 -2.014 . . . . 0.0 112.874 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.02 18.81 60.58 Favored Glycine 0 N--CA 1.484 1.894 0 C-N-CA 125.562 1.553 . . . . 0.0 112.295 -172.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -132.1 163.43 28.5 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.872 1.269 . . . . 0.0 109.365 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.5 mt -116.31 133.33 63.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 123.732 0.813 . . . . 0.0 109.887 170.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.24 175.96 5.35 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.058 174.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.8 tp -49.48 -45.35 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 118.132 2.641 . . . . 0.0 118.132 -174.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -66.85 -46.79 73.94 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.664 1.221 . . . . 0.0 114.252 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -56.63 -44.17 80.96 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 111.517 -2.583 . . . . 0.0 111.185 171.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tp -63.99 -47.22 81.21 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.723 1.209 . . . . 0.0 112.509 173.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.98 -45.67 50.58 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.606 1.098 . . . . 0.0 111.735 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -54.25 -50.57 66.91 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.3 mt -59.76 -48.55 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 123.22 0.608 . . . . 0.0 109.582 175.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -21.7 60.51 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.549 ' NH1' ' H ' ' A' ' 32' ' ' ALA . 9.5 mmm180 -74.36 158.89 33.15 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.677 1.591 . . . . 0.0 113.408 172.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.549 ' H ' ' NH1' ' A' ' 31' ' ' ARG . . . -61.05 -34.22 74.53 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.812 169.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.2 p -96.0 67.67 2.68 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.248 175.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 178.93 -67.4 0.08 OUTLIER Glycine 0 N--CA 1.48 1.617 0 CA-C-N 113.314 -1.767 . . . . 0.0 110.895 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' NH2 . . . . . 0.423 ' HN2' ' N ' ' B' ' 35' ' ' NH2 . . . . . . . . 0 C--N 1.319 -0.72 0 O-C-N 120.03 -1.865 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.201 -1.462 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -56.95 146.66 26.12 Favored 'General case' 0 N--CA 1.483 1.194 1 C-N-CA 143.011 8.524 . . . . 0.0 112.966 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 59.3 p -101.32 90.12 4.0 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.652 -1.158 . . . . 0.0 107.889 161.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.76 148.0 48.62 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -47.11 -51.22 18.49 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.8 2.04 . . . . 0.0 112.667 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -51.92 -49.98 62.01 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.401 1.081 . . . . 0.0 112.745 176.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 21.2 mt -64.19 -42.33 96.71 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 174.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.15 -40.19 61.06 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.773 1.229 . . . . 0.0 113.05 174.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -71.51 -49.36 41.81 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.16 -35.9 67.72 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 173.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 27.7 t80 -56.24 -51.72 67.06 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.572 1.949 . . . . 0.0 110.969 174.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -63.62 -30.43 71.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 112.429 -2.168 . . . . 0.0 116.13 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 37.6 mm -62.53 -46.31 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 123.67 1.7 . . . . 0.0 111.279 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -78.33 -39.97 37.95 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 128.368 2.667 . . . . 0.0 112.795 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -75.69 64.61 1.74 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.415 2.286 . . . . 0.0 109.717 174.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -39.96 -51.0 2.53 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 110.862 -2.881 . . . . 0.0 114.158 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -77.79 -17.2 57.74 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 62.96 54.9 2.09 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.441 2.296 . . . . 0.0 113.724 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 31.2 p30 -88.74 -18.43 27.83 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 116.582 2.067 . . . . 0.0 116.582 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.52 15.18 44.57 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 124.44 1.019 . . . . 0.0 113.286 -170.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -149.38 168.87 22.2 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.348 1.059 . . . . 0.0 110.93 -171.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 28.2 mm -118.29 132.37 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.776 169.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.71 173.73 6.19 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.125 -1.398 . . . . 0.0 114.627 171.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 tp -48.57 -48.48 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 -170.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . 0.254 0.0 OUTLIER -67.02 -40.79 87.32 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 177.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 88.2 mt-10 -61.34 -43.95 98.02 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 112.35 -2.205 . . . . 0.0 111.224 170.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.1 -43.21 99.24 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 169.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -45.02 -54.54 6.9 Favored Glycine 0 N--CA 1.479 1.538 0 C-N-CA 124.134 0.873 . . . . 0.0 112.823 169.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -53.44 -52.02 60.78 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 112.295 -1.952 . . . . 0.0 113.195 171.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 49.6 mt -54.82 -50.68 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.41 0.684 . . . . 0.0 110.093 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.15 -25.97 65.92 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -177.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -56.93 -46.46 82.04 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.094 0.871 . . . . 0.0 113.256 171.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.89 -57.36 3.14 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 27.2 p -118.55 95.83 5.02 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.66 1.184 . . . . 0.0 109.816 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.92 110.92 3.5 Favored Glycine 0 N--CA 1.485 1.928 0 CA-C-N 113.842 -1.526 . . . . 0.0 111.683 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' NH2 . . . . . 0.423 ' N ' ' HN2' ' A' ' 35' ' ' NH2 . . . . . . . . 0 C--N 1.316 -0.867 0 O-C-N 120.805 -1.409 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.506 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.33 87.74 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.468 1 C-N-CA 139.033 6.933 . . . . 0.0 113.381 . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.2 p -67.48 -29.76 69.28 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.243 -1.344 . . . . 0.0 113.847 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 60.89 -60.43 0.08 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 126.486 1.914 . . . . 0.0 112.87 -165.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -60.94 -53.94 51.16 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.32 -31.26 69.61 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.8 tp -58.41 -43.33 88.57 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.136 1.374 . . . . 0.0 113.242 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.79 -47.05 71.16 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.255 1.022 . . . . 0.0 112.86 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -60.66 -52.79 63.65 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 117.928 -1.034 . . . . 0.0 113.459 169.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.34 -45.11 24.44 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -52.58 -53.88 40.52 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.061 -1.882 . . . . 0.0 111.254 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -66.99 -30.72 70.92 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 111.649 -2.523 . . . . 0.0 117.095 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 35.1 mm -65.83 -44.97 92.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 122.912 1.339 . . . . 0.0 111.009 176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -70.61 -44.88 66.35 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 112.201 -2.272 . . . . 0.0 111.908 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -73.25 52.54 0.36 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 128.294 2.638 . . . . 0.0 113.27 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.68 -42.59 64.9 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 113.563 -1.653 . . . . 0.0 115.066 174.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -79.06 12.8 2.05 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 116.909 2.188 . . . . 0.0 116.909 176.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 57.72 24.93 11.19 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 119.686 3.217 . . . . 0.0 119.686 161.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -93.19 4.0 54.73 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -175.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.38 25.83 70.23 Favored Glycine 0 CA--C 1.54 1.634 0 O-C-N 123.695 0.622 . . . . 0.0 112.694 -170.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -139.85 167.12 22.85 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.676 1.19 . . . . 0.0 112.321 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -117.79 127.76 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-N 112.495 -2.139 . . . . 0.0 109.818 170.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.57 177.31 4.88 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 113.195 -1.821 . . . . 0.0 113.471 172.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.6 tp -48.47 -47.63 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -66.26 -38.57 88.16 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -67.05 -40.28 87.1 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 127.027 2.131 . . . . 0.0 113.119 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.1 tp -64.8 -41.75 95.55 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.569 168.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.36 -29.07 59.93 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 124.635 1.112 . . . . 0.0 114.331 170.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -73.13 -39.05 66.04 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 169.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 23.4 mt -62.67 -71.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 168.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.5 mt -85.25 71.02 10.91 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 124.922 2.296 . . . . 0.0 112.576 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -59.08 -37.81 77.97 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 109.039 -3.71 . . . . 0.0 113.738 -178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.62 88.94 0.97 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 122.814 1.292 . . . . 0.0 110.312 174.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.5 p -65.14 135.27 55.3 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 113.458 -1.701 . . . . 0.0 113.146 -170.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -80.14 81.51 1.52 Allowed Glycine 0 CA--C 1.533 1.167 0 CA-C-N 113.174 -1.83 . . . . 0.0 113.591 -173.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.793 0 O-C-N 121.496 -1.002 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.663 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 22.2 tttp -67.4 -50.55 59.06 Favored 'General case' 0 C--N 1.304 -1.388 1 C-N-CA 137.005 6.122 . . . . 0.0 111.506 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 14.2 p -61.25 -46.46 90.3 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 112.45 -2.159 . . . . 0.0 113.575 174.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.83 -3.75 36.86 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 175.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -53.99 -53.94 45.94 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -167.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -70.01 -32.2 70.25 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.72 -43.02 68.71 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.948 1.299 . . . . 0.0 112.968 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.57 -50.93 30.25 Favored 'General case' 0 CA--C 1.554 1.123 0 O-C-N 125.386 1.679 . . . . 0.0 113.063 176.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -63.9 -48.72 75.52 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 175.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.48 -40.87 65.68 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 176.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -52.63 -55.27 23.57 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 112.926 -1.943 . . . . 0.0 112.411 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -68.54 -20.34 64.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 110.108 -3.224 . . . . 0.0 115.962 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 51.8 mt -69.35 -52.37 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 122.856 1.312 . . . . 0.0 112.12 174.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -63.63 -35.57 80.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 112.049 -2.341 . . . . 0.0 114.317 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -65.85 46.21 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 128.961 2.904 . . . . 0.0 114.842 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -53.65 -41.68 67.03 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.903 2.081 . . . . 0.0 115.666 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -80.52 14.65 1.95 Allowed 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 56.58 23.17 7.38 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 119.757 3.243 . . . . 0.0 119.757 161.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -88.41 -8.71 54.54 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 113.096 -1.865 . . . . 0.0 115.61 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.86 27.38 73.24 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 123.953 0.787 . . . . 0.0 112.09 -167.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -140.95 170.81 15.03 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.356 1.462 . . . . 0.0 109.409 174.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mp -118.72 140.25 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.204 169.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.43 -176.41 2.91 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.036 0.934 . . . . 0.0 112.506 172.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 tp -53.57 -40.49 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -65.01 -46.58 80.75 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 122.548 1.166 . . . . 0.0 113.638 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -62.94 -44.44 96.07 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 112.06 -2.336 . . . . 0.0 112.424 173.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.82 -40.42 84.08 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.53 1.132 . . . . 0.0 111.706 170.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.67 -49.26 62.08 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 124.492 1.044 . . . . 0.0 111.847 172.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.08 -37.17 73.97 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 21.2 mt -70.99 -59.41 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.269 1.028 . . . . 0.0 109.392 175.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 6.7 mp -82.83 17.91 1.74 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 -170.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . 0.472 ' NE ' ' H ' ' B' ' 32' ' ' ALA . 0.0 OUTLIER -44.14 -55.92 4.44 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -167.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . 0.472 ' H ' ' NE ' ' B' ' 31' ' ' ARG . . . -77.48 -57.11 4.0 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 41.6 p -78.47 94.32 4.91 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.328 1.051 . . . . 0.0 111.523 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.03 -35.62 3.39 Favored Glycine 0 CA--C 1.542 1.734 0 CA-C-N 114.192 -1.367 . . . . 0.0 113.914 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.148 0 O-C-N 119.955 -1.909 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.01 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -56.5 113.44 1.6 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 117.11 -3.494 . . . . 0.0 112.502 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.5 m -49.66 124.12 9.04 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 113.714 -1.584 . . . . 0.0 112.15 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 75.77 -47.58 0.58 Allowed 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 126.078 1.751 . . . . 0.0 115.033 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.34 -57.68 11.3 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.416 1.086 . . . . 0.0 111.887 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -61.04 -43.74 98.43 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.312 1.045 . . . . 0.0 112.065 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.5 tp -45.37 -49.58 12.93 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.252 1.821 . . . . 0.0 114.309 169.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.01 -44.91 51.45 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.587 0.755 . . . . 0.0 112.932 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -71.97 -49.59 35.96 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.902 1.281 . . . . 0.0 113.838 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.89 -39.49 26.17 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -51.98 -56.29 15.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.541 173.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.36 -35.12 77.25 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 110.721 -2.945 . . . . 0.0 116.451 -177.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 53.5 mt -56.3 -58.58 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 112.975 -1.921 . . . . 0.0 111.267 175.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -67.59 -39.03 84.82 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 111.803 -2.453 . . . . 0.0 113.268 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -77.38 61.12 2.14 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 127.13 2.172 . . . . 0.0 110.07 170.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -49.5 -41.69 41.5 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 112.667 -2.06 . . . . 0.0 115.094 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 44.5 p30 -72.49 -19.43 61.54 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 64.99 55.01 1.19 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 127.194 2.197 . . . . 0.0 114.433 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -104.14 0.24 29.37 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.55 17.78 79.62 Favored Glycine 0 N--CA 1.478 1.472 0 N-CA-C 114.987 0.755 . . . . 0.0 114.987 -173.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -133.96 164.57 27.01 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.595 1.188 . . . . 0.0 109.176 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . 0.25 5.2 mt -124.08 121.06 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 113.121 -1.854 . . . . 0.0 109.163 165.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.7 173.67 7.36 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.514 -1.676 . . . . 0.0 114.256 171.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.0 tp -48.33 -47.71 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 -171.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.43 -38.67 87.99 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 175.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -69.41 -43.2 73.9 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 111.836 -2.438 . . . . 0.0 112.776 176.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.9 tp -68.18 -36.0 78.91 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 124.165 0.916 . . . . 0.0 111.756 170.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -47.79 -55.31 9.9 Favored Glycine 0 N--CA 1.477 1.427 0 C-N-CA 124.305 0.955 . . . . 0.0 112.087 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -62.41 -24.51 67.44 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.3 mt -72.55 -75.59 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 165.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -34.35 71.91 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 118.553 2.797 . . . . 0.0 118.553 -163.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.4 tpt180 -85.17 137.38 33.05 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -166.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.09 92.66 2.19 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 154.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.5 p -55.95 95.58 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -160.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -176.98 -56.35 0.06 OUTLIER Glycine 0 CA--C 1.535 1.319 0 CA-C-N 110.374 -3.103 . . . . 0.0 108.778 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.739 0 O-C-N 120.076 -1.838 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.538 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -84.39 121.6 27.77 Favored 'General case' 0 C--N 1.299 -1.63 1 C-N-CA 139.171 6.988 . . . . 0.0 112.767 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 55.5 p -59.44 -43.98 93.02 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 113.054 -1.884 . . . . 0.0 113.911 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -106.27 56.28 0.66 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.896 1.332 . . . . 0.0 112.235 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -55.42 -58.71 6.63 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 113.462 -1.699 . . . . 0.0 114.778 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -63.29 -34.47 77.75 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -170.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 30.6 tp -42.84 -48.82 5.81 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 168.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.27 -62.56 1.57 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.876 1.27 . . . . 0.0 111.102 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . 0.551 ' ND2' ' H ' ' B' ' 8' ' ' ASN . 5.6 m-80 -46.33 -53.12 11.44 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 167.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.52 -40.68 62.71 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 176.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -57.98 -48.85 78.77 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.866 175.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.89 -24.28 61.63 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 41.3 mm -70.23 -52.0 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 113.67 -1.605 . . . . 0.0 112.283 171.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -71.35 -36.3 71.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 112.63 -2.077 . . . . 0.0 114.918 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -80.38 68.14 6.46 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 127.099 2.16 . . . . 0.0 110.033 171.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -44.12 -55.41 4.77 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 111.69 -2.504 . . . . 0.0 113.724 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -85.33 16.19 3.85 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 50.82 42.15 27.41 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 166.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 38.8 p30 -98.65 3.52 47.82 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.06 -1.882 . . . . 0.0 114.486 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.07 23.63 69.76 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.442 1.496 . . . . 0.0 114.073 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -137.46 171.58 14.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.033 0.933 . . . . 0.0 111.563 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.21 133.52 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.635 163.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.35 172.92 6.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 169.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . 0.264 9.0 tp -43.16 -35.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -170.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . 0.303 0.0 OUTLIER -74.5 -44.03 53.26 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 174.252 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -58.03 -46.23 85.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 128.074 2.55 . . . . 0.0 110.404 169.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -68.32 -38.58 81.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.675 1.59 . . . . 0.0 112.425 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.19 -62.44 5.7 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 125.745 1.64 . . . . 0.0 110.953 170.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -47.98 -41.14 24.42 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 12.2 mt -66.23 -72.36 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 172.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mt -60.87 -34.12 74.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 119.124 3.009 . . . . 0.0 119.124 -168.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -66.81 -13.61 61.72 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.3 -38.91 71.89 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.358 0.663 . . . . 0.0 111.643 166.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 44.8 p -107.77 58.83 0.62 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.763 1.225 . . . . 0.0 109.434 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 157.7 59.44 0.01 OUTLIER Glycine 0 CA--C 1.539 1.559 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.617 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.144 0 O-C-N 120.463 -1.61 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.886 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . 0.471 ' HZ3' ' CZ ' ' A' ' 11' ' ' ARG . 31.8 mmtp -53.6 139.56 31.42 Favored 'General case' 0 C--N 1.299 -1.608 1 C-N-CA 142.179 8.192 . . . . 0.0 113.219 . . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.7 t -120.97 94.64 4.41 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.028 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.309 0.2 OUTLIER 42.94 -98.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 125.787 1.635 . . . . 0.0 115.006 -175.223 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -78.29 -22.53 48.08 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -87.8 92.2 9.03 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.952 2.101 . . . . 0.0 116.504 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.6 tt -85.72 151.54 23.77 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 129.298 3.039 . . . . 0.0 108.593 -20.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . 0.761 . . -40.28 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 119.812 3.264 . . . . 0.0 119.812 174.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -56.11 -45.8 79.34 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 111.038 -2.801 . . . . 0.0 112.293 169.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.36 -37.98 62.9 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 169.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -53.47 -51.37 62.93 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 112.781 -2.009 . . . . 0.0 112.056 173.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.471 ' CZ ' ' HZ3' ' A' ' 1' ' ' LYS . 21.1 mmt85 -66.85 -42.68 85.33 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 111.759 -2.473 . . . . 0.0 115.303 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 44.0 mt -60.43 -42.91 92.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.331 -1.758 . . . . 0.0 112.168 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -78.88 -32.48 45.91 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 111.969 -2.378 . . . . 0.0 115.388 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -69.45 52.27 0.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.725 2.01 . . . . 0.0 113.325 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 33.1 mttm -49.55 -52.54 29.25 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 112.222 -2.263 . . . . 0.0 112.219 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -85.21 20.26 2.0 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 52.83 34.93 17.52 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 163.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -96.09 -3.1 45.28 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.95 31.72 81.78 Favored Glycine 0 CA--C 1.538 1.471 0 O-C-N 124.164 0.915 . . . . 0.0 112.107 -168.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -146.7 169.69 18.52 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.563 1.145 . . . . 0.0 110.456 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 mp -120.33 128.02 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.647 169.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.19 172.93 6.56 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.929 -1.487 . . . . 0.0 114.752 178.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.284 10.0 tt -52.47 -44.06 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 -171.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -43.52 82.33 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 175.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -56.59 -43.79 80.42 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.205 1.802 . . . . 0.0 110.917 169.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 tp -59.96 -44.67 94.28 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.67 -55.81 21.18 Favored Glycine 0 N--CA 1.48 1.613 0 O-C-N 124.057 0.848 . . . . 0.0 111.965 170.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -55.9 -41.65 74.84 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.6 pp -72.96 -42.12 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.377 0.671 . . . . 0.0 110.573 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.3 mt -66.77 -27.14 67.36 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -50.87 -32.5 20.63 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.882 1.673 . . . . 0.0 113.638 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.65 17.79 0.11 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -173.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 t -97.95 67.92 1.98 Allowed 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 122.177 0.989 . . . . 0.0 113.308 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.57 148.48 8.42 Favored Glycine 0 CA--C 1.54 1.654 0 CA-C-O 122.957 1.31 . . . . 0.0 111.248 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.823 0 O-C-N 120.279 -1.718 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.206 -1.236 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -72.32 128.58 36.06 Favored 'General case' 0 C--N 1.301 -1.54 1 C-N-CA 138.945 6.898 . . . . 0.0 111.411 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 90.5 p -82.83 153.67 25.07 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 113.8 -1.546 . . . . 0.0 111.878 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -50.51 -39.87 49.87 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.704 1.202 . . . . 0.0 113.396 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -65.23 -45.53 84.29 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -56.92 -42.08 79.32 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.657 0.598 . . . . 0.0 112.561 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 20.6 tp -56.07 -51.22 68.63 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 173.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.55 -41.59 66.61 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.275 1.03 . . . . 0.0 113.056 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -66.34 -45.5 80.0 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 174.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.03 -36.21 65.27 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -56.69 -58.76 6.71 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.881 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -68.12 -18.83 64.74 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 111.657 -2.52 . . . . 0.0 116.739 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 55.4 mt -72.86 -49.19 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 114.319 -1.31 . . . . 0.0 112.809 171.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -77.03 -36.93 55.79 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 112.823 -1.99 . . . . 0.0 113.9 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -72.8 51.92 0.29 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 128.093 2.557 . . . . 0.0 110.501 169.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 44.5 mtmt -47.33 -47.53 25.7 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 112.34 -2.209 . . . . 0.0 112.93 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -85.27 19.86 2.14 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 52.29 31.27 9.09 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 163.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -98.4 8.62 44.61 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.491 1.664 . . . . 0.0 115.491 -174.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.92 19.8 63.75 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.419 1.009 . . . . 0.0 113.413 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -136.57 169.53 17.55 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.676 1.19 . . . . 0.0 109.209 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 8.3 mt -123.07 127.02 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 113.73 -1.577 . . . . 0.0 107.241 162.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.88 176.19 5.22 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 113.269 -1.787 . . . . 0.0 113.521 179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . 0.303 5.9 tp -49.08 -54.37 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 113.056 -1.884 . . . . 0.0 116.035 -174.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.91 -41.5 95.53 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -174.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 62.8 mt-10 -51.63 -59.72 3.96 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 110.998 -2.819 . . . . 0.0 110.721 164.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.16 -37.81 86.58 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 117.513 -1.232 . . . . 0.0 114.243 -178.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.29 -56.44 17.19 Favored Glycine 0 N--CA 1.482 1.747 0 CA-C-N 118.951 0.796 . . . . 0.0 112.273 166.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -56.62 -42.68 79.23 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 176.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 32.9 mt -58.86 -76.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 173.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp -87.1 65.41 8.88 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 125.94 2.781 . . . . 0.0 115.346 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.68 -41.82 98.11 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 110.489 -3.05 . . . . 0.0 111.913 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.18 91.77 6.21 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.164 167.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.15 154.75 44.37 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -176.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -101.28 -156.8 27.0 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-N 112.164 -2.289 . . . . 0.0 108.07 164.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.047 0 O-C-N 120.723 -1.457 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.76 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -85.85 108.15 18.0 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 118.432 -2.668 . . . . 0.0 112.895 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 91.9 p -126.94 -136.38 0.25 Allowed 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 113.384 -1.735 . . . . 0.0 108.464 171.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.08 68.96 6.37 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 123.197 1.475 . . . . 0.0 111.493 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -54.66 -42.54 71.45 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 112.824 -1.989 . . . . 0.0 113.669 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -85.74 127.68 34.59 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 166.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . 0.281 3.6 pp -87.23 10.29 17.47 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 -14.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -44.71 -42.42 7.61 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 116.52 2.045 . . . . 0.0 116.52 -173.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -53.18 -47.88 68.48 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 174.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.47 -40.2 71.34 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -57.47 -50.98 71.28 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.254 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -63.06 -35.16 79.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 112.496 -2.138 . . . . 0.0 114.267 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 56.7 mt -61.16 -43.29 96.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 113.039 -1.891 . . . . 0.0 112.191 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -77.02 -40.82 45.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.833 2.053 . . . . 0.0 114.929 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -69.2 51.72 0.09 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 128.535 2.734 . . . . 0.0 114.738 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -44.44 -59.09 2.59 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 112.221 -2.263 . . . . 0.0 113.804 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -80.29 24.44 0.44 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 -176.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 50.75 33.98 9.29 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 161.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -100.07 4.56 44.72 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 112.927 -1.942 . . . . 0.0 114.181 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.26 26.11 63.43 Favored Glycine 0 N--CA 1.479 1.529 0 C-N-CA 124.772 1.177 . . . . 0.0 112.382 -171.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -139.02 167.03 22.96 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.572 1.149 . . . . 0.0 110.296 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -112.68 127.33 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.036 168.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.08 179.27 4.67 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.384 169.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.277 5.0 tt -55.14 -40.56 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 117.071 2.248 . . . . 0.0 117.071 -171.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -67.65 -39.54 84.56 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -65.27 -43.21 91.95 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 127.208 2.203 . . . . 0.0 111.979 174.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tp -61.58 -45.38 94.35 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.561 0.744 . . . . 0.0 111.191 168.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -47.01 -50.24 16.03 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 125.684 1.611 . . . . 0.0 112.404 170.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -52.86 -52.35 57.66 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.691 0.796 . . . . 0.0 112.55 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 10.8 mt -58.17 -50.45 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 123.881 0.872 . . . . 0.0 109.362 -179.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -74.51 -3.71 32.44 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.86 108.99 7.01 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -170.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.97 81.67 2.85 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 113.202 -1.817 . . . . 0.0 111.507 172.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.7 p -80.01 75.68 6.75 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 113.45 -1.705 . . . . 0.0 110.065 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.07 -144.08 22.48 Favored Glycine 0 N--CA 1.482 1.733 0 CA-C-N 112.495 -2.139 . . . . 0.0 111.117 -175.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.8 0 O-C-N 120.182 -1.775 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.206 -1.23 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -76.49 137.5 39.68 Favored 'General case' 0 C--N 1.302 -1.472 1 C-N-CA 143.47 8.708 . . . . 0.0 110.447 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 38.8 p -48.38 -37.29 16.47 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -173.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -127.53 88.83 2.85 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.593 0.711 . . . . 0.0 110.875 169.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -51.88 -38.03 54.58 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 113.989 -1.46 . . . . 0.0 112.547 171.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -85.78 142.89 28.63 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.648 1.179 . . . . 0.0 111.932 169.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.7 mt -85.33 12.14 8.79 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 -7.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -48.72 -57.11 6.81 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.584 1.153 . . . . 0.0 112.113 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . 0.277 13.5 m-80 -85.26 149.67 25.32 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 147.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.87 4.34 4.26 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 118.849 2.907 . . . . 0.0 118.849 -13.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -49.93 -53.26 27.28 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.218 1.009 . . . . 0.0 112.662 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -31.17 72.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 110.863 -2.88 . . . . 0.0 114.623 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 22.0 mt -69.51 -39.54 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.897 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -74.18 -39.96 62.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 112.513 -2.131 . . . . 0.0 113.066 171.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -70.13 47.91 0.09 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 128.682 2.793 . . . . 0.0 114.099 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -46.04 -47.09 17.03 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 113.375 -1.739 . . . . 0.0 114.126 175.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -82.15 27.99 0.46 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 51.71 34.74 13.52 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 118.077 2.621 . . . . 0.0 118.077 156.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -107.9 -1.32 20.83 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.03 28.9 74.04 Favored Glycine 0 N--CA 1.475 1.241 0 C-N-CA 123.617 0.627 . . . . 0.0 112.678 -170.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 39.2 m-85 -142.35 168.31 20.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.209 1.003 . . . . 0.0 111.065 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -117.11 129.76 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.492 1.517 . . . . 0.0 109.956 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.93 176.85 5.07 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.056 -1.429 . . . . 0.0 113.674 172.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.9 tp -48.56 -48.86 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -67.23 -41.05 86.33 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -59.33 -42.41 91.41 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 112.477 -2.147 . . . . 0.0 112.306 171.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 tp -64.2 -43.99 93.36 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.007 0.523 . . . . 0.0 111.804 172.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.08 -45.67 56.68 Favored Glycine 0 N--CA 1.483 1.806 0 C-N-CA 124.093 0.854 . . . . 0.0 112.453 170.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -56.88 -38.04 72.2 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.909 1.283 . . . . 0.0 113.647 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 12.8 mt -69.58 -63.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mp -72.58 17.24 0.11 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 118.34 2.719 . . . . 0.0 118.34 -173.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 56.2 ttp85 -43.4 -36.67 2.02 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 128.398 2.679 . . . . 0.0 115.601 -172.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.16 -12.74 9.31 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 36.4 p -65.0 89.88 0.08 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.672 1.189 . . . . 0.0 113.259 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.06 93.45 0.42 Allowed Glycine 0 CA--C 1.535 1.312 0 CA-C-O 123.118 1.399 . . . . 0.0 112.233 173.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.967 0 O-C-N 120.192 -1.769 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -69.26 -55.48 10.41 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.418 1.087 . . . . 0.0 113.9 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.13 -9.95 36.24 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.594 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 16.1 t80 -72.86 -68.0 0.52 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.13 161.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -65.31 -25.34 67.58 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 118.625 2.824 . . . . 0.0 118.625 -169.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 56.3 mt -66.43 -49.94 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-O 123.445 1.593 . . . . 0.0 112.648 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -81.21 -38.06 27.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 111.618 -2.537 . . . . 0.0 113.699 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.594 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -82.63 86.15 6.88 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 127.953 2.501 . . . . 0.0 113.104 -171.446 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -62.89 -71.67 0.16 Allowed 'General case' 0 N--CA 1.485 1.285 1 CA-C-N 107.405 -4.452 . . . . 0.0 114.518 171.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -85.84 133.39 33.97 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -174.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 41.9 43.76 2.7 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 124.755 2.217 . . . . 0.0 116.583 164.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 1.006 ' HA ' ' H ' ' A' ' 20' ' ' TYR 0.577 1.5 p30 -94.73 67.28 3.24 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 109.895 -3.321 . . . . 0.0 119.612 -172.024 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.47 -4.44 89.29 Favored Glycine 0 CA--C 1.556 2.623 1 CA-C-N 94.818 -10.174 . . . . 0.0 116.41 112.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 1.006 ' H ' ' HA ' ' A' ' 18' ' ' ASP . 17.3 m-85 -137.99 157.26 46.73 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.61 HG22 ' HB ' ' B' ' 21' ' ' ILE . 0.0 OUTLIER -116.14 142.97 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 129.576 3.15 . . . . 0.0 109.879 172.699 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.29 -176.56 2.93 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.93 1.292 . . . . 0.0 112.87 173.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 tp -52.61 -45.87 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 117.503 2.409 . . . . 0.0 117.503 -175.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -66.78 -43.31 84.31 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -62.79 -40.78 98.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 111.983 -2.371 . . . . 0.0 112.392 172.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.71 ' HA ' HD12 ' A' ' 29' ' ' ILE . 3.2 tp -59.45 -48.08 83.01 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.32 1.048 . . . . 0.0 111.554 170.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.73 -50.39 31.67 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.315 0.96 . . . . 0.0 111.652 171.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -54.84 -43.83 73.37 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.71 HD12 ' HA ' ' A' ' 26' ' ' LEU . 8.5 mt -61.46 -47.77 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.029 0.532 . . . . 0.0 110.198 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 174.68 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 6.1 tp . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.77 -47.07 59.74 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.824 1.25 . . . . 0.0 112.241 171.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -60.31 -49.95 75.56 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 171.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.79 -41.28 63.98 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 174.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.512 ' HD1' HD22 ' A' ' 26' ' ' LEU . 20.5 t80 -57.31 -47.96 80.16 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.054 -1.885 . . . . 0.0 111.932 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -38.52 91.37 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 112.179 -2.282 . . . . 0.0 114.915 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 46.7 mt -61.94 -41.98 92.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 112.985 -1.916 . . . . 0.0 113.016 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -77.99 -38.69 44.44 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 112.339 -2.21 . . . . 0.0 114.802 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -75.13 59.4 0.97 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.489 2.315 . . . . 0.0 111.299 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -46.75 -50.1 18.64 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 111.864 -2.425 . . . . 0.0 114.627 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -84.71 16.82 3.04 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 54.16 28.95 9.67 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 117.869 2.544 . . . . 0.0 117.869 166.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -89.28 4.59 48.26 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 -174.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.32 21.84 66.78 Favored Glycine 0 CA--C 1.546 2.029 0 C-N-CA 124.829 1.204 . . . . 0.0 113.758 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -140.54 172.25 12.98 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.285 1.434 . . . . 0.0 108.931 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.61 ' HB ' HG22 ' A' ' 21' ' ' ILE . 1.3 mp -124.21 146.08 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-N 114.427 -1.261 . . . . 0.0 108.512 161.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -118.57 178.53 4.43 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.594 1.158 . . . . 0.0 114.059 175.815 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' B' ' 26' ' ' LEU . 7.2 tp -44.43 -45.46 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 118.671 2.841 . . . . 0.0 118.671 -174.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -73.13 -46.76 49.23 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' B' ' 22' ' ' ASP . 65.3 mt-10 -51.65 -40.84 60.73 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 112.117 -2.311 . . . . 0.0 112.559 167.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.494 ' HA ' HD12 ' B' ' 29' ' ' ILE . 4.3 tp -54.93 -40.36 69.81 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 173.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.7 -52.12 21.25 Favored Glycine 0 N--CA 1.477 1.372 0 C-N-CA 124.717 1.151 . . . . 0.0 112.951 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -55.3 -44.59 75.91 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 113.93 -1.135 . . . . 0.0 113.025 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' B' ' 26' ' ' LEU . 13.2 mt -65.59 -48.91 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.735 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 177.956 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 10' ' ' PHE . . . . . . . . 0 CA--C 1.542 0.644 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -69.48 -44.45 71.13 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.286 1.588 . . . . 0.0 115.286 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.07 -42.73 77.12 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.44 ' HB3' ' O ' ' A' ' 7' ' ' ALA . 51.2 t80 -53.77 -51.85 62.09 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 112.525 -2.125 . . . . 0.0 111.617 174.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.505 ' HA ' ' HB3' ' A' ' 14' ' ' ASP . 7.8 mmm180 -73.84 -18.57 60.92 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 111.228 -2.715 . . . . 0.0 116.551 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . 0.274 60.7 mt -70.97 -48.99 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.52 170.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -67.72 -44.26 78.05 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 112.508 -2.133 . . . . 0.0 111.645 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.505 ' HB3' ' HA ' ' A' ' 11' ' ' ARG . 65.6 t0 -67.07 62.64 0.05 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 127.72 2.408 . . . . 0.0 112.484 177.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -62.12 -37.48 85.3 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 110.692 -2.958 . . . . 0.0 115.293 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -79.27 -2.53 41.71 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.85 37.99 21.52 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.353 1.861 . . . . 0.0 115.944 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.0 p-10 -87.95 -9.72 52.7 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.96 26.91 71.5 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.182 0.896 . . . . 0.0 113.012 -167.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' B' ' 20' ' ' TYR . 62.0 m-85 -145.91 178.85 7.87 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.265 1.426 . . . . 0.0 109.614 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.518 HG21 HD11 ' A' ' 29' ' ' ILE . 15.2 mt -128.73 138.53 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 C-N-CA 125.615 1.566 . . . . 0.0 109.29 167.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -114.7 176.42 5.06 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.344 1.858 . . . . 0.0 115.836 173.552 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 tp -43.62 -49.81 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 117.645 2.461 . . . . 0.0 117.645 -171.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -38.4 85.73 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 85.9 mt-10 -68.72 -38.71 80.41 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 128.487 2.715 . . . . 0.0 113.276 171.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.514 HD12 HD12 ' A' ' 29' ' ' ILE . 16.6 tp -56.13 -41.85 75.97 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.062 165.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.48 -50.9 6.72 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 125.345 1.45 . . . . 0.0 112.68 167.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 42.4 mt-10 -51.45 -53.19 39.57 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 172.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.518 HD11 HG21 ' A' ' 21' ' ' ILE . 2.9 mt -63.34 -44.38 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 124.555 1.142 . . . . 0.0 109.234 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.29 -39.31 63.86 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.916 1.286 . . . . 0.0 113.419 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -73.82 -49.43 25.25 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.8 -42.65 68.6 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -51.16 -52.68 41.77 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 112.466 -2.152 . . . . 0.0 111.28 173.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.509 ' HD3' ' HA ' ' B' ' 11' ' ' ARG . 8.3 mmt180 -71.43 -25.37 62.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 111.061 -2.791 . . . . 0.0 117.723 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 30.5 mt -69.09 -41.68 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-O 122.827 1.299 . . . . 0.0 111.858 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -68.48 -44.77 74.04 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 112.966 -1.924 . . . . 0.0 111.225 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -69.85 65.6 0.23 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 128.706 2.802 . . . . 0.0 113.36 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.463 ' NZ ' ' HG2' ' B' ' 28' ' ' GLU . 63.3 mttp -49.38 -53.64 21.44 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 109.904 -3.317 . . . . 0.0 114.071 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -85.35 17.92 2.9 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 53.68 33.79 17.42 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 162.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -93.75 1.75 56.43 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.77 28.72 73.9 Favored Glycine 0 N--CA 1.486 1.993 0 C-N-CA 123.906 0.765 . . . . 0.0 112.674 -169.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 59.7 m-85 -143.76 176.64 9.09 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.502 1.121 . . . . 0.0 111.877 -175.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 30.4 mm -123.38 128.41 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 168.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -98.38 173.36 7.01 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 168.258 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.4 tp -49.98 -49.98 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 -173.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.95 -38.35 90.69 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' B' ' 22' ' ' ASP . 62.7 mt-10 -61.83 -42.25 98.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.714 -2.039 . . . . 0.0 113.613 171.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.485 ' HA ' HD12 ' B' ' 29' ' ' ILE . 47.9 tp -54.89 -40.57 69.9 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 167.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.23 -47.42 68.01 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 124.354 0.978 . . . . 0.0 112.485 170.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.463 ' HG2' ' NZ ' ' B' ' 15' ' ' LYS . 1.6 mp0 -56.09 -35.1 66.63 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' B' ' 26' ' ' LEU . 17.2 mt -71.84 -59.33 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 -177.236 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.852 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -65.47 -47.62 75.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 114.395 1.258 . . . . 0.0 114.395 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.75 -46.17 67.38 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.525 ' HD1' ' HG ' ' B' ' 26' ' ' LEU . 12.0 t80 -55.14 -49.37 71.97 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.772 175.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -67.41 -35.61 79.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 111.855 -2.43 . . . . 0.0 117.297 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 38.2 mt -60.62 -51.87 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 123.496 1.617 . . . . 0.0 110.111 175.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -76.77 -36.19 57.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 111.061 -2.79 . . . . 0.0 115.272 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -78.36 53.18 1.23 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.986 2.114 . . . . 0.0 112.672 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -48.55 -54.11 15.71 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 111.174 -2.739 . . . . 0.0 114.396 -173.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -82.19 12.69 4.05 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 53.93 32.65 15.68 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 170.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -82.92 0.73 42.99 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 112.769 -2.014 . . . . 0.0 112.874 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.02 18.81 60.58 Favored Glycine 0 N--CA 1.484 1.894 0 C-N-CA 125.562 1.553 . . . . 0.0 112.295 -172.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.824 ' HB3' ' HB3' ' B' ' 20' ' ' TYR . 11.4 m-85 -132.1 163.43 28.5 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.872 1.269 . . . . 0.0 109.365 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.5 mt -116.31 133.33 63.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 123.732 0.813 . . . . 0.0 109.887 170.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -102.24 175.96 5.35 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.058 174.849 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' B' ' 6' ' ' LEU . 8.8 tp -49.48 -45.35 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 118.132 2.641 . . . . 0.0 118.132 -174.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -66.85 -46.79 73.94 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.664 1.221 . . . . 0.0 114.252 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 81.9 mt-10 -56.63 -44.17 80.96 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 111.517 -2.583 . . . . 0.0 111.185 171.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.633 HD22 ' HD1' ' B' ' 10' ' ' PHE . 1.4 tp -63.99 -47.22 81.21 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.723 1.209 . . . . 0.0 112.509 173.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.98 -45.67 50.58 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.606 1.098 . . . . 0.0 111.735 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -54.25 -50.57 66.91 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.3 mt -59.76 -48.55 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 123.22 0.608 . . . . 0.0 109.582 175.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.521 ' HB3' HD11 ' A' ' 23' ' ' ILE . 21.2 mt . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.15 -40.19 61.06 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.773 1.229 . . . . 0.0 113.05 174.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -71.51 -49.36 41.81 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.16 -35.9 67.72 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 173.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.633 ' HD1' HD22 ' A' ' 26' ' ' LEU . 27.7 t80 -56.24 -51.72 67.06 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.572 1.949 . . . . 0.0 110.969 174.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.721 HH12 ' HA2' ' B' ' 19' ' ' GLY . 2.3 mpt_? -63.62 -30.43 71.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 112.429 -2.168 . . . . 0.0 116.13 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 37.6 mm -62.53 -46.31 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 123.67 1.7 . . . . 0.0 111.279 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -78.33 -39.97 37.95 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 128.368 2.667 . . . . 0.0 112.795 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' ASP . . . . . 0.405 ' HB3' ' HA ' ' B' ' 11' ' ' ARG . 61.9 t0 -75.69 64.61 1.74 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.415 2.286 . . . . 0.0 109.717 174.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -39.96 -51.0 2.53 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 110.862 -2.881 . . . . 0.0 114.158 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -77.79 -17.2 57.74 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 62.96 54.9 2.09 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.441 2.296 . . . . 0.0 113.724 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 31.2 p30 -88.74 -18.43 27.83 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 116.582 2.067 . . . . 0.0 116.582 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' GLY . . . . . 0.721 ' HA2' HH12 ' B' ' 11' ' ' ARG . . . 95.52 15.18 44.57 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 124.44 1.019 . . . . 0.0 113.286 -170.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' TYR . . . . . 0.824 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 14.7 m-85 -149.38 168.87 22.2 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.348 1.059 . . . . 0.0 110.93 -171.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 28.2 mm -118.29 132.37 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.776 169.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -107.71 173.73 6.19 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.125 -1.398 . . . . 0.0 114.627 171.567 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 tp -48.57 -48.48 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 -170.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . 0.254 0.0 OUTLIER -67.02 -40.79 87.32 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 177.716 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 25' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' B' ' 28' ' ' GLU . 88.2 mt-10 -61.34 -43.95 98.02 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 112.35 -2.205 . . . . 0.0 111.224 170.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.525 ' HG ' ' HD1' ' A' ' 10' ' ' PHE . 2.8 tm? -61.1 -43.21 99.24 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 169.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -45.02 -54.54 6.9 Favored Glycine 0 N--CA 1.479 1.538 0 C-N-CA 124.134 0.873 . . . . 0.0 112.823 169.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' B' ' 25' ' ' GLU . 20.5 tt0 -53.44 -52.02 60.78 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 112.295 -1.952 . . . . 0.0 113.195 171.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 49.6 mt -54.82 -50.68 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.41 0.684 . . . . 0.0 110.093 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.467 0.4 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.517 ' O ' HG12 ' A' ' 12' ' ' ILE . 65.1 m-80 -60.66 -52.79 63.65 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 117.928 -1.034 . . . . 0.0 113.459 169.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.34 -45.11 24.44 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -52.58 -53.88 40.52 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.061 -1.882 . . . . 0.0 111.254 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -66.99 -30.72 70.92 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 111.649 -2.523 . . . . 0.0 117.095 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 8' ' ' ASN . 35.1 mm -65.83 -44.97 92.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 122.912 1.339 . . . . 0.0 111.009 176.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -70.61 -44.88 66.35 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 112.201 -2.272 . . . . 0.0 111.908 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -73.25 52.54 0.36 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 128.294 2.638 . . . . 0.0 113.27 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HD2' ' N ' ' A' ' 16' ' ' ASN . 0.1 OUTLIER -52.68 -42.59 64.9 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 113.563 -1.653 . . . . 0.0 115.066 174.615 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.476 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 5.1 p-10 -79.06 12.8 2.05 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 116.909 2.188 . . . . 0.0 116.909 176.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 57.72 24.93 11.19 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 119.686 3.217 . . . . 0.0 119.686 161.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -93.19 4.0 54.73 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -175.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.38 25.83 70.23 Favored Glycine 0 CA--C 1.54 1.634 0 O-C-N 123.695 0.622 . . . . 0.0 112.694 -170.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.51 ' HB3' ' HB3' ' B' ' 20' ' ' TYR . 36.2 m-85 -139.85 167.12 22.85 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.676 1.19 . . . . 0.0 112.321 -178.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -117.79 127.76 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-N 112.495 -2.139 . . . . 0.0 109.818 170.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.57 177.31 4.88 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 113.195 -1.821 . . . . 0.0 113.471 172.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.6 tp -48.47 -47.63 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -66.26 -38.57 88.16 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -67.05 -40.28 87.1 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 127.027 2.131 . . . . 0.0 113.119 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 29' ' ' ILE . 6.1 tp -64.8 -41.75 95.55 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.569 168.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.36 -29.07 59.93 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 124.635 1.112 . . . . 0.0 114.331 170.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -73.13 -39.05 66.04 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 169.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 26' ' ' LEU . 23.4 mt -62.67 -71.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 168.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 C--O 1.239 0.527 0 CA-C-O 124.922 2.296 . . . . 0.0 112.576 174.827 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.549 0.904 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' B' ' 10' ' ' PHE . . . -48.57 -50.93 30.25 Favored 'General case' 0 CA--C 1.554 1.123 0 O-C-N 125.386 1.679 . . . . 0.0 113.063 176.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -63.9 -48.72 75.52 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 175.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.42 ' HA ' HD12 ' B' ' 12' ' ' ILE . . . -53.48 -40.87 65.68 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 176.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.437 ' HB3' ' O ' ' B' ' 7' ' ' ALA . 47.7 t80 -52.63 -55.27 23.57 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 112.926 -1.943 . . . . 0.0 112.411 173.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -68.54 -20.34 64.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 110.108 -3.224 . . . . 0.0 115.962 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' B' ' 9' ' ' ALA . 51.8 mt -69.35 -52.37 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 122.856 1.312 . . . . 0.0 112.12 174.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -63.63 -35.57 80.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 112.049 -2.341 . . . . 0.0 114.317 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -65.85 46.21 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 128.961 2.904 . . . . 0.0 114.842 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -53.65 -41.68 67.03 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.903 2.081 . . . . 0.0 115.666 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -80.52 14.65 1.95 Allowed 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 56.58 23.17 7.38 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 119.757 3.243 . . . . 0.0 119.757 161.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -88.41 -8.71 54.54 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 113.096 -1.865 . . . . 0.0 115.61 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.86 27.38 73.24 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 123.953 0.787 . . . . 0.0 112.09 -167.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' TYR . . . . . 0.51 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 51.6 m-85 -140.95 170.81 15.03 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.356 1.462 . . . . 0.0 109.409 174.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.44 ' HA ' ' OE1' ' B' ' 25' ' ' GLU . 1.4 mp -118.72 140.25 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.204 169.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.43 -176.41 2.91 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.036 0.934 . . . . 0.0 112.506 172.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 tp -53.57 -40.49 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -65.01 -46.58 80.75 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 122.548 1.166 . . . . 0.0 113.638 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 25' ' ' GLU . . . . . 0.44 ' OE1' ' HA ' ' B' ' 21' ' ' ILE . 84.4 mt-10 -62.94 -44.44 96.07 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 112.06 -2.336 . . . . 0.0 112.424 173.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.53 ' HG ' HD13 ' B' ' 30' ' ' LEU . 0.9 OUTLIER -58.82 -40.42 84.08 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.53 1.132 . . . . 0.0 111.706 170.765 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.67 -49.26 62.08 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 124.492 1.044 . . . . 0.0 111.847 172.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.08 -37.17 73.97 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' B' ' 26' ' ' LEU . 21.2 mt -70.99 -59.41 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.269 1.028 . . . . 0.0 109.392 175.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.53 HD13 ' HG ' ' B' ' 26' ' ' LEU . 6.7 mp . . . . . 0 CA--C 1.543 0.69 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 -170.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -71.97 -49.59 35.96 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.902 1.281 . . . . 0.0 113.838 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.89 -39.49 26.17 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -51.98 -56.29 15.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.541 173.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.422 ' NH2' ' HA2' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -68.36 -35.12 77.25 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 110.721 -2.945 . . . . 0.0 116.451 -177.697 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 53.5 mt -56.3 -58.58 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 112.975 -1.921 . . . . 0.0 111.267 175.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -67.59 -39.03 84.82 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 111.803 -2.453 . . . . 0.0 113.268 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -77.38 61.12 2.14 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 127.13 2.172 . . . . 0.0 110.07 170.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -49.5 -41.69 41.5 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 112.667 -2.06 . . . . 0.0 115.094 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 44.5 p30 -72.49 -19.43 61.54 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 64.99 55.01 1.19 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 127.194 2.197 . . . . 0.0 114.433 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -104.14 0.24 29.37 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.422 ' HA2' ' NH2' ' A' ' 11' ' ' ARG . . . 76.55 17.78 79.62 Favored Glycine 0 N--CA 1.478 1.472 0 N-CA-C 114.987 0.755 . . . . 0.0 114.987 -173.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -133.96 164.57 27.01 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.595 1.188 . . . . 0.0 109.176 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.409 ' HB ' HG22 ' B' ' 21' ' ' ILE 0.25 5.2 mt -124.08 121.06 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 113.121 -1.854 . . . . 0.0 109.163 165.472 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -95.7 173.67 7.36 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.514 -1.676 . . . . 0.0 114.256 171.361 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.0 tp -48.33 -47.71 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 -171.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.43 -38.67 87.99 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 175.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 82.9 mt-10 -69.41 -43.2 73.9 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 111.836 -2.438 . . . . 0.0 112.776 176.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.613 HD22 ' HD1' ' B' ' 10' ' ' PHE . 4.9 tp -68.18 -36.0 78.91 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 124.165 0.916 . . . . 0.0 111.756 170.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -47.79 -55.31 9.9 Favored Glycine 0 N--CA 1.477 1.427 0 C-N-CA 124.305 0.955 . . . . 0.0 112.087 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -62.41 -24.51 67.44 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 26' ' ' LEU . 14.3 mt -72.55 -75.59 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 165.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 118.553 2.797 . . . . 0.0 118.553 -163.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 30.6 tp . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.27 -62.56 1.57 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.876 1.27 . . . . 0.0 111.102 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -46.33 -53.12 11.44 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 167.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.52 -40.68 62.71 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 176.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.613 ' HD1' HD22 ' A' ' 26' ' ' LEU . 4.9 t80 -57.98 -48.85 78.77 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.866 175.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.89 -24.28 61.63 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 41.3 mm -70.23 -52.0 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 113.67 -1.605 . . . . 0.0 112.283 171.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -71.35 -36.3 71.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 112.63 -2.077 . . . . 0.0 114.918 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -80.38 68.14 6.46 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 127.099 2.16 . . . . 0.0 110.033 171.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -44.12 -55.41 4.77 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 111.69 -2.504 . . . . 0.0 113.724 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -85.33 16.19 3.85 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 50.82 42.15 27.41 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 166.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 38.8 p30 -98.65 3.52 47.82 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.06 -1.882 . . . . 0.0 114.486 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.07 23.63 69.76 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.442 1.496 . . . . 0.0 114.073 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -137.46 171.58 14.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.033 0.933 . . . . 0.0 111.563 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.409 HG22 ' HB ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -129.21 133.52 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.635 163.22 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -115.35 172.92 6.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 169.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . 0.264 9.0 tp -43.16 -35.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -170.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . 0.303 0.0 OUTLIER -74.5 -44.03 53.26 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 174.252 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 25' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' B' ' 22' ' ' ASP . 49.9 mt-10 -58.03 -46.23 85.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 128.074 2.55 . . . . 0.0 110.404 169.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -68.32 -38.58 81.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.675 1.59 . . . . 0.0 112.425 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.19 -62.44 5.7 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 125.745 1.64 . . . . 0.0 110.953 170.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -47.98 -41.14 24.42 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.407 HG13 ' O ' ' B' ' 25' ' ' GLU . 12.2 mt -66.23 -72.36 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 172.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mt . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 119.124 3.009 . . . . 0.0 119.124 -168.575 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.555 ' O ' ' HB3' ' A' ' 10' ' ' PHE 0.761 . . . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 119.812 3.264 . . . . 0.0 119.812 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -56.11 -45.8 79.34 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 111.038 -2.801 . . . . 0.0 112.293 169.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.36 -37.98 62.9 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 169.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.555 ' HB3' ' O ' ' A' ' 7' ' ' ALA . 14.7 t80 -53.47 -51.37 62.93 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 112.781 -2.009 . . . . 0.0 112.056 173.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -66.85 -42.68 85.33 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 111.759 -2.473 . . . . 0.0 115.303 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 44.0 mt -60.43 -42.91 92.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.331 -1.758 . . . . 0.0 112.168 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -78.88 -32.48 45.91 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 111.969 -2.378 . . . . 0.0 115.388 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -69.45 52.27 0.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.725 2.01 . . . . 0.0 113.325 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.463 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 33.1 mttm -49.55 -52.54 29.25 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 112.222 -2.263 . . . . 0.0 112.219 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -85.21 20.26 2.0 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 52.83 34.93 17.52 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 163.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -96.09 -3.1 45.28 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.95 31.72 81.78 Favored Glycine 0 CA--C 1.538 1.471 0 O-C-N 124.164 0.915 . . . . 0.0 112.107 -168.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -146.7 169.69 18.52 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.563 1.145 . . . . 0.0 110.456 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.441 ' HA ' ' OE1' ' A' ' 25' ' ' GLU . 2.3 mp -120.33 128.02 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.647 169.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -109.19 172.93 6.56 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.929 -1.487 . . . . 0.0 114.752 178.121 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.284 10.0 tt -52.47 -44.06 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 -171.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -43.52 82.33 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 175.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 29' ' ' ILE . 38.8 mt-10 -56.59 -43.79 80.42 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.205 1.802 . . . . 0.0 110.917 169.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.416 ' O ' HG13 ' A' ' 29' ' ' ILE . 3.4 tp -59.96 -44.67 94.28 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.425 ' HA2' HD11 ' B' ' 6' ' ' LEU . . . -52.67 -55.81 21.18 Favored Glycine 0 N--CA 1.48 1.613 0 O-C-N 124.057 0.848 . . . . 0.0 111.965 170.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -55.9 -41.65 74.84 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.48 HG23 ' O ' ' A' ' 25' ' ' GLU . 1.6 pp -72.96 -42.12 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.377 0.671 . . . . 0.0 110.573 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.3 mt . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 176.985 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.425 HD11 ' HA2' ' A' ' 27' ' ' GLY . 20.6 tp . . . . . 0 CA--C 1.542 0.64 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.55 -41.59 66.61 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.275 1.03 . . . . 0.0 113.056 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -66.34 -45.5 80.0 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 174.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.03 -36.21 65.27 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -56.69 -58.76 6.71 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.881 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -68.12 -18.83 64.74 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 111.657 -2.52 . . . . 0.0 116.739 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 55.4 mt -72.86 -49.19 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 114.319 -1.31 . . . . 0.0 112.809 171.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -77.03 -36.93 55.79 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 112.823 -1.99 . . . . 0.0 113.9 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -72.8 51.92 0.29 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 128.093 2.557 . . . . 0.0 110.501 169.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' LYS . . . . . 0.576 ' HE3' ' HG2' ' B' ' 25' ' ' GLU . 44.5 mtmt -47.33 -47.53 25.7 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 112.34 -2.209 . . . . 0.0 112.93 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -85.27 19.86 2.14 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 52.29 31.27 9.09 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 163.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -98.4 8.62 44.61 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.491 1.664 . . . . 0.0 115.491 -174.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.92 19.8 63.75 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.419 1.009 . . . . 0.0 113.413 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -136.57 169.53 17.55 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.676 1.19 . . . . 0.0 109.209 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 8.3 mt -123.07 127.02 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 113.73 -1.577 . . . . 0.0 107.241 162.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -107.88 176.19 5.22 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 113.269 -1.787 . . . . 0.0 113.521 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . 0.303 5.9 tp -49.08 -54.37 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 113.056 -1.884 . . . . 0.0 116.035 -174.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.91 -41.5 95.53 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -174.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' GLU . . . . . 0.576 ' HG2' ' HE3' ' B' ' 15' ' ' LYS . 62.8 mt-10 -51.63 -59.72 3.96 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 110.998 -2.819 . . . . 0.0 110.721 164.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' B' ' 29' ' ' ILE . 0.9 OUTLIER -66.16 -37.81 86.58 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 117.513 -1.232 . . . . 0.0 114.243 -178.087 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.29 -56.44 17.19 Favored Glycine 0 N--CA 1.482 1.747 0 CA-C-N 118.951 0.796 . . . . 0.0 112.273 166.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -56.62 -42.68 79.23 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 176.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' B' ' 26' ' ' LEU . 32.9 mt -58.86 -76.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 173.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 125.94 2.781 . . . . 0.0 115.346 -178.936 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 116.52 2.045 . . . . 0.0 116.52 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -53.18 -47.88 68.48 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 174.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.47 -40.2 71.34 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -57.47 -50.98 71.28 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.254 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -63.06 -35.16 79.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 112.496 -2.138 . . . . 0.0 114.267 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 56.7 mt -61.16 -43.29 96.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 113.039 -1.891 . . . . 0.0 112.191 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -77.02 -40.82 45.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.833 2.053 . . . . 0.0 114.929 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -69.2 51.72 0.09 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 128.535 2.734 . . . . 0.0 114.738 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -44.44 -59.09 2.59 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 112.221 -2.263 . . . . 0.0 113.804 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -80.29 24.44 0.44 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 -176.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 50.75 33.98 9.29 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 161.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -100.07 4.56 44.72 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 112.927 -1.942 . . . . 0.0 114.181 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.26 26.11 63.43 Favored Glycine 0 N--CA 1.479 1.529 0 C-N-CA 124.772 1.177 . . . . 0.0 112.382 -171.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.557 ' HB3' ' HB3' ' B' ' 20' ' ' TYR . 13.3 m-85 -139.02 167.03 22.96 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.572 1.149 . . . . 0.0 110.296 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -112.68 127.33 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.036 168.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.08 179.27 4.67 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.384 169.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.277 5.0 tt -55.14 -40.56 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 117.071 2.248 . . . . 0.0 117.071 -171.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -67.65 -39.54 84.56 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -65.27 -43.21 91.95 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 127.208 2.203 . . . . 0.0 111.979 174.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.569 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.4 tp -61.58 -45.38 94.35 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.561 0.744 . . . . 0.0 111.191 168.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -47.01 -50.24 16.03 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 125.684 1.611 . . . . 0.0 112.404 170.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -52.86 -52.35 57.66 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.691 0.796 . . . . 0.0 112.55 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.569 HD12 ' HA ' ' A' ' 26' ' ' LEU . 10.8 mt -58.17 -50.45 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 123.881 0.872 . . . . 0.0 109.362 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 CA--C 1.544 0.717 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -178.217 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.7 mt . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 7' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' B' ' 11' ' ' ARG . . . -48.72 -57.11 6.81 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.584 1.153 . . . . 0.0 112.113 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . 0.277 13.5 m-80 -85.26 149.67 25.32 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 147.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.87 4.34 4.26 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 118.849 2.907 . . . . 0.0 118.849 -13.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' PHE . . . . . 0.528 ' HD1' HD22 ' A' ' 26' ' ' LEU . 33.4 t80 -49.93 -53.26 27.28 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.218 1.009 . . . . 0.0 112.662 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ARG . . . . . 0.535 ' HA ' ' HB3' ' B' ' 14' ' ' ASP . 0.0 OUTLIER -64.81 -31.17 72.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 110.863 -2.88 . . . . 0.0 114.623 -178.066 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 22.0 mt -69.51 -39.54 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.897 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -74.18 -39.96 62.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 112.513 -2.131 . . . . 0.0 113.066 171.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' ASP . . . . . 0.535 ' HB3' ' HA ' ' B' ' 11' ' ' ARG . 12.1 t0 -70.13 47.91 0.09 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 128.682 2.793 . . . . 0.0 114.099 176.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -46.04 -47.09 17.03 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 113.375 -1.739 . . . . 0.0 114.126 175.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -82.15 27.99 0.46 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 51.71 34.74 13.52 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 118.077 2.621 . . . . 0.0 118.077 156.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -107.9 -1.32 20.83 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.03 28.9 74.04 Favored Glycine 0 N--CA 1.475 1.241 0 C-N-CA 123.617 0.627 . . . . 0.0 112.678 -170.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 20' ' ' TYR . . . . . 0.557 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 39.2 m-85 -142.35 168.31 20.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.209 1.003 . . . . 0.0 111.065 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -117.11 129.76 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.492 1.517 . . . . 0.0 109.956 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -101.93 176.85 5.07 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.056 -1.429 . . . . 0.0 113.674 172.386 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.9 tp -48.56 -48.86 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -67.23 -41.05 86.33 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' B' ' 22' ' ' ASP . 79.5 mt-10 -59.33 -42.41 91.41 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 112.477 -2.147 . . . . 0.0 112.306 171.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' B' ' 29' ' ' ILE . 1.8 tp -64.2 -43.99 93.36 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.007 0.523 . . . . 0.0 111.804 172.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.08 -45.67 56.68 Favored Glycine 0 N--CA 1.483 1.806 0 C-N-CA 124.093 0.854 . . . . 0.0 112.453 170.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -56.88 -38.04 72.2 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.909 1.283 . . . . 0.0 113.647 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' B' ' 26' ' ' LEU . 12.8 mt -69.58 -63.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 118.34 2.719 . . . . 0.0 118.34 -173.72 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.436 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -44.47 -76.8 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.147 1 C-N-CA 139.926 7.29 . . . . 0.0 112.793 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m -49.38 -47.29 47.79 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.522 1.929 . . . . 0.0 113.978 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -63.32 -50.13 71.24 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.053 0.941 . . . . 0.0 111.585 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -58.85 -51.2 71.03 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.504 1.122 . . . . 0.0 111.494 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -49.93 -48.82 51.58 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.991 1.316 . . . . 0.0 112.362 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.463 HD12 HD23 ' B' ' 26' ' ' LEU . 29.3 tp -53.8 -55.43 26.62 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 176.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.31 -39.64 60.85 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -69.26 -55.48 10.41 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.418 1.087 . . . . 0.0 113.9 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.13 -9.95 36.24 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.594 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 16.1 t80 -72.86 -68.0 0.52 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.13 161.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -65.31 -25.34 67.58 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 118.625 2.824 . . . . 0.0 118.625 -169.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 56.3 mt -66.43 -49.94 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-O 123.445 1.593 . . . . 0.0 112.648 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -81.21 -38.06 27.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 111.618 -2.537 . . . . 0.0 113.699 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.594 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -82.63 86.15 6.88 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 127.953 2.501 . . . . 0.0 113.104 -171.446 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -62.89 -71.67 0.16 Allowed 'General case' 0 N--CA 1.485 1.285 1 CA-C-N 107.405 -4.452 . . . . 0.0 114.518 171.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -85.84 133.39 33.97 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -174.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 41.9 43.76 2.7 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 124.755 2.217 . . . . 0.0 116.583 164.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 1.006 ' HA ' ' H ' ' A' ' 20' ' ' TYR 0.577 1.5 p30 -94.73 67.28 3.24 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 109.895 -3.321 . . . . 0.0 119.612 -172.024 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.47 -4.44 89.29 Favored Glycine 0 CA--C 1.556 2.623 1 CA-C-N 94.818 -10.174 . . . . 0.0 116.41 112.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 1.006 ' H ' ' HA ' ' A' ' 18' ' ' ASP . 17.3 m-85 -137.99 157.26 46.73 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.61 HG22 ' HB ' ' B' ' 21' ' ' ILE . 0.0 OUTLIER -116.14 142.97 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 129.576 3.15 . . . . 0.0 109.879 172.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.29 -176.56 2.93 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.93 1.292 . . . . 0.0 112.87 173.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 tp -52.61 -45.87 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 117.503 2.409 . . . . 0.0 117.503 -175.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -66.78 -43.31 84.31 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -62.79 -40.78 98.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 111.983 -2.371 . . . . 0.0 112.392 172.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.71 ' HA ' HD12 ' A' ' 29' ' ' ILE . 3.2 tp -59.45 -48.08 83.01 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.32 1.048 . . . . 0.0 111.554 170.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . -49.73 -50.39 31.67 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.315 0.96 . . . . 0.0 111.652 171.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -54.84 -43.83 73.37 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.71 HD12 ' HA ' ' A' ' 26' ' ' LEU . 8.5 mt -61.46 -47.77 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.029 0.532 . . . . 0.0 110.198 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 mp -55.27 -43.92 75.15 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 27' ' ' GLY . 67.8 mtt180 -59.62 -39.76 85.35 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.425 -1.261 . . . . 0.0 112.859 175.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.38 -43.45 81.34 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.4 p -101.65 -45.02 5.39 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 116.315 1.968 . . . . 0.0 116.315 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.57 -77.98 0.13 Allowed Glycine 0 N--CA 1.487 2.069 0 CA-C-O 123.116 1.398 . . . . 0.0 113.048 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' NH2 . . . . . 0.675 ' N ' ' H ' ' B' ' 33' ' ' THR . . . . . . . . 0 C--N 1.31 -1.15 0 O-C-N 120.422 -1.634 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.211 -0.935 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -57.92 125.26 22.33 Favored 'General case' 0 C--N 1.306 -1.321 1 C-N-CA 135.933 5.693 . . . . 0.0 113.403 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 81.6 p -156.52 161.56 40.0 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 112.477 -2.147 . . . . 0.0 108.703 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -50.06 -43.94 51.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 123.799 0.687 . . . . 0.0 112.329 171.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -58.31 -51.08 71.29 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.158 1.383 . . . . 0.0 112.688 175.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.43 -42.34 98.6 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 6.1 tp -65.33 -33.32 75.7 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.77 -47.07 59.74 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.824 1.25 . . . . 0.0 112.241 171.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -60.31 -49.95 75.56 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 171.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.79 -41.28 63.98 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 174.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.512 ' HD1' HD22 ' A' ' 26' ' ' LEU . 20.5 t80 -57.31 -47.96 80.16 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.054 -1.885 . . . . 0.0 111.932 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -38.52 91.37 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 112.179 -2.282 . . . . 0.0 114.915 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 46.7 mt -61.94 -41.98 92.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 112.985 -1.916 . . . . 0.0 113.016 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -77.99 -38.69 44.44 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 112.339 -2.21 . . . . 0.0 114.802 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -75.13 59.4 0.97 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.489 2.315 . . . . 0.0 111.299 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -46.75 -50.1 18.64 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 111.864 -2.425 . . . . 0.0 114.627 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -84.71 16.82 3.04 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 54.16 28.95 9.67 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 117.869 2.544 . . . . 0.0 117.869 166.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -89.28 4.59 48.26 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 -174.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.32 21.84 66.78 Favored Glycine 0 CA--C 1.546 2.029 0 C-N-CA 124.829 1.204 . . . . 0.0 113.758 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -140.54 172.25 12.98 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.285 1.434 . . . . 0.0 108.931 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.61 ' HB ' HG22 ' A' ' 21' ' ' ILE . 1.3 mp -124.21 146.08 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-N 114.427 -1.261 . . . . 0.0 108.512 161.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -118.57 178.53 4.43 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.594 1.158 . . . . 0.0 114.059 175.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' B' ' 26' ' ' LEU . 7.2 tp -44.43 -45.46 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 118.671 2.841 . . . . 0.0 118.671 -174.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -73.13 -46.76 49.23 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' B' ' 22' ' ' ASP . 65.3 mt-10 -51.65 -40.84 60.73 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 112.117 -2.311 . . . . 0.0 112.559 167.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.494 ' HA ' HD12 ' B' ' 29' ' ' ILE . 4.3 tp -54.93 -40.36 69.81 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 173.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.489 ' O ' ' HG2' ' B' ' 31' ' ' ARG . . . -48.7 -52.12 21.25 Favored Glycine 0 N--CA 1.477 1.372 0 C-N-CA 124.717 1.151 . . . . 0.0 112.951 174.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -55.3 -44.59 75.91 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 113.93 -1.135 . . . . 0.0 113.025 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' B' ' 26' ' ' LEU . 13.2 mt -65.59 -48.91 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.735 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 77.5 mt -54.46 -41.36 69.37 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' B' ' 27' ' ' GLY . 46.2 mmt-85 -59.48 -34.21 72.28 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.08 -1.418 . . . . 0.0 112.514 178.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' B' ' 33' ' ' THR . . . -84.76 126.32 33.31 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' THR . . . . . 0.675 ' H ' ' N ' ' A' ' 35' ' ' NH2 . 1.7 p -118.17 91.72 3.64 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.876 2.47 . . . . 0.0 109.895 -10.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.52 -149.55 5.29 Favored Glycine 0 N--CA 1.481 1.672 0 CA-C-N 113.599 -1.637 . . . . 0.0 113.222 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.074 0 O-C-N 119.946 -1.914 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.209 -1.029 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -75.75 131.6 39.92 Favored 'General case' 0 C--N 1.31 -1.121 1 C-N-CA 135.469 5.508 . . . . 0.0 113.529 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.8 m -61.43 153.37 27.23 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.257 1.023 . . . . 0.0 112.551 173.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 75.44 -41.72 0.45 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 126.492 1.917 . . . . 0.0 112.19 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.0 -51.61 63.45 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.702 1.201 . . . . 0.0 109.17 160.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -84.65 134.67 34.36 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.216 1.406 . . . . 0.0 110.089 162.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.0 mt -78.43 -18.01 55.55 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 120.587 3.551 . . . . 0.0 120.587 6.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 10' ' ' PHE . . . -41.88 -49.3 4.5 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -172.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -69.48 -44.45 71.13 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.286 1.588 . . . . 0.0 115.286 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.07 -42.73 77.12 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.44 ' HB3' ' O ' ' A' ' 7' ' ' ALA . 51.2 t80 -53.77 -51.85 62.09 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 112.525 -2.125 . . . . 0.0 111.617 174.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.505 ' HA ' ' HB3' ' A' ' 14' ' ' ASP . 7.8 mmm180 -73.84 -18.57 60.92 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 111.228 -2.715 . . . . 0.0 116.551 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . 0.274 60.7 mt -70.97 -48.99 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.52 170.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -67.72 -44.26 78.05 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 112.508 -2.133 . . . . 0.0 111.645 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.505 ' HB3' ' HA ' ' A' ' 11' ' ' ARG . 65.6 t0 -67.07 62.64 0.05 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 127.72 2.408 . . . . 0.0 112.484 177.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -62.12 -37.48 85.3 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 110.692 -2.958 . . . . 0.0 115.293 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -79.27 -2.53 41.71 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.85 37.99 21.52 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.353 1.861 . . . . 0.0 115.944 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.0 p-10 -87.95 -9.72 52.7 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.96 26.91 71.5 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.182 0.896 . . . . 0.0 113.012 -167.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' B' ' 20' ' ' TYR . 62.0 m-85 -145.91 178.85 7.87 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.265 1.426 . . . . 0.0 109.614 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.518 HG21 HD11 ' A' ' 29' ' ' ILE . 15.2 mt -128.73 138.53 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 C-N-CA 125.615 1.566 . . . . 0.0 109.29 167.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -114.7 176.42 5.06 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.344 1.858 . . . . 0.0 115.836 173.552 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 tp -43.62 -49.81 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 117.645 2.461 . . . . 0.0 117.645 -171.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -38.4 85.73 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 85.9 mt-10 -68.72 -38.71 80.41 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 128.487 2.715 . . . . 0.0 113.276 171.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.514 HD12 HD12 ' A' ' 29' ' ' ILE . 16.6 tp -56.13 -41.85 75.97 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.062 165.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . -43.48 -50.9 6.72 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 125.345 1.45 . . . . 0.0 112.68 167.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 42.4 mt-10 -51.45 -53.19 39.57 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 172.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.518 HD11 HG21 ' A' ' 21' ' ' ILE . 2.9 mt -63.34 -44.38 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 124.555 1.142 . . . . 0.0 109.234 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.01 -9.72 32.96 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 177.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 27' ' ' GLY . 74.5 mtt180 -78.98 89.07 4.74 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.295 0.569 . . . . 0.0 109.65 174.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.74 83.38 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 112.94 -1.936 . . . . 0.0 112.311 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.2 p -77.15 69.22 3.4 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 113.528 -1.669 . . . . 0.0 112.541 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -141.37 -107.88 0.69 Allowed Glycine 0 N--CA 1.482 1.703 0 CA-C-N 112.333 -2.212 . . . . 0.0 109.661 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.737 0 O-C-N 119.994 -1.886 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.682 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -42.08 126.95 3.39 Favored 'General case' 0 C--N 1.304 -1.377 1 C-N-CA 134.92 5.288 . . . . 0.0 111.635 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' B' ' 5' ' ' GLU . 34.8 t -138.17 143.88 40.46 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.038 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -40.39 -52.56 2.72 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.738 1.215 . . . . 0.0 114.151 168.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -60.04 -44.06 94.92 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.938 0.895 . . . . 0.0 112.16 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' B' ' 2' ' ' SER . 11.4 tt0 -53.37 -57.38 10.8 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.831 1.252 . . . . 0.0 111.04 170.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.96 -40.93 73.96 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 176.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.29 -39.31 63.86 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.916 1.286 . . . . 0.0 113.419 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -73.82 -49.43 25.25 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.8 -42.65 68.6 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -51.16 -52.68 41.77 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 112.466 -2.152 . . . . 0.0 111.28 173.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.509 ' HD3' ' HA ' ' B' ' 11' ' ' ARG . 8.3 mmt180 -71.43 -25.37 62.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 111.061 -2.791 . . . . 0.0 117.723 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 30.5 mt -69.09 -41.68 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-O 122.827 1.299 . . . . 0.0 111.858 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -68.48 -44.77 74.04 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 112.966 -1.924 . . . . 0.0 111.225 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -69.85 65.6 0.23 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 128.706 2.802 . . . . 0.0 113.36 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.463 ' NZ ' ' HG2' ' B' ' 28' ' ' GLU . 63.3 mttp -49.38 -53.64 21.44 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 109.904 -3.317 . . . . 0.0 114.071 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -85.35 17.92 2.9 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 53.68 33.79 17.42 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 162.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -93.75 1.75 56.43 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.77 28.72 73.9 Favored Glycine 0 N--CA 1.486 1.993 0 C-N-CA 123.906 0.765 . . . . 0.0 112.674 -169.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 59.7 m-85 -143.76 176.64 9.09 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.502 1.121 . . . . 0.0 111.877 -175.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 30.4 mm -123.38 128.41 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 168.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -98.38 173.36 7.01 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 168.258 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.4 tp -49.98 -49.98 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 -173.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.95 -38.35 90.69 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' B' ' 22' ' ' ASP . 62.7 mt-10 -61.83 -42.25 98.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.714 -2.039 . . . . 0.0 113.613 171.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.485 ' HA ' HD12 ' B' ' 29' ' ' ILE . 47.9 tp -54.89 -40.57 69.9 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 167.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.23 -47.42 68.01 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 124.354 0.978 . . . . 0.0 112.485 170.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.48 ' HG3' ' CZ ' ' B' ' 31' ' ' ARG . 1.6 mp0 -56.09 -35.1 66.63 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' B' ' 26' ' ' LEU . 17.2 mt -71.84 -59.33 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 66.5 mt -63.53 -10.35 17.54 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.48 ' CZ ' ' HG3' ' B' ' 28' ' ' GLU . 65.2 mtt180 -40.64 -45.63 2.39 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 126.005 1.722 . . . . 0.0 115.313 172.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.77 -41.17 68.69 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 2.2 p -78.39 28.75 0.19 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -175.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.69 -116.68 4.92 Favored Glycine 0 N--CA 1.48 1.593 0 CA-C-O 122.489 1.05 . . . . 0.0 113.236 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.128 0 O-C-N 119.861 -1.964 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 70' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.2 -1.517 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -66.74 161.46 23.54 Favored 'General case' 0 C--N 1.308 -1.22 1 C-N-CA 139.701 7.2 . . . . 0.0 112.817 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 t 57.35 -149.6 0.46 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.151 1.781 . . . . 0.0 112.397 173.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -54.12 -25.74 23.76 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -64.34 -32.74 74.47 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -54.21 -37.54 64.69 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.802 0.841 . . . . 0.0 112.218 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.839 HD11 ' HA2' ' B' ' 27' ' ' GLY . 5.9 tp -59.37 -50.56 73.48 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.174 1.39 . . . . 0.0 114.063 174.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.89 -48.05 70.48 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.674 1.19 . . . . 0.0 111.965 176.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -65.47 -47.62 75.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 114.395 1.258 . . . . 0.0 114.395 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.75 -46.17 67.38 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.525 ' HD1' ' HG ' ' B' ' 26' ' ' LEU . 12.0 t80 -55.14 -49.37 71.97 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.772 175.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -67.41 -35.61 79.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 111.855 -2.43 . . . . 0.0 117.297 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 38.2 mt -60.62 -51.87 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 123.496 1.617 . . . . 0.0 110.111 175.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -76.77 -36.19 57.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 111.061 -2.79 . . . . 0.0 115.272 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -78.36 53.18 1.23 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.986 2.114 . . . . 0.0 112.672 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -48.55 -54.11 15.71 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 111.174 -2.739 . . . . 0.0 114.396 -173.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -82.19 12.69 4.05 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 53.93 32.65 15.68 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 170.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -82.92 0.73 42.99 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 112.769 -2.014 . . . . 0.0 112.874 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.02 18.81 60.58 Favored Glycine 0 N--CA 1.484 1.894 0 C-N-CA 125.562 1.553 . . . . 0.0 112.295 -172.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.824 ' HB3' ' HB3' ' B' ' 20' ' ' TYR . 11.4 m-85 -132.1 163.43 28.5 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.872 1.269 . . . . 0.0 109.365 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.5 mt -116.31 133.33 63.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 123.732 0.813 . . . . 0.0 109.887 170.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -102.24 175.96 5.35 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.058 174.849 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' B' ' 6' ' ' LEU . 8.8 tp -49.48 -45.35 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 118.132 2.641 . . . . 0.0 118.132 -174.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.518 ' HG3' ' O ' ' B' ' 0' ' ' ACE . 26.0 tt0 -66.85 -46.79 73.94 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.664 1.221 . . . . 0.0 114.252 178.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 81.9 mt-10 -56.63 -44.17 80.96 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 111.517 -2.583 . . . . 0.0 111.185 171.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.633 HD22 ' HD1' ' B' ' 10' ' ' PHE . 1.4 tp -63.99 -47.22 81.21 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.723 1.209 . . . . 0.0 112.509 173.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.98 -45.67 50.58 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.606 1.098 . . . . 0.0 111.735 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.458 ' O ' ' HA3' ' A' ' 34' ' ' GLY . 36.6 mt-10 -54.25 -50.57 66.91 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 172.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.3 mt -59.76 -48.55 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 123.22 0.608 . . . . 0.0 109.582 175.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -21.7 60.51 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.565 ' NH1' ' H ' ' A' ' 32' ' ' ALA . 9.5 mmm180 -74.36 158.89 33.15 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.677 1.591 . . . . 0.0 113.408 172.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.565 ' H ' ' NH1' ' A' ' 31' ' ' ARG . . . -61.05 -34.22 74.53 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.812 169.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.2 p -96.0 67.67 2.68 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.248 175.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 28' ' ' GLU . . . 178.93 -67.4 0.08 OUTLIER Glycine 0 N--CA 1.48 1.617 0 CA-C-N 113.314 -1.767 . . . . 0.0 110.895 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.72 0 O-C-N 120.03 -1.865 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 0' ' ' ACE . . . . . 0.518 ' O ' ' HG3' ' A' ' 24' ' ' GLU . . . . . . . . 0 C--O 1.201 -1.462 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -56.95 146.66 26.12 Favored 'General case' 0 N--CA 1.483 1.194 1 C-N-CA 143.011 8.524 . . . . 0.0 112.966 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 59.3 p -101.32 90.12 4.0 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.652 -1.158 . . . . 0.0 107.889 161.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.76 148.0 48.62 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -47.11 -51.22 18.49 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.8 2.04 . . . . 0.0 112.667 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -51.92 -49.98 62.01 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.401 1.081 . . . . 0.0 112.745 176.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.521 ' HB3' HD11 ' A' ' 23' ' ' ILE . 21.2 mt -64.19 -42.33 96.71 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.15 -40.19 61.06 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.773 1.229 . . . . 0.0 113.05 174.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -71.51 -49.36 41.81 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.16 -35.9 67.72 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 173.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.633 ' HD1' HD22 ' A' ' 26' ' ' LEU . 27.7 t80 -56.24 -51.72 67.06 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.572 1.949 . . . . 0.0 110.969 174.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.721 HH12 ' HA2' ' B' ' 19' ' ' GLY . 2.3 mpt_? -63.62 -30.43 71.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 112.429 -2.168 . . . . 0.0 116.13 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 37.6 mm -62.53 -46.31 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 123.67 1.7 . . . . 0.0 111.279 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -78.33 -39.97 37.95 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 128.368 2.667 . . . . 0.0 112.795 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' ASP . . . . . 0.405 ' HB3' ' HA ' ' B' ' 11' ' ' ARG . 61.9 t0 -75.69 64.61 1.74 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.415 2.286 . . . . 0.0 109.717 174.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -39.96 -51.0 2.53 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 110.862 -2.881 . . . . 0.0 114.158 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -77.79 -17.2 57.74 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 62.96 54.9 2.09 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.441 2.296 . . . . 0.0 113.724 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 31.2 p30 -88.74 -18.43 27.83 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 116.582 2.067 . . . . 0.0 116.582 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' GLY . . . . . 0.721 ' HA2' HH12 ' B' ' 11' ' ' ARG . . . 95.52 15.18 44.57 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 124.44 1.019 . . . . 0.0 113.286 -170.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' TYR . . . . . 0.824 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 14.7 m-85 -149.38 168.87 22.2 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.348 1.059 . . . . 0.0 110.93 -171.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 28.2 mm -118.29 132.37 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.776 169.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -107.71 173.73 6.19 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.125 -1.398 . . . . 0.0 114.627 171.567 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 tp -48.57 -48.48 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 -170.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . 0.254 0.0 OUTLIER -67.02 -40.79 87.32 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 177.716 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' B' ' 28' ' ' GLU . 88.2 mt-10 -61.34 -43.95 98.02 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 112.35 -2.205 . . . . 0.0 111.224 170.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.525 ' HG ' ' HD1' ' A' ' 10' ' ' PHE . 2.8 tm? -61.1 -43.21 99.24 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 169.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.839 ' HA2' HD11 ' A' ' 6' ' ' LEU . . . -45.02 -54.54 6.9 Favored Glycine 0 N--CA 1.479 1.538 0 C-N-CA 124.134 0.873 . . . . 0.0 112.823 169.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' B' ' 25' ' ' GLU . 20.5 tt0 -53.44 -52.02 60.78 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 112.295 -1.952 . . . . 0.0 113.195 171.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 49.6 mt -54.82 -50.68 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.41 0.684 . . . . 0.0 110.093 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.552 HD22 HD12 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -60.15 -25.97 65.92 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -177.246 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -56.93 -46.46 82.04 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.094 0.871 . . . . 0.0 113.256 171.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.89 -57.36 3.14 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 27.2 p -118.55 95.83 5.02 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.66 1.184 . . . . 0.0 109.816 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.92 110.92 3.5 Favored Glycine 0 N--CA 1.485 1.928 0 CA-C-N 113.842 -1.526 . . . . 0.0 111.683 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.867 0 O-C-N 120.805 -1.409 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 70' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.506 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . 0.422 ' NZ ' ' HA ' ' B' ' 31' ' ' ARG . 0.0 OUTLIER -47.33 87.74 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.468 1 C-N-CA 139.033 6.933 . . . . 0.0 113.381 . . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.2 p -67.48 -29.76 69.28 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.243 -1.344 . . . . 0.0 113.847 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 60.89 -60.43 0.08 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 126.486 1.914 . . . . 0.0 112.87 -165.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -60.94 -53.94 51.16 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.32 -31.26 69.61 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.8 tp -58.41 -43.33 88.57 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.136 1.374 . . . . 0.0 113.242 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.79 -47.05 71.16 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.255 1.022 . . . . 0.0 112.86 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.517 ' O ' HG12 ' A' ' 12' ' ' ILE . 65.1 m-80 -60.66 -52.79 63.65 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 117.928 -1.034 . . . . 0.0 113.459 169.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.34 -45.11 24.44 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -52.58 -53.88 40.52 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.061 -1.882 . . . . 0.0 111.254 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -66.99 -30.72 70.92 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 111.649 -2.523 . . . . 0.0 117.095 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 8' ' ' ASN . 35.1 mm -65.83 -44.97 92.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 122.912 1.339 . . . . 0.0 111.009 176.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -70.61 -44.88 66.35 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 112.201 -2.272 . . . . 0.0 111.908 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -73.25 52.54 0.36 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 128.294 2.638 . . . . 0.0 113.27 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HD2' ' N ' ' A' ' 16' ' ' ASN . 0.1 OUTLIER -52.68 -42.59 64.9 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 113.563 -1.653 . . . . 0.0 115.066 174.615 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.476 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 5.1 p-10 -79.06 12.8 2.05 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 116.909 2.188 . . . . 0.0 116.909 176.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 57.72 24.93 11.19 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 119.686 3.217 . . . . 0.0 119.686 161.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -93.19 4.0 54.73 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -175.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.38 25.83 70.23 Favored Glycine 0 CA--C 1.54 1.634 0 O-C-N 123.695 0.622 . . . . 0.0 112.694 -170.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.51 ' HB3' ' HB3' ' B' ' 20' ' ' TYR . 36.2 m-85 -139.85 167.12 22.85 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.676 1.19 . . . . 0.0 112.321 -178.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -117.79 127.76 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-N 112.495 -2.139 . . . . 0.0 109.818 170.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.57 177.31 4.88 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 113.195 -1.821 . . . . 0.0 113.471 172.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.6 tp -48.47 -47.63 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -66.26 -38.57 88.16 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -67.05 -40.28 87.1 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 127.027 2.131 . . . . 0.0 113.119 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 29' ' ' ILE . 6.1 tp -64.8 -41.75 95.55 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.569 168.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 31' ' ' ARG . . . -57.36 -29.07 59.93 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 124.635 1.112 . . . . 0.0 114.331 170.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -73.13 -39.05 66.04 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 169.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 26' ' ' LEU . 23.4 mt -62.67 -71.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 168.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.5 mt -85.25 71.02 10.91 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 124.922 2.296 . . . . 0.0 112.576 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 41.0 ttt180 -59.08 -37.81 77.97 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 109.039 -3.71 . . . . 0.0 113.738 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.62 88.94 0.97 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 122.814 1.292 . . . . 0.0 110.312 174.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.5 p -65.14 135.27 55.3 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 113.458 -1.701 . . . . 0.0 113.146 -170.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.499 ' HA3' ' HB3' ' B' ' 5' ' ' GLU . . . -80.14 81.51 1.52 Allowed Glycine 0 CA--C 1.533 1.167 0 CA-C-N 113.174 -1.83 . . . . 0.0 113.591 -173.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.793 0 O-C-N 121.496 -1.002 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.663 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 22.2 tttp -67.4 -50.55 59.06 Favored 'General case' 0 C--N 1.304 -1.388 1 C-N-CA 137.005 6.122 . . . . 0.0 111.506 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 14.2 p -61.25 -46.46 90.3 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 112.45 -2.159 . . . . 0.0 113.575 174.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.83 -3.75 36.86 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 175.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -53.99 -53.94 45.94 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -167.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.499 ' HB3' ' HA3' ' A' ' 34' ' ' GLY . 8.4 tp10 -70.01 -32.2 70.25 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.72 -43.02 68.71 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.948 1.299 . . . . 0.0 112.968 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' B' ' 10' ' ' PHE . . . -48.57 -50.93 30.25 Favored 'General case' 0 CA--C 1.554 1.123 0 O-C-N 125.386 1.679 . . . . 0.0 113.063 176.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -63.9 -48.72 75.52 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 175.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.42 ' HA ' HD12 ' B' ' 12' ' ' ILE . . . -53.48 -40.87 65.68 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 176.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.437 ' HB3' ' O ' ' B' ' 7' ' ' ALA . 47.7 t80 -52.63 -55.27 23.57 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 112.926 -1.943 . . . . 0.0 112.411 173.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -68.54 -20.34 64.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 110.108 -3.224 . . . . 0.0 115.962 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' B' ' 9' ' ' ALA . 51.8 mt -69.35 -52.37 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 122.856 1.312 . . . . 0.0 112.12 174.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -63.63 -35.57 80.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 112.049 -2.341 . . . . 0.0 114.317 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -65.85 46.21 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 128.961 2.904 . . . . 0.0 114.842 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -53.65 -41.68 67.03 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.903 2.081 . . . . 0.0 115.666 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -80.52 14.65 1.95 Allowed 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 56.58 23.17 7.38 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 119.757 3.243 . . . . 0.0 119.757 161.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -88.41 -8.71 54.54 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 113.096 -1.865 . . . . 0.0 115.61 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.86 27.38 73.24 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 123.953 0.787 . . . . 0.0 112.09 -167.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' TYR . . . . . 0.51 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 51.6 m-85 -140.95 170.81 15.03 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.356 1.462 . . . . 0.0 109.409 174.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.44 ' HA ' ' OE1' ' B' ' 25' ' ' GLU . 1.4 mp -118.72 140.25 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.204 169.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.43 -176.41 2.91 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.036 0.934 . . . . 0.0 112.506 172.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 tp -53.57 -40.49 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -65.01 -46.58 80.75 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 122.548 1.166 . . . . 0.0 113.638 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.44 ' OE1' ' HA ' ' B' ' 21' ' ' ILE . 84.4 mt-10 -62.94 -44.44 96.07 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 112.06 -2.336 . . . . 0.0 112.424 173.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.53 ' HG ' HD13 ' B' ' 30' ' ' LEU . 0.9 OUTLIER -58.82 -40.42 84.08 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.53 1.132 . . . . 0.0 111.706 170.765 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.67 -49.26 62.08 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 124.492 1.044 . . . . 0.0 111.847 172.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.08 -37.17 73.97 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' B' ' 26' ' ' LEU . 21.2 mt -70.99 -59.41 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.269 1.028 . . . . 0.0 109.392 175.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.53 HD13 ' HG ' ' B' ' 26' ' ' LEU . 6.7 mp -82.83 17.91 1.74 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 -170.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.515 ' CZ ' ' H ' ' B' ' 32' ' ' ALA . 0.0 OUTLIER -44.14 -55.92 4.44 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -167.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ALA . . . . . 0.515 ' H ' ' CZ ' ' B' ' 31' ' ' ARG . . . -77.48 -57.11 4.0 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 41.6 p -78.47 94.32 4.91 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.328 1.051 . . . . 0.0 111.523 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.03 -35.62 3.39 Favored Glycine 0 CA--C 1.542 1.734 0 CA-C-N 114.192 -1.367 . . . . 0.0 113.914 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.148 0 O-C-N 119.955 -1.909 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 70' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.01 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -56.5 113.44 1.6 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 117.11 -3.494 . . . . 0.0 112.502 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.447 ' HA ' ' NH1' ' B' ' 31' ' ' ARG . 18.5 m -49.66 124.12 9.04 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 113.714 -1.584 . . . . 0.0 112.15 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 6' ' ' LEU . 8.1 mp0 75.77 -47.58 0.58 Allowed 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 126.078 1.751 . . . . 0.0 115.033 -176.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.34 -57.68 11.3 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.416 1.086 . . . . 0.0 111.887 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -61.04 -43.74 98.43 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.312 1.045 . . . . 0.0 112.065 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.799 HD13 ' HE ' ' B' ' 31' ' ' ARG . 5.5 tp -45.37 -49.58 12.93 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.252 1.821 . . . . 0.0 114.309 169.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.01 -44.91 51.45 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.587 0.755 . . . . 0.0 112.932 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -71.97 -49.59 35.96 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.902 1.281 . . . . 0.0 113.838 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.89 -39.49 26.17 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -51.98 -56.29 15.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.541 173.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.422 ' NH2' ' HA2' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -68.36 -35.12 77.25 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 110.721 -2.945 . . . . 0.0 116.451 -177.697 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 53.5 mt -56.3 -58.58 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 112.975 -1.921 . . . . 0.0 111.267 175.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -67.59 -39.03 84.82 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 111.803 -2.453 . . . . 0.0 113.268 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -77.38 61.12 2.14 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 127.13 2.172 . . . . 0.0 110.07 170.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -49.5 -41.69 41.5 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 112.667 -2.06 . . . . 0.0 115.094 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 44.5 p30 -72.49 -19.43 61.54 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 64.99 55.01 1.19 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 127.194 2.197 . . . . 0.0 114.433 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -104.14 0.24 29.37 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.422 ' HA2' ' NH2' ' A' ' 11' ' ' ARG . . . 76.55 17.78 79.62 Favored Glycine 0 N--CA 1.478 1.472 0 N-CA-C 114.987 0.755 . . . . 0.0 114.987 -173.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -133.96 164.57 27.01 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.595 1.188 . . . . 0.0 109.176 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.409 ' HB ' HG22 ' B' ' 21' ' ' ILE 0.25 5.2 mt -124.08 121.06 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 113.121 -1.854 . . . . 0.0 109.163 165.472 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -95.7 173.67 7.36 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.514 -1.676 . . . . 0.0 114.256 171.361 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.0 tp -48.33 -47.71 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 -171.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.43 -38.67 87.99 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 175.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 82.9 mt-10 -69.41 -43.2 73.9 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 111.836 -2.438 . . . . 0.0 112.776 176.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.613 HD22 ' HD1' ' B' ' 10' ' ' PHE . 4.9 tp -68.18 -36.0 78.91 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 124.165 0.916 . . . . 0.0 111.756 170.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -47.79 -55.31 9.9 Favored Glycine 0 N--CA 1.477 1.427 0 C-N-CA 124.305 0.955 . . . . 0.0 112.087 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -62.41 -24.51 67.44 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 26' ' ' LEU . 14.3 mt -72.55 -75.59 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 165.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -34.35 71.91 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 118.553 2.797 . . . . 0.0 118.553 -163.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.736 ' HD3' ' HB2' ' B' ' 6' ' ' LEU . 2.4 tpt180 -85.17 137.38 33.05 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -166.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.09 92.66 2.19 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 154.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.5 p -55.95 95.58 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -160.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -176.98 -56.35 0.06 OUTLIER Glycine 0 CA--C 1.535 1.319 0 CA-C-N 110.374 -3.103 . . . . 0.0 108.778 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.739 0 O-C-N 120.076 -1.838 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.538 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' LYS . . . . . 0.539 ' HE2' ' HG3' ' B' ' 3' ' ' GLU . 75.1 tttt -84.39 121.6 27.77 Favored 'General case' 0 C--N 1.299 -1.63 1 C-N-CA 139.171 6.988 . . . . 0.0 112.767 . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 55.5 p -59.44 -43.98 93.02 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 113.054 -1.884 . . . . 0.0 113.911 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.539 ' HG3' ' HE2' ' B' ' 1' ' ' LYS . 15.9 pt-20 -106.27 56.28 0.66 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.896 1.332 . . . . 0.0 112.235 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -55.42 -58.71 6.63 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 113.462 -1.699 . . . . 0.0 114.778 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' GLU . . . . . 0.639 ' HB2' HH12 ' A' ' 31' ' ' ARG . 22.6 mm-40 -63.29 -34.47 77.75 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -170.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.736 ' HB2' ' HD3' ' A' ' 31' ' ' ARG . 30.6 tp -42.84 -48.82 5.81 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 168.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.27 -62.56 1.57 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.876 1.27 . . . . 0.0 111.102 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -46.33 -53.12 11.44 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 167.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.52 -40.68 62.71 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 176.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.613 ' HD1' HD22 ' A' ' 26' ' ' LEU . 4.9 t80 -57.98 -48.85 78.77 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.866 175.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.89 -24.28 61.63 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 41.3 mm -70.23 -52.0 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 113.67 -1.605 . . . . 0.0 112.283 171.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -71.35 -36.3 71.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 112.63 -2.077 . . . . 0.0 114.918 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -80.38 68.14 6.46 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 127.099 2.16 . . . . 0.0 110.033 171.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -44.12 -55.41 4.77 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 111.69 -2.504 . . . . 0.0 113.724 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -85.33 16.19 3.85 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 50.82 42.15 27.41 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 166.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 38.8 p30 -98.65 3.52 47.82 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.06 -1.882 . . . . 0.0 114.486 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.07 23.63 69.76 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.442 1.496 . . . . 0.0 114.073 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -137.46 171.58 14.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.033 0.933 . . . . 0.0 111.563 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.409 HG22 ' HB ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -129.21 133.52 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.635 163.22 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -115.35 172.92 6.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 169.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . 0.264 9.0 tp -43.16 -35.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -170.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . 0.303 0.0 OUTLIER -74.5 -44.03 53.26 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 174.252 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' B' ' 22' ' ' ASP . 49.9 mt-10 -58.03 -46.23 85.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 128.074 2.55 . . . . 0.0 110.404 169.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -68.32 -38.58 81.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.675 1.59 . . . . 0.0 112.425 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.19 -62.44 5.7 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 125.745 1.64 . . . . 0.0 110.953 170.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -47.98 -41.14 24.42 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.407 HG13 ' O ' ' B' ' 25' ' ' GLU . 12.2 mt -66.23 -72.36 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 172.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mt -60.87 -34.12 74.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 119.124 3.009 . . . . 0.0 119.124 -168.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ARG . . . . . 0.799 ' HE ' HD13 ' A' ' 6' ' ' LEU . 2.9 mmp_? -66.81 -13.61 61.72 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.3 -38.91 71.89 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.358 0.663 . . . . 0.0 111.643 166.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 44.8 p -107.77 58.83 0.62 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.763 1.225 . . . . 0.0 109.434 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 157.7 59.44 0.01 OUTLIER Glycine 0 CA--C 1.539 1.559 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.617 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.144 0 O-C-N 120.463 -1.61 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 70' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.886 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -53.6 139.56 31.42 Favored 'General case' 0 C--N 1.299 -1.608 1 C-N-CA 142.179 8.192 . . . . 0.0 113.219 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.7 t -120.97 94.64 4.41 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.028 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.309 0.2 OUTLIER 42.94 -98.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 125.787 1.635 . . . . 0.0 115.006 -175.223 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -78.29 -22.53 48.08 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -87.8 92.2 9.03 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.952 2.101 . . . . 0.0 116.504 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.537 HD22 ' HE ' ' A' ' 11' ' ' ARG . 6.6 tt -85.72 151.54 23.77 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 129.298 3.039 . . . . 0.0 108.593 -20.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.555 ' O ' ' HB3' ' A' ' 10' ' ' PHE 0.761 . . -40.28 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 119.812 3.264 . . . . 0.0 119.812 174.775 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -56.11 -45.8 79.34 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 111.038 -2.801 . . . . 0.0 112.293 169.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.36 -37.98 62.9 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 169.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.555 ' HB3' ' O ' ' A' ' 7' ' ' ALA . 14.7 t80 -53.47 -51.37 62.93 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 112.781 -2.009 . . . . 0.0 112.056 173.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.537 ' HE ' HD22 ' A' ' 6' ' ' LEU . 21.1 mmt85 -66.85 -42.68 85.33 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 111.759 -2.473 . . . . 0.0 115.303 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 44.0 mt -60.43 -42.91 92.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.331 -1.758 . . . . 0.0 112.168 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -78.88 -32.48 45.91 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 111.969 -2.378 . . . . 0.0 115.388 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -69.45 52.27 0.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.725 2.01 . . . . 0.0 113.325 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.463 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 33.1 mttm -49.55 -52.54 29.25 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 112.222 -2.263 . . . . 0.0 112.219 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -85.21 20.26 2.0 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 52.83 34.93 17.52 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 163.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -96.09 -3.1 45.28 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.95 31.72 81.78 Favored Glycine 0 CA--C 1.538 1.471 0 O-C-N 124.164 0.915 . . . . 0.0 112.107 -168.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -146.7 169.69 18.52 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.563 1.145 . . . . 0.0 110.456 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.441 ' HA ' ' OE1' ' A' ' 25' ' ' GLU . 2.3 mp -120.33 128.02 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.647 169.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -109.19 172.93 6.56 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.929 -1.487 . . . . 0.0 114.752 178.121 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.284 10.0 tt -52.47 -44.06 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 -171.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -43.52 82.33 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 175.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 29' ' ' ILE . 38.8 mt-10 -56.59 -43.79 80.42 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.205 1.802 . . . . 0.0 110.917 169.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.416 ' O ' HG13 ' A' ' 29' ' ' ILE . 3.4 tp -59.96 -44.67 94.28 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.425 ' HA2' HD11 ' B' ' 6' ' ' LEU . . . -52.67 -55.81 21.18 Favored Glycine 0 N--CA 1.48 1.613 0 O-C-N 124.057 0.848 . . . . 0.0 111.965 170.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -55.9 -41.65 74.84 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.48 HG23 ' O ' ' A' ' 25' ' ' GLU . 1.6 pp -72.96 -42.12 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.377 0.671 . . . . 0.0 110.573 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.3 mt -66.77 -27.14 67.36 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -50.87 -32.5 20.63 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.882 1.673 . . . . 0.0 113.638 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.65 17.79 0.11 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -173.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 t -97.95 67.92 1.98 Allowed 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 122.177 0.989 . . . . 0.0 113.308 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.57 148.48 8.42 Favored Glycine 0 CA--C 1.54 1.654 0 CA-C-O 122.957 1.31 . . . . 0.0 111.248 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.823 0 O-C-N 120.279 -1.718 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.206 -1.236 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -72.32 128.58 36.06 Favored 'General case' 0 C--N 1.301 -1.54 1 C-N-CA 138.945 6.898 . . . . 0.0 111.411 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 90.5 p -82.83 153.67 25.07 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 113.8 -1.546 . . . . 0.0 111.878 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -50.51 -39.87 49.87 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.704 1.202 . . . . 0.0 113.396 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -65.23 -45.53 84.29 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -56.92 -42.08 79.32 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.657 0.598 . . . . 0.0 112.561 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.425 HD11 ' HA2' ' A' ' 27' ' ' GLY . 20.6 tp -56.07 -51.22 68.63 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 173.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.55 -41.59 66.61 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.275 1.03 . . . . 0.0 113.056 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -66.34 -45.5 80.0 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 174.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.03 -36.21 65.27 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -56.69 -58.76 6.71 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.881 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -68.12 -18.83 64.74 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 111.657 -2.52 . . . . 0.0 116.739 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 55.4 mt -72.86 -49.19 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 114.319 -1.31 . . . . 0.0 112.809 171.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -77.03 -36.93 55.79 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 112.823 -1.99 . . . . 0.0 113.9 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -72.8 51.92 0.29 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 128.093 2.557 . . . . 0.0 110.501 169.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' LYS . . . . . 0.576 ' HE3' ' HG2' ' B' ' 25' ' ' GLU . 44.5 mtmt -47.33 -47.53 25.7 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 112.34 -2.209 . . . . 0.0 112.93 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -85.27 19.86 2.14 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 52.29 31.27 9.09 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 163.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -98.4 8.62 44.61 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.491 1.664 . . . . 0.0 115.491 -174.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.92 19.8 63.75 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.419 1.009 . . . . 0.0 113.413 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -136.57 169.53 17.55 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.676 1.19 . . . . 0.0 109.209 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 8.3 mt -123.07 127.02 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 113.73 -1.577 . . . . 0.0 107.241 162.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -107.88 176.19 5.22 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 113.269 -1.787 . . . . 0.0 113.521 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.45 HD11 ' H ' ' A' ' 7' ' ' ALA 0.303 5.9 tp -49.08 -54.37 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 113.056 -1.884 . . . . 0.0 116.035 -174.226 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.91 -41.5 95.53 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -174.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.576 ' HG2' ' HE3' ' B' ' 15' ' ' LYS . 62.8 mt-10 -51.63 -59.72 3.96 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 110.998 -2.819 . . . . 0.0 110.721 164.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' B' ' 29' ' ' ILE . 0.9 OUTLIER -66.16 -37.81 86.58 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 117.513 -1.232 . . . . 0.0 114.243 -178.087 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.29 -56.44 17.19 Favored Glycine 0 N--CA 1.482 1.747 0 CA-C-N 118.951 0.796 . . . . 0.0 112.273 166.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -56.62 -42.68 79.23 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 176.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' B' ' 26' ' ' LEU . 32.9 mt -58.86 -76.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 173.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp -87.1 65.41 8.88 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 125.94 2.781 . . . . 0.0 115.346 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.68 -41.82 98.11 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 110.489 -3.05 . . . . 0.0 111.913 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.18 91.77 6.21 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.164 167.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.15 154.75 44.37 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -176.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -101.28 -156.8 27.0 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-N 112.164 -2.289 . . . . 0.0 108.07 164.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.047 0 O-C-N 120.723 -1.457 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 70' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.76 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -85.85 108.15 18.0 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 118.432 -2.668 . . . . 0.0 112.895 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 91.9 p -126.94 -136.38 0.25 Allowed 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 113.384 -1.735 . . . . 0.0 108.464 171.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.08 68.96 6.37 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 123.197 1.475 . . . . 0.0 111.493 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -54.66 -42.54 71.45 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 112.824 -1.989 . . . . 0.0 113.669 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 1.2 mt-10 -85.74 127.68 34.59 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 166.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 5' ' ' GLU 0.281 3.6 pp -87.23 10.29 17.47 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 -14.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -44.71 -42.42 7.61 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 116.52 2.045 . . . . 0.0 116.52 -173.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -53.18 -47.88 68.48 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 174.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.47 -40.2 71.34 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -57.47 -50.98 71.28 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.254 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -63.06 -35.16 79.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 112.496 -2.138 . . . . 0.0 114.267 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 56.7 mt -61.16 -43.29 96.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 113.039 -1.891 . . . . 0.0 112.191 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -77.02 -40.82 45.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.833 2.053 . . . . 0.0 114.929 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -69.2 51.72 0.09 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 128.535 2.734 . . . . 0.0 114.738 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -44.44 -59.09 2.59 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 112.221 -2.263 . . . . 0.0 113.804 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -80.29 24.44 0.44 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 -176.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 50.75 33.98 9.29 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 161.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -100.07 4.56 44.72 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 112.927 -1.942 . . . . 0.0 114.181 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.26 26.11 63.43 Favored Glycine 0 N--CA 1.479 1.529 0 C-N-CA 124.772 1.177 . . . . 0.0 112.382 -171.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.557 ' HB3' ' HB3' ' B' ' 20' ' ' TYR . 13.3 m-85 -139.02 167.03 22.96 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.572 1.149 . . . . 0.0 110.296 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -112.68 127.33 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.036 168.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.08 179.27 4.67 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.384 169.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.277 5.0 tt -55.14 -40.56 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 117.071 2.248 . . . . 0.0 117.071 -171.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -67.65 -39.54 84.56 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -65.27 -43.21 91.95 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 127.208 2.203 . . . . 0.0 111.979 174.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.569 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.4 tp -61.58 -45.38 94.35 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.561 0.744 . . . . 0.0 111.191 168.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -47.01 -50.24 16.03 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 125.684 1.611 . . . . 0.0 112.404 170.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -52.86 -52.35 57.66 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.691 0.796 . . . . 0.0 112.55 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.569 HD12 ' HA ' ' A' ' 26' ' ' LEU . 10.8 mt -58.17 -50.45 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 123.881 0.872 . . . . 0.0 109.362 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -74.51 -3.71 32.44 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.86 108.99 7.01 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -170.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.97 81.67 2.85 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 113.202 -1.817 . . . . 0.0 111.507 172.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.7 p -80.01 75.68 6.75 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 113.45 -1.705 . . . . 0.0 110.065 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.07 -144.08 22.48 Favored Glycine 0 N--CA 1.482 1.733 0 CA-C-N 112.495 -2.139 . . . . 0.0 111.117 -175.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.8 0 O-C-N 120.182 -1.775 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.206 -1.23 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' LYS . . . . . 0.623 ' HD3' ' H ' ' B' ' 3' ' ' GLU . 12.0 tmtt? -76.49 137.5 39.68 Favored 'General case' 0 C--N 1.302 -1.472 1 C-N-CA 143.47 8.708 . . . . 0.0 110.447 . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 38.8 p -48.38 -37.29 16.47 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -173.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.623 ' H ' ' HD3' ' B' ' 1' ' ' LYS . 0.2 OUTLIER -127.53 88.83 2.85 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.593 0.711 . . . . 0.0 110.875 169.17 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -51.88 -38.03 54.58 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 113.989 -1.46 . . . . 0.0 112.547 171.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -85.78 142.89 28.63 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.648 1.179 . . . . 0.0 111.932 169.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.7 mt -85.33 12.14 8.79 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 -7.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' B' ' 11' ' ' ARG . . . -48.72 -57.11 6.81 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.584 1.153 . . . . 0.0 112.113 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . 0.277 13.5 m-80 -85.26 149.67 25.32 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 147.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.87 4.34 4.26 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 118.849 2.907 . . . . 0.0 118.849 -13.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' PHE . . . . . 0.528 ' HD1' HD22 ' A' ' 26' ' ' LEU . 33.4 t80 -49.93 -53.26 27.28 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.218 1.009 . . . . 0.0 112.662 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ARG . . . . . 0.535 ' HA ' ' HB3' ' B' ' 14' ' ' ASP . 0.0 OUTLIER -64.81 -31.17 72.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 110.863 -2.88 . . . . 0.0 114.623 -178.066 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 22.0 mt -69.51 -39.54 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.897 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -74.18 -39.96 62.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 112.513 -2.131 . . . . 0.0 113.066 171.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' ASP . . . . . 0.535 ' HB3' ' HA ' ' B' ' 11' ' ' ARG . 12.1 t0 -70.13 47.91 0.09 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 128.682 2.793 . . . . 0.0 114.099 176.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -46.04 -47.09 17.03 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 113.375 -1.739 . . . . 0.0 114.126 175.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -82.15 27.99 0.46 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 51.71 34.74 13.52 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 118.077 2.621 . . . . 0.0 118.077 156.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -107.9 -1.32 20.83 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.03 28.9 74.04 Favored Glycine 0 N--CA 1.475 1.241 0 C-N-CA 123.617 0.627 . . . . 0.0 112.678 -170.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 20' ' ' TYR . . . . . 0.557 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 39.2 m-85 -142.35 168.31 20.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.209 1.003 . . . . 0.0 111.065 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -117.11 129.76 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.492 1.517 . . . . 0.0 109.956 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -101.93 176.85 5.07 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.056 -1.429 . . . . 0.0 113.674 172.386 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.9 tp -48.56 -48.86 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -67.23 -41.05 86.33 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' B' ' 22' ' ' ASP . 79.5 mt-10 -59.33 -42.41 91.41 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 112.477 -2.147 . . . . 0.0 112.306 171.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' B' ' 29' ' ' ILE . 1.8 tp -64.2 -43.99 93.36 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.007 0.523 . . . . 0.0 111.804 172.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.08 -45.67 56.68 Favored Glycine 0 N--CA 1.483 1.806 0 C-N-CA 124.093 0.854 . . . . 0.0 112.453 170.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -56.88 -38.04 72.2 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.909 1.283 . . . . 0.0 113.647 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' B' ' 26' ' ' LEU . 12.8 mt -69.58 -63.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mp -72.58 17.24 0.11 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 118.34 2.719 . . . . 0.0 118.34 -173.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 56.2 ttp85 -43.4 -36.67 2.02 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 128.398 2.679 . . . . 0.0 115.601 -172.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.16 -12.74 9.31 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 36.4 p -65.0 89.88 0.08 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.672 1.189 . . . . 0.0 113.259 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.06 93.45 0.42 Allowed Glycine 0 CA--C 1.535 1.312 0 CA-C-O 123.118 1.399 . . . . 0.0 112.233 173.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.967 0 O-C-N 120.192 -1.769 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 70' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -69.26 -55.48 10.41 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.418 1.087 . . . . 0.0 113.9 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.13 -9.95 36.24 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.594 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 16.1 t80 -72.86 -68.0 0.52 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.13 161.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -65.31 -25.34 67.58 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 118.625 2.824 . . . . 0.0 118.625 -169.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 56.3 mt -66.43 -49.94 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-O 123.445 1.593 . . . . 0.0 112.648 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -81.21 -38.06 27.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 111.618 -2.537 . . . . 0.0 113.699 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.594 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -82.63 86.15 6.88 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 127.953 2.501 . . . . 0.0 113.104 -171.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -62.89 -71.67 0.16 Allowed 'General case' 0 N--CA 1.485 1.285 1 CA-C-N 107.405 -4.452 . . . . 0.0 114.518 171.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -85.84 133.39 33.97 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -174.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 41.9 43.76 2.7 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 124.755 2.217 . . . . 0.0 116.583 164.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 1.006 ' HA ' ' H ' ' A' ' 20' ' ' TYR 0.577 1.5 p30 -94.73 67.28 3.24 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 109.895 -3.321 . . . . 0.0 119.612 -172.024 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.47 -4.44 89.29 Favored Glycine 0 CA--C 1.556 2.623 1 CA-C-N 94.818 -10.174 . . . . 0.0 116.41 112.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 1.006 ' H ' ' HA ' ' A' ' 18' ' ' ASP . 17.3 m-85 -137.99 157.26 46.73 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.61 HG22 ' HB ' ' B' ' 21' ' ' ILE . 0.0 OUTLIER -116.14 142.97 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 129.576 3.15 . . . . 0.0 109.879 172.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.29 -176.56 2.93 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.93 1.292 . . . . 0.0 112.87 173.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 tp -52.61 -45.87 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 117.503 2.409 . . . . 0.0 117.503 -175.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -66.78 -43.31 84.31 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -62.79 -40.78 98.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 111.983 -2.371 . . . . 0.0 112.392 172.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.71 ' HA ' HD12 ' A' ' 29' ' ' ILE . 3.2 tp -59.45 -48.08 83.01 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.32 1.048 . . . . 0.0 111.554 170.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -49.73 -50.39 31.67 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.315 0.96 . . . . 0.0 111.652 171.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -54.84 -43.83 73.37 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.71 HD12 ' HA ' ' A' ' 26' ' ' LEU . 8.5 mt -61.46 -47.77 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.029 0.532 . . . . 0.0 110.198 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 mp . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 174.68 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 6.1 tp . . . . . 0 N--CA 1.472 0.627 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.77 -47.07 59.74 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.824 1.25 . . . . 0.0 112.241 171.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -60.31 -49.95 75.56 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 171.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.79 -41.28 63.98 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 174.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.512 ' HD1' HD22 ' A' ' 26' ' ' LEU . 20.5 t80 -57.31 -47.96 80.16 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.054 -1.885 . . . . 0.0 111.932 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -38.52 91.37 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 112.179 -2.282 . . . . 0.0 114.915 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 46.7 mt -61.94 -41.98 92.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 112.985 -1.916 . . . . 0.0 113.016 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -77.99 -38.69 44.44 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 112.339 -2.21 . . . . 0.0 114.802 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -75.13 59.4 0.97 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.489 2.315 . . . . 0.0 111.299 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -46.75 -50.1 18.64 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 111.864 -2.425 . . . . 0.0 114.627 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -84.71 16.82 3.04 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 54.16 28.95 9.67 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 117.869 2.544 . . . . 0.0 117.869 166.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -89.28 4.59 48.26 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 -174.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.32 21.84 66.78 Favored Glycine 0 CA--C 1.546 2.029 0 C-N-CA 124.829 1.204 . . . . 0.0 113.758 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -140.54 172.25 12.98 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.285 1.434 . . . . 0.0 108.931 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.61 ' HB ' HG22 ' A' ' 21' ' ' ILE . 1.3 mp -124.21 146.08 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-N 114.427 -1.261 . . . . 0.0 108.512 161.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -118.57 178.53 4.43 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.594 1.158 . . . . 0.0 114.059 175.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' B' ' 26' ' ' LEU . 7.2 tp -44.43 -45.46 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 118.671 2.841 . . . . 0.0 118.671 -174.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -73.13 -46.76 49.23 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' B' ' 22' ' ' ASP . 65.3 mt-10 -51.65 -40.84 60.73 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 112.117 -2.311 . . . . 0.0 112.559 167.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.494 ' HA ' HD12 ' B' ' 29' ' ' ILE . 4.3 tp -54.93 -40.36 69.81 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 173.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -48.7 -52.12 21.25 Favored Glycine 0 N--CA 1.477 1.372 0 C-N-CA 124.717 1.151 . . . . 0.0 112.951 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -55.3 -44.59 75.91 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 113.93 -1.135 . . . . 0.0 113.025 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' B' ' 26' ' ' LEU . 13.2 mt -65.59 -48.91 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.735 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 77.5 mt . . . . . 0 N--CA 1.489 1.483 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 177.956 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 10' ' ' PHE . . . . . . . . 0 CA--C 1.542 0.644 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -69.48 -44.45 71.13 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.286 1.588 . . . . 0.0 115.286 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.07 -42.73 77.12 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.44 ' HB3' ' O ' ' A' ' 7' ' ' ALA . 51.2 t80 -53.77 -51.85 62.09 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 112.525 -2.125 . . . . 0.0 111.617 174.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.505 ' HA ' ' HB3' ' A' ' 14' ' ' ASP . 7.8 mmm180 -73.84 -18.57 60.92 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 111.228 -2.715 . . . . 0.0 116.551 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . 0.274 60.7 mt -70.97 -48.99 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.52 170.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -67.72 -44.26 78.05 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 112.508 -2.133 . . . . 0.0 111.645 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.505 ' HB3' ' HA ' ' A' ' 11' ' ' ARG . 65.6 t0 -67.07 62.64 0.05 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 127.72 2.408 . . . . 0.0 112.484 177.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -62.12 -37.48 85.3 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 110.692 -2.958 . . . . 0.0 115.293 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -79.27 -2.53 41.71 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.85 37.99 21.52 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.353 1.861 . . . . 0.0 115.944 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.0 p-10 -87.95 -9.72 52.7 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.96 26.91 71.5 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.182 0.896 . . . . 0.0 113.012 -167.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' B' ' 20' ' ' TYR . 62.0 m-85 -145.91 178.85 7.87 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.265 1.426 . . . . 0.0 109.614 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.518 HG21 HD11 ' A' ' 29' ' ' ILE . 15.2 mt -128.73 138.53 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 C-N-CA 125.615 1.566 . . . . 0.0 109.29 167.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -114.7 176.42 5.06 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.344 1.858 . . . . 0.0 115.836 173.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 tp -43.62 -49.81 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 117.645 2.461 . . . . 0.0 117.645 -171.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -38.4 85.73 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 85.9 mt-10 -68.72 -38.71 80.41 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 128.487 2.715 . . . . 0.0 113.276 171.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.514 HD12 HD12 ' A' ' 29' ' ' ILE . 16.6 tp -56.13 -41.85 75.97 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.062 165.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -43.48 -50.9 6.72 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 125.345 1.45 . . . . 0.0 112.68 167.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 42.4 mt-10 -51.45 -53.19 39.57 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 172.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.518 HD11 HG21 ' A' ' 21' ' ' ILE . 2.9 mt -63.34 -44.38 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 124.555 1.142 . . . . 0.0 109.234 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 177.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.525 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.29 -39.31 63.86 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.916 1.286 . . . . 0.0 113.419 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -73.82 -49.43 25.25 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.8 -42.65 68.6 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -51.16 -52.68 41.77 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 112.466 -2.152 . . . . 0.0 111.28 173.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.509 ' HD3' ' HA ' ' B' ' 11' ' ' ARG . 8.3 mmt180 -71.43 -25.37 62.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 111.061 -2.791 . . . . 0.0 117.723 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 30.5 mt -69.09 -41.68 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-O 122.827 1.299 . . . . 0.0 111.858 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -68.48 -44.77 74.04 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 112.966 -1.924 . . . . 0.0 111.225 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -69.85 65.6 0.23 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 128.706 2.802 . . . . 0.0 113.36 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.463 ' NZ ' ' HG2' ' B' ' 28' ' ' GLU . 63.3 mttp -49.38 -53.64 21.44 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 109.904 -3.317 . . . . 0.0 114.071 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -85.35 17.92 2.9 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 53.68 33.79 17.42 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 162.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -93.75 1.75 56.43 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.77 28.72 73.9 Favored Glycine 0 N--CA 1.486 1.993 0 C-N-CA 123.906 0.765 . . . . 0.0 112.674 -169.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 59.7 m-85 -143.76 176.64 9.09 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.502 1.121 . . . . 0.0 111.877 -175.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 30.4 mm -123.38 128.41 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 168.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -98.38 173.36 7.01 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 168.258 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.4 tp -49.98 -49.98 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 -173.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.95 -38.35 90.69 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' B' ' 22' ' ' ASP . 62.7 mt-10 -61.83 -42.25 98.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.714 -2.039 . . . . 0.0 113.613 171.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.485 ' HA ' HD12 ' B' ' 29' ' ' ILE . 47.9 tp -54.89 -40.57 69.9 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 167.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.23 -47.42 68.01 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 124.354 0.978 . . . . 0.0 112.485 170.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.463 ' HG2' ' NZ ' ' B' ' 15' ' ' LYS . 1.6 mp0 -56.09 -35.1 66.63 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' B' ' 26' ' ' LEU . 17.2 mt -71.84 -59.33 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 66.5 mt . . . . . 0 N--CA 1.482 1.164 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 -177.236 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.852 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -65.47 -47.62 75.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 114.395 1.258 . . . . 0.0 114.395 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.75 -46.17 67.38 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.525 ' HD1' ' HG ' ' B' ' 26' ' ' LEU . 12.0 t80 -55.14 -49.37 71.97 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.772 175.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -67.41 -35.61 79.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 111.855 -2.43 . . . . 0.0 117.297 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 38.2 mt -60.62 -51.87 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 123.496 1.617 . . . . 0.0 110.111 175.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -76.77 -36.19 57.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 111.061 -2.79 . . . . 0.0 115.272 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -78.36 53.18 1.23 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.986 2.114 . . . . 0.0 112.672 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -48.55 -54.11 15.71 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 111.174 -2.739 . . . . 0.0 114.396 -173.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -82.19 12.69 4.05 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 53.93 32.65 15.68 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 170.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -82.92 0.73 42.99 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 112.769 -2.014 . . . . 0.0 112.874 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.02 18.81 60.58 Favored Glycine 0 N--CA 1.484 1.894 0 C-N-CA 125.562 1.553 . . . . 0.0 112.295 -172.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.824 ' HB3' ' HB3' ' B' ' 20' ' ' TYR . 11.4 m-85 -132.1 163.43 28.5 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.872 1.269 . . . . 0.0 109.365 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.5 mt -116.31 133.33 63.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 123.732 0.813 . . . . 0.0 109.887 170.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -102.24 175.96 5.35 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.058 174.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' B' ' 6' ' ' LEU . 8.8 tp -49.48 -45.35 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 118.132 2.641 . . . . 0.0 118.132 -174.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -66.85 -46.79 73.94 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.664 1.221 . . . . 0.0 114.252 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 81.9 mt-10 -56.63 -44.17 80.96 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 111.517 -2.583 . . . . 0.0 111.185 171.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.633 HD22 ' HD1' ' B' ' 10' ' ' PHE . 1.4 tp -63.99 -47.22 81.21 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.723 1.209 . . . . 0.0 112.509 173.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.98 -45.67 50.58 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.606 1.098 . . . . 0.0 111.735 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -54.25 -50.57 66.91 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 172.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.3 mt -59.76 -48.55 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 123.22 0.608 . . . . 0.0 109.582 175.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.784 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.521 ' HB3' HD11 ' A' ' 23' ' ' ILE . 21.2 mt . . . . . 0 N--CA 1.47 0.564 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.15 -40.19 61.06 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.773 1.229 . . . . 0.0 113.05 174.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -71.51 -49.36 41.81 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.16 -35.9 67.72 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 173.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.633 ' HD1' HD22 ' A' ' 26' ' ' LEU . 27.7 t80 -56.24 -51.72 67.06 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.572 1.949 . . . . 0.0 110.969 174.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.721 HH12 ' HA2' ' B' ' 19' ' ' GLY . 2.3 mpt_? -63.62 -30.43 71.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 112.429 -2.168 . . . . 0.0 116.13 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 37.6 mm -62.53 -46.31 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 123.67 1.7 . . . . 0.0 111.279 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -78.33 -39.97 37.95 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 128.368 2.667 . . . . 0.0 112.795 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . 0.405 ' HB3' ' HA ' ' B' ' 11' ' ' ARG . 61.9 t0 -75.69 64.61 1.74 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.415 2.286 . . . . 0.0 109.717 174.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -39.96 -51.0 2.53 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 110.862 -2.881 . . . . 0.0 114.158 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -77.79 -17.2 57.74 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 62.96 54.9 2.09 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.441 2.296 . . . . 0.0 113.724 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 31.2 p30 -88.74 -18.43 27.83 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 116.582 2.067 . . . . 0.0 116.582 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . 0.721 ' HA2' HH12 ' B' ' 11' ' ' ARG . . . 95.52 15.18 44.57 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 124.44 1.019 . . . . 0.0 113.286 -170.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . 0.824 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 14.7 m-85 -149.38 168.87 22.2 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.348 1.059 . . . . 0.0 110.93 -171.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 28.2 mm -118.29 132.37 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.776 169.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -107.71 173.73 6.19 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.125 -1.398 . . . . 0.0 114.627 171.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 tp -48.57 -48.48 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 -170.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . 0.254 0.0 OUTLIER -67.02 -40.79 87.32 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 177.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' B' ' 28' ' ' GLU . 88.2 mt-10 -61.34 -43.95 98.02 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 112.35 -2.205 . . . . 0.0 111.224 170.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.525 ' HG ' ' HD1' ' A' ' 10' ' ' PHE . 2.8 tm? -61.1 -43.21 99.24 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 169.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -45.02 -54.54 6.9 Favored Glycine 0 N--CA 1.479 1.538 0 C-N-CA 124.134 0.873 . . . . 0.0 112.823 169.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' B' ' 25' ' ' GLU . 20.5 tt0 -53.44 -52.02 60.78 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 112.295 -1.952 . . . . 0.0 113.195 171.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 49.6 mt -54.82 -50.68 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.41 0.684 . . . . 0.0 110.093 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.467 0.4 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.81 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.517 ' O ' HG12 ' A' ' 12' ' ' ILE . 65.1 m-80 -60.66 -52.79 63.65 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 117.928 -1.034 . . . . 0.0 113.459 169.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.34 -45.11 24.44 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -52.58 -53.88 40.52 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.061 -1.882 . . . . 0.0 111.254 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -66.99 -30.72 70.92 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 111.649 -2.523 . . . . 0.0 117.095 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 8' ' ' ASN . 35.1 mm -65.83 -44.97 92.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 122.912 1.339 . . . . 0.0 111.009 176.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -70.61 -44.88 66.35 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 112.201 -2.272 . . . . 0.0 111.908 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -73.25 52.54 0.36 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 128.294 2.638 . . . . 0.0 113.27 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HD2' ' N ' ' A' ' 16' ' ' ASN . 0.1 OUTLIER -52.68 -42.59 64.9 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 113.563 -1.653 . . . . 0.0 115.066 174.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.476 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 5.1 p-10 -79.06 12.8 2.05 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 116.909 2.188 . . . . 0.0 116.909 176.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 57.72 24.93 11.19 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 119.686 3.217 . . . . 0.0 119.686 161.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -93.19 4.0 54.73 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -175.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.38 25.83 70.23 Favored Glycine 0 CA--C 1.54 1.634 0 O-C-N 123.695 0.622 . . . . 0.0 112.694 -170.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.51 ' HB3' ' HB3' ' B' ' 20' ' ' TYR . 36.2 m-85 -139.85 167.12 22.85 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.676 1.19 . . . . 0.0 112.321 -178.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -117.79 127.76 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-N 112.495 -2.139 . . . . 0.0 109.818 170.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.57 177.31 4.88 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 113.195 -1.821 . . . . 0.0 113.471 172.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.6 tp -48.47 -47.63 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -66.26 -38.57 88.16 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -67.05 -40.28 87.1 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 127.027 2.131 . . . . 0.0 113.119 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 29' ' ' ILE . 6.1 tp -64.8 -41.75 95.55 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.569 168.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.36 -29.07 59.93 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 124.635 1.112 . . . . 0.0 114.331 170.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -73.13 -39.05 66.04 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 169.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 26' ' ' LEU . 23.4 mt -62.67 -71.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 168.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.5 mt . . . . . 0 C--O 1.239 0.527 0 CA-C-O 124.922 2.296 . . . . 0.0 112.576 174.827 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.549 0.904 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' B' ' 10' ' ' PHE . . . -48.57 -50.93 30.25 Favored 'General case' 0 CA--C 1.554 1.123 0 O-C-N 125.386 1.679 . . . . 0.0 113.063 176.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -63.9 -48.72 75.52 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 175.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.42 ' HA ' HD12 ' B' ' 12' ' ' ILE . . . -53.48 -40.87 65.68 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 176.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.437 ' HB3' ' O ' ' B' ' 7' ' ' ALA . 47.7 t80 -52.63 -55.27 23.57 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 112.926 -1.943 . . . . 0.0 112.411 173.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -68.54 -20.34 64.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 110.108 -3.224 . . . . 0.0 115.962 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' B' ' 9' ' ' ALA . 51.8 mt -69.35 -52.37 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 122.856 1.312 . . . . 0.0 112.12 174.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -63.63 -35.57 80.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 112.049 -2.341 . . . . 0.0 114.317 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -65.85 46.21 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 128.961 2.904 . . . . 0.0 114.842 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -53.65 -41.68 67.03 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.903 2.081 . . . . 0.0 115.666 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -80.52 14.65 1.95 Allowed 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 56.58 23.17 7.38 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 119.757 3.243 . . . . 0.0 119.757 161.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -88.41 -8.71 54.54 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 113.096 -1.865 . . . . 0.0 115.61 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.86 27.38 73.24 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 123.953 0.787 . . . . 0.0 112.09 -167.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . 0.51 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 51.6 m-85 -140.95 170.81 15.03 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.356 1.462 . . . . 0.0 109.409 174.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.44 ' HA ' ' OE1' ' B' ' 25' ' ' GLU . 1.4 mp -118.72 140.25 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.204 169.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.43 -176.41 2.91 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.036 0.934 . . . . 0.0 112.506 172.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 tp -53.57 -40.49 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -65.01 -46.58 80.75 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 122.548 1.166 . . . . 0.0 113.638 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . 0.44 ' OE1' ' HA ' ' B' ' 21' ' ' ILE . 84.4 mt-10 -62.94 -44.44 96.07 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 112.06 -2.336 . . . . 0.0 112.424 173.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.53 ' HG ' HD13 ' B' ' 30' ' ' LEU . 0.9 OUTLIER -58.82 -40.42 84.08 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.53 1.132 . . . . 0.0 111.706 170.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.67 -49.26 62.08 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 124.492 1.044 . . . . 0.0 111.847 172.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.08 -37.17 73.97 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' B' ' 26' ' ' LEU . 21.2 mt -70.99 -59.41 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.269 1.028 . . . . 0.0 109.392 175.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.53 HD13 ' HG ' ' B' ' 26' ' ' LEU . 6.7 mp . . . . . 0 CA--C 1.543 0.69 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 -170.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 112.932 0.715 . . . . 0.0 112.932 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -71.97 -49.59 35.96 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.902 1.281 . . . . 0.0 113.838 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.89 -39.49 26.17 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -51.98 -56.29 15.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.541 173.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.422 ' NH2' ' HA2' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -68.36 -35.12 77.25 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 110.721 -2.945 . . . . 0.0 116.451 -177.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 53.5 mt -56.3 -58.58 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 112.975 -1.921 . . . . 0.0 111.267 175.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -67.59 -39.03 84.82 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 111.803 -2.453 . . . . 0.0 113.268 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -77.38 61.12 2.14 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 127.13 2.172 . . . . 0.0 110.07 170.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -49.5 -41.69 41.5 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 112.667 -2.06 . . . . 0.0 115.094 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 44.5 p30 -72.49 -19.43 61.54 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 64.99 55.01 1.19 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 127.194 2.197 . . . . 0.0 114.433 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -104.14 0.24 29.37 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.422 ' HA2' ' NH2' ' A' ' 11' ' ' ARG . . . 76.55 17.78 79.62 Favored Glycine 0 N--CA 1.478 1.472 0 N-CA-C 114.987 0.755 . . . . 0.0 114.987 -173.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -133.96 164.57 27.01 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.595 1.188 . . . . 0.0 109.176 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.409 ' HB ' HG22 ' B' ' 21' ' ' ILE 0.25 5.2 mt -124.08 121.06 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 113.121 -1.854 . . . . 0.0 109.163 165.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -95.7 173.67 7.36 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.514 -1.676 . . . . 0.0 114.256 171.361 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.0 tp -48.33 -47.71 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 -171.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.43 -38.67 87.99 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 175.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 82.9 mt-10 -69.41 -43.2 73.9 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 111.836 -2.438 . . . . 0.0 112.776 176.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.613 HD22 ' HD1' ' B' ' 10' ' ' PHE . 4.9 tp -68.18 -36.0 78.91 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 124.165 0.916 . . . . 0.0 111.756 170.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -47.79 -55.31 9.9 Favored Glycine 0 N--CA 1.477 1.427 0 C-N-CA 124.305 0.955 . . . . 0.0 112.087 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -62.41 -24.51 67.44 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 26' ' ' LEU . 14.3 mt -72.55 -75.59 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 165.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 118.553 2.797 . . . . 0.0 118.553 -163.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 30.6 tp . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.27 -62.56 1.57 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.876 1.27 . . . . 0.0 111.102 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . 0.581 ' H ' ' ND2' ' B' ' 8' ' ' ASN . 5.6 m-80 -46.33 -53.12 11.44 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 167.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.52 -40.68 62.71 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 176.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.613 ' HD1' HD22 ' A' ' 26' ' ' LEU . 4.9 t80 -57.98 -48.85 78.77 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.866 175.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.89 -24.28 61.63 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 41.3 mm -70.23 -52.0 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 113.67 -1.605 . . . . 0.0 112.283 171.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -71.35 -36.3 71.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 112.63 -2.077 . . . . 0.0 114.918 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -80.38 68.14 6.46 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 127.099 2.16 . . . . 0.0 110.033 171.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -44.12 -55.41 4.77 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 111.69 -2.504 . . . . 0.0 113.724 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -85.33 16.19 3.85 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 50.82 42.15 27.41 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 166.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 38.8 p30 -98.65 3.52 47.82 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.06 -1.882 . . . . 0.0 114.486 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.07 23.63 69.76 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.442 1.496 . . . . 0.0 114.073 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -137.46 171.58 14.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.033 0.933 . . . . 0.0 111.563 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.409 HG22 ' HB ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -129.21 133.52 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.635 163.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -115.35 172.92 6.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 169.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . 0.264 9.0 tp -43.16 -35.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -170.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . 0.303 0.0 OUTLIER -74.5 -44.03 53.26 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 174.252 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' B' ' 22' ' ' ASP . 49.9 mt-10 -58.03 -46.23 85.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 128.074 2.55 . . . . 0.0 110.404 169.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -68.32 -38.58 81.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.675 1.59 . . . . 0.0 112.425 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.19 -62.44 5.7 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 125.745 1.64 . . . . 0.0 110.953 170.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -47.98 -41.14 24.42 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.407 HG13 ' O ' ' B' ' 25' ' ' GLU . 12.2 mt -66.23 -72.36 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 172.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mt . . . . . 0 N--CA 1.471 0.592 0 N-CA-C 119.124 3.009 . . . . 0.0 119.124 -168.575 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.555 ' O ' ' HB3' ' A' ' 10' ' ' PHE 0.761 . . . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 119.812 3.264 . . . . 0.0 119.812 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -56.11 -45.8 79.34 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 111.038 -2.801 . . . . 0.0 112.293 169.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.36 -37.98 62.9 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 169.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.555 ' HB3' ' O ' ' A' ' 7' ' ' ALA . 14.7 t80 -53.47 -51.37 62.93 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 112.781 -2.009 . . . . 0.0 112.056 173.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.1 mmt85 -66.85 -42.68 85.33 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 111.759 -2.473 . . . . 0.0 115.303 179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 44.0 mt -60.43 -42.91 92.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.331 -1.758 . . . . 0.0 112.168 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -78.88 -32.48 45.91 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 111.969 -2.378 . . . . 0.0 115.388 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -69.45 52.27 0.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.725 2.01 . . . . 0.0 113.325 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.463 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 33.1 mttm -49.55 -52.54 29.25 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 112.222 -2.263 . . . . 0.0 112.219 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -85.21 20.26 2.0 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 52.83 34.93 17.52 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 163.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -96.09 -3.1 45.28 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.95 31.72 81.78 Favored Glycine 0 CA--C 1.538 1.471 0 O-C-N 124.164 0.915 . . . . 0.0 112.107 -168.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -146.7 169.69 18.52 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.563 1.145 . . . . 0.0 110.456 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.441 ' HA ' ' OE1' ' A' ' 25' ' ' GLU . 2.3 mp -120.33 128.02 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.647 169.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -109.19 172.93 6.56 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.929 -1.487 . . . . 0.0 114.752 178.121 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.284 10.0 tt -52.47 -44.06 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 -171.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -43.52 82.33 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 175.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 29' ' ' ILE . 38.8 mt-10 -56.59 -43.79 80.42 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.205 1.802 . . . . 0.0 110.917 169.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.416 ' O ' HG13 ' A' ' 29' ' ' ILE . 3.4 tp -59.96 -44.67 94.28 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.425 ' HA2' HD11 ' B' ' 6' ' ' LEU . . . -52.67 -55.81 21.18 Favored Glycine 0 N--CA 1.48 1.613 0 O-C-N 124.057 0.848 . . . . 0.0 111.965 170.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -55.9 -41.65 74.84 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.48 HG23 ' O ' ' A' ' 25' ' ' GLU . 1.6 pp -72.96 -42.12 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.377 0.671 . . . . 0.0 110.573 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.3 mt . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 176.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.425 HD11 ' HA2' ' A' ' 27' ' ' GLY . 20.6 tp . . . . . 0 CA--C 1.542 0.64 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.55 -41.59 66.61 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.275 1.03 . . . . 0.0 113.056 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -66.34 -45.5 80.0 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 174.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.03 -36.21 65.27 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -56.69 -58.76 6.71 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.881 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -68.12 -18.83 64.74 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 111.657 -2.52 . . . . 0.0 116.739 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 55.4 mt -72.86 -49.19 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 114.319 -1.31 . . . . 0.0 112.809 171.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -77.03 -36.93 55.79 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 112.823 -1.99 . . . . 0.0 113.9 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -72.8 51.92 0.29 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 128.093 2.557 . . . . 0.0 110.501 169.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . 0.576 ' HE3' ' HG2' ' B' ' 25' ' ' GLU . 44.5 mtmt -47.33 -47.53 25.7 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 112.34 -2.209 . . . . 0.0 112.93 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -85.27 19.86 2.14 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 52.29 31.27 9.09 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 163.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -98.4 8.62 44.61 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.491 1.664 . . . . 0.0 115.491 -174.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.92 19.8 63.75 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.419 1.009 . . . . 0.0 113.413 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -136.57 169.53 17.55 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.676 1.19 . . . . 0.0 109.209 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 8.3 mt -123.07 127.02 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 113.73 -1.577 . . . . 0.0 107.241 162.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -107.88 176.19 5.22 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 113.269 -1.787 . . . . 0.0 113.521 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . 0.303 5.9 tp -49.08 -54.37 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 113.056 -1.884 . . . . 0.0 116.035 -174.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.91 -41.5 95.53 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -174.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . 0.576 ' HG2' ' HE3' ' B' ' 15' ' ' LYS . 62.8 mt-10 -51.63 -59.72 3.96 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 110.998 -2.819 . . . . 0.0 110.721 164.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' B' ' 29' ' ' ILE . 0.9 OUTLIER -66.16 -37.81 86.58 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 117.513 -1.232 . . . . 0.0 114.243 -178.087 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.29 -56.44 17.19 Favored Glycine 0 N--CA 1.482 1.747 0 CA-C-N 118.951 0.796 . . . . 0.0 112.273 166.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -56.62 -42.68 79.23 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 176.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' B' ' 26' ' ' LEU . 32.9 mt -58.86 -76.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 173.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 N--CA 1.471 0.608 0 CA-C-O 125.94 2.781 . . . . 0.0 115.346 -178.936 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.706 0 N-CA-C 116.52 2.045 . . . . 0.0 116.52 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -53.18 -47.88 68.48 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 174.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.47 -40.2 71.34 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -57.47 -50.98 71.28 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.254 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -63.06 -35.16 79.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 112.496 -2.138 . . . . 0.0 114.267 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 56.7 mt -61.16 -43.29 96.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 113.039 -1.891 . . . . 0.0 112.191 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -77.02 -40.82 45.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.833 2.053 . . . . 0.0 114.929 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -69.2 51.72 0.09 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 128.535 2.734 . . . . 0.0 114.738 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -44.44 -59.09 2.59 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 112.221 -2.263 . . . . 0.0 113.804 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -80.29 24.44 0.44 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 -176.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 50.75 33.98 9.29 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 161.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -100.07 4.56 44.72 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 112.927 -1.942 . . . . 0.0 114.181 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.26 26.11 63.43 Favored Glycine 0 N--CA 1.479 1.529 0 C-N-CA 124.772 1.177 . . . . 0.0 112.382 -171.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.557 ' HB3' ' HB3' ' B' ' 20' ' ' TYR . 13.3 m-85 -139.02 167.03 22.96 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.572 1.149 . . . . 0.0 110.296 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -112.68 127.33 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.036 168.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.08 179.27 4.67 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.384 169.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.277 5.0 tt -55.14 -40.56 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 117.071 2.248 . . . . 0.0 117.071 -171.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -67.65 -39.54 84.56 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -65.27 -43.21 91.95 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 127.208 2.203 . . . . 0.0 111.979 174.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.569 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.4 tp -61.58 -45.38 94.35 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.561 0.744 . . . . 0.0 111.191 168.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -47.01 -50.24 16.03 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 125.684 1.611 . . . . 0.0 112.404 170.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -52.86 -52.35 57.66 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.691 0.796 . . . . 0.0 112.55 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.569 HD12 ' HA ' ' A' ' 26' ' ' LEU . 10.8 mt -58.17 -50.45 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 123.881 0.872 . . . . 0.0 109.362 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 CA--C 1.544 0.717 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -178.217 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.7 mt . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' B' ' 11' ' ' ARG . . . -48.72 -57.11 6.81 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.584 1.153 . . . . 0.0 112.113 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ASN . . . . . . . . . . . . 0.277 13.5 m-80 -85.26 149.67 25.32 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 147.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.87 4.34 4.26 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 118.849 2.907 . . . . 0.0 118.849 -13.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' PHE . . . . . 0.528 ' HD1' HD22 ' A' ' 26' ' ' LEU . 33.4 t80 -49.93 -53.26 27.28 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.218 1.009 . . . . 0.0 112.662 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ARG . . . . . 0.535 ' HA ' ' HB3' ' B' ' 14' ' ' ASP . 0.0 OUTLIER -64.81 -31.17 72.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 110.863 -2.88 . . . . 0.0 114.623 -178.066 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 22.0 mt -69.51 -39.54 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.897 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -74.18 -39.96 62.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 112.513 -2.131 . . . . 0.0 113.066 171.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' ASP . . . . . 0.535 ' HB3' ' HA ' ' B' ' 11' ' ' ARG . 12.1 t0 -70.13 47.91 0.09 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 128.682 2.793 . . . . 0.0 114.099 176.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -46.04 -47.09 17.03 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 113.375 -1.739 . . . . 0.0 114.126 175.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -82.15 27.99 0.46 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 51.71 34.74 13.52 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 118.077 2.621 . . . . 0.0 118.077 156.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -107.9 -1.32 20.83 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.03 28.9 74.04 Favored Glycine 0 N--CA 1.475 1.241 0 C-N-CA 123.617 0.627 . . . . 0.0 112.678 -170.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' TYR . . . . . 0.557 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 39.2 m-85 -142.35 168.31 20.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.209 1.003 . . . . 0.0 111.065 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -117.11 129.76 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.492 1.517 . . . . 0.0 109.956 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -101.93 176.85 5.07 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.056 -1.429 . . . . 0.0 113.674 172.386 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.9 tp -48.56 -48.86 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -67.23 -41.05 86.33 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' B' ' 22' ' ' ASP . 79.5 mt-10 -59.33 -42.41 91.41 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 112.477 -2.147 . . . . 0.0 112.306 171.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' B' ' 29' ' ' ILE . 1.8 tp -64.2 -43.99 93.36 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.007 0.523 . . . . 0.0 111.804 172.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.08 -45.67 56.68 Favored Glycine 0 N--CA 1.483 1.806 0 C-N-CA 124.093 0.854 . . . . 0.0 112.453 170.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -56.88 -38.04 72.2 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.909 1.283 . . . . 0.0 113.647 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' B' ' 26' ' ' LEU . 12.8 mt -69.58 -63.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mp . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 118.34 2.719 . . . . 0.0 118.34 -173.72 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.436 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -44.47 -76.8 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.147 1 C-N-CA 139.926 7.29 . . . . 0.0 112.793 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m -49.38 -47.29 47.79 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 126.522 1.929 . . . . 0.0 113.978 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.9 mp0 -63.32 -50.13 71.24 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.053 0.941 . . . . 0.0 111.585 -177.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -58.85 -51.2 71.03 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.504 1.122 . . . . 0.0 111.494 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -49.93 -48.82 51.58 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.991 1.316 . . . . 0.0 112.362 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.463 HD12 HD23 ' B' ' 26' ' ' LEU . 29.3 tp -53.8 -55.43 26.62 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 176.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.31 -39.64 60.85 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 113.604 0.965 . . . . 0.0 113.604 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -69.26 -55.48 10.41 Favored 'General case' 0 C--O 1.226 -0.146 0 C-N-CA 124.418 1.087 . . . . 0.0 113.9 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.13 -9.95 36.24 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 117.042 2.238 . . . . 0.0 117.042 175.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.594 ' O ' ' HB2' ' A' ' 14' ' ' ASP . 16.1 t80 -72.86 -68.0 0.52 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 114.952 -1.022 . . . . 0.0 109.13 161.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.5 mmt85 -65.31 -25.34 67.58 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 118.625 2.824 . . . . 0.0 118.625 -169.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 56.3 mt -66.43 -49.94 71.35 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.923 0 CA-C-O 123.445 1.593 . . . . 0.0 112.648 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 18.5 m-85 -81.21 -38.06 27.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 111.618 -2.537 . . . . 0.0 113.699 -178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.594 ' HB2' ' O ' ' A' ' 10' ' ' PHE . 0.3 OUTLIER -82.63 86.15 6.88 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 127.953 2.501 . . . . 0.0 113.104 -171.446 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -62.89 -71.67 0.16 Allowed 'General case' 0 N--CA 1.485 1.285 1 CA-C-N 107.405 -4.452 . . . . 0.0 114.518 171.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -85.84 133.39 33.97 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -174.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 41.9 43.76 2.7 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 124.755 2.217 . . . . 0.0 116.583 164.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 1.006 ' HA ' ' H ' ' A' ' 20' ' ' TYR 0.577 1.5 p30 -94.73 67.28 3.24 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-N 109.895 -3.321 . . . . 0.0 119.612 -172.024 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.47 -4.44 89.29 Favored Glycine 0 CA--C 1.556 2.623 1 CA-C-N 94.818 -10.174 . . . . 0.0 116.41 112.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 1.006 ' H ' ' HA ' ' A' ' 18' ' ' ASP . 17.3 m-85 -137.99 157.26 46.73 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 117.013 2.227 . . . . 0.0 117.013 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.61 HG22 ' HB ' ' B' ' 21' ' ' ILE . 0.0 OUTLIER -116.14 142.97 27.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 129.576 3.15 . . . . 0.0 109.879 172.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -114.29 -176.56 2.93 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.93 1.292 . . . . 0.0 112.87 173.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.1 tp -52.61 -45.87 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 N-CA-C 117.503 2.409 . . . . 0.0 117.503 -175.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -66.78 -43.31 84.31 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 114.901 1.445 . . . . 0.0 114.901 177.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -62.79 -40.78 98.41 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 111.983 -2.371 . . . . 0.0 112.392 172.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.71 ' HA ' HD12 ' A' ' 29' ' ' ILE . 3.2 tp -59.45 -48.08 83.01 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.32 1.048 . . . . 0.0 111.554 170.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.443 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . -49.73 -50.39 31.67 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.315 0.96 . . . . 0.0 111.652 171.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -54.84 -43.83 73.37 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.909 1.448 . . . . 0.0 114.909 175.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.71 HD12 ' HA ' ' A' ' 26' ' ' LEU . 8.5 mt -61.46 -47.77 91.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 C-N-CA 123.029 0.532 . . . . 0.0 110.198 175.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.3 mp -55.27 -43.92 75.15 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 174.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 27' ' ' GLY . 67.8 mtt180 -59.62 -39.76 85.35 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.425 -1.261 . . . . 0.0 112.859 175.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.38 -43.45 81.34 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 70.4 p -101.65 -45.02 5.39 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 116.315 1.968 . . . . 0.0 116.315 -175.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.57 -77.98 0.13 Allowed Glycine 0 N--CA 1.487 2.069 0 CA-C-O 123.116 1.398 . . . . 0.0 113.048 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' NH2 . . . . . 0.675 ' N ' ' H ' ' B' ' 33' ' ' THR . . . . . . . . 0 C--N 1.31 -1.15 0 O-C-N 120.422 -1.634 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.211 -0.935 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -57.92 125.26 22.33 Favored 'General case' 0 C--N 1.306 -1.321 1 C-N-CA 135.933 5.693 . . . . 0.0 113.403 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 81.6 p -156.52 161.56 40.0 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-N 112.477 -2.147 . . . . 0.0 108.703 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -50.06 -43.94 51.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 123.799 0.687 . . . . 0.0 112.329 171.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -58.31 -51.08 71.29 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.158 1.383 . . . . 0.0 112.688 175.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -61.43 -42.34 98.6 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 175.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 6.1 tp -65.33 -33.32 75.7 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 113.834 1.05 . . . . 0.0 113.834 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.77 -47.07 59.74 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.824 1.25 . . . . 0.0 112.241 171.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -60.31 -49.95 75.56 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 171.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.79 -41.28 63.98 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 174.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.512 ' HD1' HD22 ' A' ' 26' ' ' LEU . 20.5 t80 -57.31 -47.96 80.16 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.054 -1.885 . . . . 0.0 111.932 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -38.52 91.37 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 112.179 -2.282 . . . . 0.0 114.915 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 46.7 mt -61.94 -41.98 92.97 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.046 0 CA-C-N 112.985 -1.916 . . . . 0.0 113.016 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -77.99 -38.69 44.44 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 112.339 -2.21 . . . . 0.0 114.802 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -75.13 59.4 0.97 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.489 2.315 . . . . 0.0 111.299 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -46.75 -50.1 18.64 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 111.864 -2.425 . . . . 0.0 114.627 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -84.71 16.82 3.04 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 117.024 2.231 . . . . 0.0 117.024 178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 54.16 28.95 9.67 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 117.869 2.544 . . . . 0.0 117.869 166.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 53.7 p-10 -89.28 4.59 48.26 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 -174.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.32 21.84 66.78 Favored Glycine 0 CA--C 1.546 2.029 0 C-N-CA 124.829 1.204 . . . . 0.0 113.758 -171.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -140.54 172.25 12.98 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 125.285 1.434 . . . . 0.0 108.931 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.61 ' HB ' HG22 ' A' ' 21' ' ' ILE . 1.3 mp -124.21 146.08 30.31 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 CA-C-N 114.427 -1.261 . . . . 0.0 108.512 161.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.431 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -118.57 178.53 4.43 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.594 1.158 . . . . 0.0 114.059 175.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.411 ' O ' ' HB3' ' B' ' 26' ' ' LEU . 7.2 tp -44.43 -45.46 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 N-CA-C 118.671 2.841 . . . . 0.0 118.671 -174.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -73.13 -46.76 49.23 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 114.722 1.379 . . . . 0.0 114.722 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.431 ' HB2' ' O ' ' B' ' 22' ' ' ASP . 65.3 mt-10 -51.65 -40.84 60.73 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 112.117 -2.311 . . . . 0.0 112.559 167.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.494 ' HA ' HD12 ' B' ' 29' ' ' ILE . 4.3 tp -54.93 -40.36 69.81 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 173.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.489 ' O ' ' HG2' ' B' ' 31' ' ' ARG . . . -48.7 -52.12 21.25 Favored Glycine 0 N--CA 1.477 1.372 0 C-N-CA 124.717 1.151 . . . . 0.0 112.951 174.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -55.3 -44.59 75.91 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 113.93 -1.135 . . . . 0.0 113.025 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' B' ' 26' ' ' LEU . 13.2 mt -65.59 -48.91 80.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.735 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 77.5 mt -54.46 -41.36 69.37 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 116.009 1.855 . . . . 0.0 116.009 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' B' ' 27' ' ' GLY . 46.2 mmt-85 -59.48 -34.21 72.28 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 114.08 -1.418 . . . . 0.0 112.514 178.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' B' ' 33' ' ' THR . . . -84.76 126.32 33.31 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -178.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . 0.675 ' H ' ' N ' ' A' ' 35' ' ' NH2 . 1.7 p -118.17 91.72 3.64 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.876 2.47 . . . . 0.0 109.895 -10.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -79.52 -149.55 5.29 Favored Glycine 0 N--CA 1.481 1.672 0 CA-C-N 113.599 -1.637 . . . . 0.0 113.222 178.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.074 0 O-C-N 119.946 -1.914 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.209 -1.029 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -75.75 131.6 39.92 Favored 'General case' 0 C--N 1.31 -1.121 1 C-N-CA 135.469 5.508 . . . . 0.0 113.529 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.8 m -61.43 153.37 27.23 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.257 1.023 . . . . 0.0 112.551 173.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 75.44 -41.72 0.45 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 126.492 1.917 . . . . 0.0 112.19 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.0 -51.61 63.45 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.702 1.201 . . . . 0.0 109.17 160.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -84.65 134.67 34.36 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.216 1.406 . . . . 0.0 110.089 162.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 63.0 mt -78.43 -18.01 55.55 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 120.587 3.551 . . . . 0.0 120.587 6.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 10' ' ' PHE . . . -41.88 -49.3 4.5 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 116.071 1.878 . . . . 0.0 116.071 -172.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -69.48 -44.45 71.13 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 115.286 1.588 . . . . 0.0 115.286 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.07 -42.73 77.12 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 114.459 1.281 . . . . 0.0 114.459 173.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.44 ' HB3' ' O ' ' A' ' 7' ' ' ALA . 51.2 t80 -53.77 -51.85 62.09 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 112.525 -2.125 . . . . 0.0 111.617 174.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.505 ' HA ' ' HB3' ' A' ' 14' ' ' ASP . 7.8 mmm180 -73.84 -18.57 60.92 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 111.228 -2.715 . . . . 0.0 116.551 -177.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . 0.274 60.7 mt -70.97 -48.99 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.52 170.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -67.72 -44.26 78.05 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 112.508 -2.133 . . . . 0.0 111.645 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.505 ' HB3' ' HA ' ' A' ' 11' ' ' ARG . 65.6 t0 -67.07 62.64 0.05 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 127.72 2.408 . . . . 0.0 112.484 177.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -62.12 -37.48 85.3 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 110.692 -2.958 . . . . 0.0 115.293 177.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -79.27 -2.53 41.71 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 176.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.85 37.99 21.52 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 126.353 1.861 . . . . 0.0 115.944 175.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.0 p-10 -87.95 -9.72 52.7 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 116.226 1.936 . . . . 0.0 116.226 -177.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.96 26.91 71.5 Favored Glycine 0 CA--C 1.539 1.585 0 C-N-CA 124.182 0.896 . . . . 0.0 113.012 -167.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' B' ' 20' ' ' TYR . 62.0 m-85 -145.91 178.85 7.87 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.265 1.426 . . . . 0.0 109.614 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.518 HG21 HD11 ' A' ' 29' ' ' ILE . 15.2 mt -128.73 138.53 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.314 0 C-N-CA 125.615 1.566 . . . . 0.0 109.29 167.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -114.7 176.42 5.06 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.344 1.858 . . . . 0.0 115.836 173.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 tp -43.62 -49.81 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 N-CA-C 117.645 2.461 . . . . 0.0 117.645 -171.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -38.4 85.73 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 85.9 mt-10 -68.72 -38.71 80.41 Favored 'General case' 0 C--N 1.317 -0.809 0 C-N-CA 128.487 2.715 . . . . 0.0 113.276 171.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.514 HD12 HD12 ' A' ' 29' ' ' ILE . 16.6 tp -56.13 -41.85 75.97 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.062 165.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 31' ' ' ARG . . . -43.48 -50.9 6.72 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 125.345 1.45 . . . . 0.0 112.68 167.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 25' ' ' GLU . 42.4 mt-10 -51.45 -53.19 39.57 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 172.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.518 HD11 HG21 ' A' ' 21' ' ' ILE . 2.9 mt -63.34 -44.38 99.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 C-N-CA 124.555 1.142 . . . . 0.0 109.234 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.01 -9.72 32.96 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 116.846 2.165 . . . . 0.0 116.846 177.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 27' ' ' GLY . 74.5 mtt180 -78.98 89.07 4.74 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.295 0.569 . . . . 0.0 109.65 174.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.74 83.38 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 112.94 -1.936 . . . . 0.0 112.311 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 72.2 p -77.15 69.22 3.4 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 113.528 -1.669 . . . . 0.0 112.541 -176.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -141.37 -107.88 0.69 Allowed Glycine 0 N--CA 1.482 1.703 0 CA-C-N 112.333 -2.212 . . . . 0.0 109.661 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.737 0 O-C-N 119.994 -1.886 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.682 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -42.08 126.95 3.39 Favored 'General case' 0 C--N 1.304 -1.377 1 C-N-CA 134.92 5.288 . . . . 0.0 111.635 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' B' ' 5' ' ' GLU . 34.8 t -138.17 143.88 40.46 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 114.547 -1.206 . . . . 0.0 112.038 177.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -40.39 -52.56 2.72 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.738 1.215 . . . . 0.0 114.151 168.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -60.04 -44.06 94.92 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.938 0.895 . . . . 0.0 112.16 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' B' ' 2' ' ' SER . 11.4 tt0 -53.37 -57.38 10.8 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.831 1.252 . . . . 0.0 111.04 170.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.96 -40.93 73.96 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 176.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.29 -39.31 63.86 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.916 1.286 . . . . 0.0 113.419 174.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -73.82 -49.43 25.25 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 174.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.8 -42.65 68.6 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 18.6 t80 -51.16 -52.68 41.77 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 112.466 -2.152 . . . . 0.0 111.28 173.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.509 ' HD3' ' HA ' ' B' ' 11' ' ' ARG . 8.3 mmt180 -71.43 -25.37 62.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 111.061 -2.791 . . . . 0.0 117.723 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 30.5 mt -69.09 -41.68 81.62 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 CA-C-O 122.827 1.299 . . . . 0.0 111.858 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -68.48 -44.77 74.04 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 112.966 -1.924 . . . . 0.0 111.225 176.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -69.85 65.6 0.23 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 128.706 2.802 . . . . 0.0 113.36 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.463 ' NZ ' ' HG2' ' B' ' 28' ' ' GLU . 63.3 mttp -49.38 -53.64 21.44 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 109.904 -3.317 . . . . 0.0 114.071 174.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 17.1 p-10 -85.35 17.92 2.9 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 -178.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 53.68 33.79 17.42 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 162.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -93.75 1.75 56.43 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -175.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.77 28.72 73.9 Favored Glycine 0 N--CA 1.486 1.993 0 C-N-CA 123.906 0.765 . . . . 0.0 112.674 -169.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 59.7 m-85 -143.76 176.64 9.09 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.502 1.121 . . . . 0.0 111.877 -175.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 30.4 mm -123.38 128.41 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.094 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 168.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -98.38 173.36 7.01 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 168.258 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 7.4 tp -49.98 -49.98 20.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 116.965 2.209 . . . . 0.0 116.965 -173.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.95 -38.35 90.69 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 176.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.426 ' HB2' ' O ' ' B' ' 22' ' ' ASP . 62.7 mt-10 -61.83 -42.25 98.8 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 112.714 -2.039 . . . . 0.0 113.613 171.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.485 ' HA ' HD12 ' B' ' 29' ' ' ILE . 47.9 tp -54.89 -40.57 69.9 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 112.562 0.579 . . . . 0.0 112.562 167.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.23 -47.42 68.01 Favored Glycine 0 CA--C 1.54 1.636 0 C-N-CA 124.354 0.978 . . . . 0.0 112.485 170.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.48 ' HG3' ' CZ ' ' B' ' 31' ' ' ARG . 1.6 mp0 -56.09 -35.1 66.63 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 175.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.485 HD12 ' HA ' ' B' ' 26' ' ' LEU . 17.2 mt -71.84 -59.33 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 66.5 mt -63.53 -10.35 17.54 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 118.496 2.776 . . . . 0.0 118.496 -177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.48 ' CZ ' ' HG3' ' B' ' 28' ' ' GLU . 65.2 mtt180 -40.64 -45.63 2.39 Favored 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 126.005 1.722 . . . . 0.0 115.313 172.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.77 -41.17 68.69 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 2.2 p -78.39 28.75 0.19 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 116.039 1.866 . . . . 0.0 116.039 -175.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.69 -116.68 4.92 Favored Glycine 0 N--CA 1.48 1.593 0 CA-C-O 122.489 1.05 . . . . 0.0 113.236 176.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.128 0 O-C-N 119.861 -1.964 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.2 -1.517 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -66.74 161.46 23.54 Favored 'General case' 0 C--N 1.308 -1.22 1 C-N-CA 139.701 7.2 . . . . 0.0 112.817 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.6 t 57.35 -149.6 0.46 Allowed 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 126.151 1.781 . . . . 0.0 112.397 173.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -54.12 -25.74 23.76 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 114.667 1.358 . . . . 0.0 114.667 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 25.9 mp0 -64.34 -32.74 74.47 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 179.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -54.21 -37.54 64.69 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.802 0.841 . . . . 0.0 112.218 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.839 HD11 ' HA2' ' B' ' 27' ' ' GLY . 5.9 tp -59.37 -50.56 73.48 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.174 1.39 . . . . 0.0 114.063 174.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.89 -48.05 70.48 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.674 1.19 . . . . 0.0 111.965 176.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -65.47 -47.62 75.47 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 114.395 1.258 . . . . 0.0 114.395 174.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.75 -46.17 67.38 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 173.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.525 ' HD1' ' HG ' ' B' ' 26' ' ' LEU . 12.0 t80 -55.14 -49.37 71.97 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 113.865 -1.516 . . . . 0.0 110.772 175.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -67.41 -35.61 79.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 111.855 -2.43 . . . . 0.0 117.297 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 38.2 mt -60.62 -51.87 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 CA-C-O 123.496 1.617 . . . . 0.0 110.111 175.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -76.77 -36.19 57.19 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 111.061 -2.79 . . . . 0.0 115.272 -176.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -78.36 53.18 1.23 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.986 2.114 . . . . 0.0 112.672 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -48.55 -54.11 15.71 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 111.174 -2.739 . . . . 0.0 114.396 -173.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -82.19 12.69 4.05 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 115.854 1.798 . . . . 0.0 115.854 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 53.93 32.65 15.68 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 170.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 42.2 p-10 -82.92 0.73 42.99 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 112.769 -2.014 . . . . 0.0 112.874 176.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.02 18.81 60.58 Favored Glycine 0 N--CA 1.484 1.894 0 C-N-CA 125.562 1.553 . . . . 0.0 112.295 -172.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.824 ' HB3' ' HB3' ' B' ' 20' ' ' TYR . 11.4 m-85 -132.1 163.43 28.5 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.872 1.269 . . . . 0.0 109.365 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.5 mt -116.31 133.33 63.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 C-N-CA 123.732 0.813 . . . . 0.0 109.887 170.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -102.24 175.96 5.35 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 114.769 -1.105 . . . . 0.0 113.058 174.849 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' B' ' 6' ' ' LEU . 8.8 tp -49.48 -45.35 19.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 118.132 2.641 . . . . 0.0 118.132 -174.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.518 ' HG3' ' O ' ' B' ' 0' ' ' ACE . 26.0 tt0 -66.85 -46.79 73.94 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 122.664 1.221 . . . . 0.0 114.252 178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 81.9 mt-10 -56.63 -44.17 80.96 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 111.517 -2.583 . . . . 0.0 111.185 171.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.633 HD22 ' HD1' ' B' ' 10' ' ' PHE . 1.4 tp -63.99 -47.22 81.21 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.723 1.209 . . . . 0.0 112.509 173.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -50.98 -45.67 50.58 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 124.606 1.098 . . . . 0.0 111.735 174.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.458 ' O ' ' HA3' ' A' ' 34' ' ' GLY . 36.6 mt-10 -54.25 -50.57 66.91 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 172.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.3 mt -59.76 -48.55 87.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 C-N-CA 123.22 0.608 . . . . 0.0 109.582 175.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -21.7 60.51 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.565 ' NH1' ' H ' ' A' ' 32' ' ' ALA . 9.5 mmm180 -74.36 158.89 33.15 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.677 1.591 . . . . 0.0 113.408 172.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.565 ' H ' ' NH1' ' A' ' 31' ' ' ARG . . . -61.05 -34.22 74.53 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.812 169.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 38.2 p -96.0 67.67 2.68 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.248 175.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.458 ' HA3' ' O ' ' A' ' 28' ' ' GLU . . . 178.93 -67.4 0.08 OUTLIER Glycine 0 N--CA 1.48 1.617 0 CA-C-N 113.314 -1.767 . . . . 0.0 110.895 -178.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.72 0 O-C-N 120.03 -1.865 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 0' ' ' ACE . . . . . 0.518 ' O ' ' HG3' ' A' ' 24' ' ' GLU . . . . . . . . 0 C--O 1.201 -1.462 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -56.95 146.66 26.12 Favored 'General case' 0 N--CA 1.483 1.194 1 C-N-CA 143.011 8.524 . . . . 0.0 112.966 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 59.3 p -101.32 90.12 4.0 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.652 -1.158 . . . . 0.0 107.889 161.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.76 148.0 48.62 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 115.559 1.688 . . . . 0.0 115.559 -177.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -47.11 -51.22 18.49 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 126.8 2.04 . . . . 0.0 112.667 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -51.92 -49.98 62.01 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.401 1.081 . . . . 0.0 112.745 176.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.521 ' HB3' HD11 ' A' ' 23' ' ' ILE . 21.2 mt -64.19 -42.33 96.71 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -52.15 -40.19 61.06 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.773 1.229 . . . . 0.0 113.05 174.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -71.51 -49.36 41.81 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 174.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.16 -35.9 67.72 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 173.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.633 ' HD1' HD22 ' A' ' 26' ' ' LEU . 27.7 t80 -56.24 -51.72 67.06 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 126.572 1.949 . . . . 0.0 110.969 174.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.721 HH12 ' HA2' ' B' ' 19' ' ' GLY . 2.3 mpt_? -63.62 -30.43 71.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 112.429 -2.168 . . . . 0.0 116.13 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 37.6 mm -62.53 -46.31 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 123.67 1.7 . . . . 0.0 111.279 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 23.1 m-30 -78.33 -39.97 37.95 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 128.368 2.667 . . . . 0.0 112.795 -179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . 0.405 ' HB3' ' HA ' ' B' ' 11' ' ' ARG . 61.9 t0 -75.69 64.61 1.74 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.415 2.286 . . . . 0.0 109.717 174.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -39.96 -51.0 2.53 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 110.862 -2.881 . . . . 0.0 114.158 177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -77.79 -17.2 57.74 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 62.96 54.9 2.09 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 127.441 2.296 . . . . 0.0 113.724 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 31.2 p30 -88.74 -18.43 27.83 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 116.582 2.067 . . . . 0.0 116.582 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . 0.721 ' HA2' HH12 ' B' ' 11' ' ' ARG . . . 95.52 15.18 44.57 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 124.44 1.019 . . . . 0.0 113.286 -170.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . 0.824 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 14.7 m-85 -149.38 168.87 22.2 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.348 1.059 . . . . 0.0 110.93 -171.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 28.2 mm -118.29 132.37 68.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.776 169.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -107.71 173.73 6.19 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.125 -1.398 . . . . 0.0 114.627 171.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 9.3 tp -48.57 -48.48 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 117.922 2.564 . . . . 0.0 117.922 -170.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . 0.254 0.0 OUTLIER -67.02 -40.79 87.32 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 177.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' B' ' 28' ' ' GLU . 88.2 mt-10 -61.34 -43.95 98.02 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 112.35 -2.205 . . . . 0.0 111.224 170.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.525 ' HG ' ' HD1' ' A' ' 10' ' ' PHE . 2.8 tm? -61.1 -43.21 99.24 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 169.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.839 ' HA2' HD11 ' A' ' 6' ' ' LEU . . . -45.02 -54.54 6.9 Favored Glycine 0 N--CA 1.479 1.538 0 C-N-CA 124.134 0.873 . . . . 0.0 112.823 169.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' B' ' 25' ' ' GLU . 20.5 tt0 -53.44 -52.02 60.78 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 112.295 -1.952 . . . . 0.0 113.195 171.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 49.6 mt -54.82 -50.68 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 123.41 0.684 . . . . 0.0 110.093 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.552 HD22 HD12 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -60.15 -25.97 65.92 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -177.246 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 27.6 mtm180 -56.93 -46.46 82.04 Favored 'General case' 0 N--CA 1.476 0.842 0 O-C-N 124.094 0.871 . . . . 0.0 113.256 171.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -84.89 -57.36 3.14 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 27.2 p -118.55 95.83 5.02 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.66 1.184 . . . . 0.0 109.816 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -105.92 110.92 3.5 Favored Glycine 0 N--CA 1.485 1.928 0 CA-C-N 113.842 -1.526 . . . . 0.0 111.683 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.867 0 O-C-N 120.805 -1.409 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.506 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.422 ' NZ ' ' HA ' ' B' ' 31' ' ' ARG . 0.0 OUTLIER -47.33 87.74 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.468 1 C-N-CA 139.033 6.933 . . . . 0.0 113.381 . . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.2 p -67.48 -29.76 69.28 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 114.243 -1.344 . . . . 0.0 113.847 177.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 51.9 mm-40 60.89 -60.43 0.08 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 126.486 1.914 . . . . 0.0 112.87 -165.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -60.94 -53.94 51.16 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.32 -31.26 69.61 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.8 tp -58.41 -43.33 88.57 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.136 1.374 . . . . 0.0 113.242 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.79 -47.05 71.16 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.255 1.022 . . . . 0.0 112.86 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.517 ' O ' HG12 ' A' ' 12' ' ' ILE . 65.1 m-80 -60.66 -52.79 63.65 Favored 'General case' 0 C--O 1.223 -0.293 0 CA-C-O 117.928 -1.034 . . . . 0.0 113.459 169.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -47.34 -45.11 24.44 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 175.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -52.58 -53.88 40.52 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 113.061 -1.882 . . . . 0.0 111.254 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -66.99 -30.72 70.92 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 111.649 -2.523 . . . . 0.0 117.095 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 8' ' ' ASN . 35.1 mm -65.83 -44.97 92.68 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.876 0 CA-C-O 122.912 1.339 . . . . 0.0 111.009 176.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -70.61 -44.88 66.35 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 112.201 -2.272 . . . . 0.0 111.908 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -73.25 52.54 0.36 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 128.294 2.638 . . . . 0.0 113.27 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HD2' ' N ' ' A' ' 16' ' ' ASN . 0.1 OUTLIER -52.68 -42.59 64.9 Favored 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 113.563 -1.653 . . . . 0.0 115.066 174.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.476 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 5.1 p-10 -79.06 12.8 2.05 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 116.909 2.188 . . . . 0.0 116.909 176.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 57.72 24.93 11.19 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 119.686 3.217 . . . . 0.0 119.686 161.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.9 p-10 -93.19 4.0 54.73 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 -175.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.38 25.83 70.23 Favored Glycine 0 CA--C 1.54 1.634 0 O-C-N 123.695 0.622 . . . . 0.0 112.694 -170.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.51 ' HB3' ' HB3' ' B' ' 20' ' ' TYR . 36.2 m-85 -139.85 167.12 22.85 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.676 1.19 . . . . 0.0 112.321 -178.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -117.79 127.76 75.05 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 CA-C-N 112.495 -2.139 . . . . 0.0 109.818 170.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.57 177.31 4.88 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 113.195 -1.821 . . . . 0.0 113.471 172.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.6 tp -48.47 -47.63 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 -176.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -66.26 -38.57 88.16 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -67.05 -40.28 87.1 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 127.027 2.131 . . . . 0.0 113.119 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 29' ' ' ILE . 6.1 tp -64.8 -41.75 95.55 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.569 168.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 31' ' ' ARG . . . -57.36 -29.07 59.93 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 124.635 1.112 . . . . 0.0 114.331 170.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -73.13 -39.05 66.04 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 169.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.402 HD12 ' HA ' ' A' ' 26' ' ' LEU . 23.4 mt -62.67 -71.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 168.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.5 mt -85.25 71.02 10.91 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 124.922 2.296 . . . . 0.0 112.576 174.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.402 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 41.0 ttt180 -59.08 -37.81 77.97 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 109.039 -3.71 . . . . 0.0 113.738 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -71.62 88.94 0.97 Allowed 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 122.814 1.292 . . . . 0.0 110.312 174.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 66.5 p -65.14 135.27 55.3 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 113.458 -1.701 . . . . 0.0 113.146 -170.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.499 ' HA3' ' HB3' ' B' ' 5' ' ' GLU . . . -80.14 81.51 1.52 Allowed Glycine 0 CA--C 1.533 1.167 0 CA-C-N 113.174 -1.83 . . . . 0.0 113.591 -173.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.793 0 O-C-N 121.496 -1.002 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -0.663 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 22.2 tttp -67.4 -50.55 59.06 Favored 'General case' 0 C--N 1.304 -1.388 1 C-N-CA 137.005 6.122 . . . . 0.0 111.506 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 14.2 p -61.25 -46.46 90.3 Favored 'General case' 0 N--CA 1.481 1.091 0 CA-C-N 112.45 -2.159 . . . . 0.0 113.575 174.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -75.83 -3.75 36.86 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 117.925 2.565 . . . . 0.0 117.925 175.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -53.99 -53.94 45.94 Favored 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -167.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.499 ' HB3' ' HA3' ' A' ' 34' ' ' GLY . 8.4 tp10 -70.01 -32.2 70.25 Favored 'General case' 0 CA--C 1.55 0.946 0 N-CA-C 114.577 1.325 . . . . 0.0 114.577 177.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.72 -43.02 68.71 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.948 1.299 . . . . 0.0 112.968 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.437 ' O ' ' HB3' ' B' ' 10' ' ' PHE . . . -48.57 -50.93 30.25 Favored 'General case' 0 CA--C 1.554 1.123 0 O-C-N 125.386 1.679 . . . . 0.0 113.063 176.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -63.9 -48.72 75.52 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 175.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.42 ' HA ' HD12 ' B' ' 12' ' ' ILE . . . -53.48 -40.87 65.68 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 176.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.437 ' HB3' ' O ' ' B' ' 7' ' ' ALA . 47.7 t80 -52.63 -55.27 23.57 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 112.926 -1.943 . . . . 0.0 112.411 173.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -68.54 -20.34 64.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 110.108 -3.224 . . . . 0.0 115.962 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . 0.42 HD12 ' HA ' ' B' ' 9' ' ' ALA . 51.8 mt -69.35 -52.37 33.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-O 122.856 1.312 . . . . 0.0 112.12 174.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 22.6 m-30 -63.63 -35.57 80.95 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 112.049 -2.341 . . . . 0.0 114.317 178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -65.85 46.21 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 128.961 2.904 . . . . 0.0 114.842 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -53.65 -41.68 67.03 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.903 2.081 . . . . 0.0 115.666 177.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -80.52 14.65 1.95 Allowed 'General case' 0 CA--C 1.557 1.243 0 N-CA-C 115.17 1.544 . . . . 0.0 115.17 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 56.58 23.17 7.38 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 119.757 3.243 . . . . 0.0 119.757 161.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 45.3 p-10 -88.41 -8.71 54.54 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 113.096 -1.865 . . . . 0.0 115.61 -176.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.86 27.38 73.24 Favored Glycine 0 N--CA 1.485 1.927 0 C-N-CA 123.953 0.787 . . . . 0.0 112.09 -167.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . 0.51 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 51.6 m-85 -140.95 170.81 15.03 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.356 1.462 . . . . 0.0 109.409 174.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.44 ' HA ' ' OE1' ' B' ' 25' ' ' GLU . 1.4 mp -118.72 140.25 43.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 113.734 -1.575 . . . . 0.0 109.204 169.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.43 -176.41 2.91 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.036 0.934 . . . . 0.0 112.506 172.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 9.5 tp -53.57 -40.49 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -174.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -65.01 -46.58 80.75 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 122.548 1.166 . . . . 0.0 113.638 176.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.44 ' OE1' ' HA ' ' B' ' 21' ' ' ILE . 84.4 mt-10 -62.94 -44.44 96.07 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 112.06 -2.336 . . . . 0.0 112.424 173.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.53 ' HG ' HD13 ' B' ' 30' ' ' LEU . 0.9 OUTLIER -58.82 -40.42 84.08 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 124.53 1.132 . . . . 0.0 111.706 170.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -54.67 -49.26 62.08 Favored Glycine 0 N--CA 1.483 1.802 0 C-N-CA 124.492 1.044 . . . . 0.0 111.847 172.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.08 -37.17 73.97 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 175.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.519 HD12 ' HA ' ' B' ' 26' ' ' LEU . 21.2 mt -70.99 -59.41 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 124.269 1.028 . . . . 0.0 109.392 175.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.53 HD13 ' HG ' ' B' ' 26' ' ' LEU . 6.7 mp -82.83 17.91 1.74 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 117.944 2.572 . . . . 0.0 117.944 -170.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.515 ' CZ ' ' H ' ' B' ' 32' ' ' ALA . 0.0 OUTLIER -44.14 -55.92 4.44 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 117.471 2.397 . . . . 0.0 117.471 -167.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . 0.515 ' H ' ' CZ ' ' B' ' 31' ' ' ARG . . . -77.48 -57.11 4.0 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 41.6 p -78.47 94.32 4.91 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.328 1.051 . . . . 0.0 111.523 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.03 -35.62 3.39 Favored Glycine 0 CA--C 1.542 1.734 0 CA-C-N 114.192 -1.367 . . . . 0.0 113.914 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.148 0 O-C-N 119.955 -1.909 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.21 -1.01 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 73.1 mttt -56.5 113.44 1.6 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 117.11 -3.494 . . . . 0.0 112.502 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.447 ' HA ' ' NH1' ' B' ' 31' ' ' ARG . 18.5 m -49.66 124.12 9.04 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 113.714 -1.584 . . . . 0.0 112.15 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 6' ' ' LEU . 8.1 mp0 75.77 -47.58 0.58 Allowed 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 126.078 1.751 . . . . 0.0 115.033 -176.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.34 -57.68 11.3 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.416 1.086 . . . . 0.0 111.887 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -61.04 -43.74 98.43 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.312 1.045 . . . . 0.0 112.065 176.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.799 HD13 ' HE ' ' B' ' 31' ' ' ARG . 5.5 tp -45.37 -49.58 12.93 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.252 1.821 . . . . 0.0 114.309 169.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -50.01 -44.91 51.45 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.587 0.755 . . . . 0.0 112.932 177.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -71.97 -49.59 35.96 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.902 1.281 . . . . 0.0 113.838 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -48.89 -39.49 26.17 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.128 1.529 . . . . 0.0 115.128 174.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.3 t80 -51.98 -56.29 15.14 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 113.857 -1.519 . . . . 0.0 110.541 173.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.422 ' NH2' ' HA2' ' A' ' 19' ' ' GLY . 0.1 OUTLIER -68.36 -35.12 77.25 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 110.721 -2.945 . . . . 0.0 116.451 -177.697 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 53.5 mt -56.3 -58.58 4.77 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.024 0 CA-C-N 112.975 -1.921 . . . . 0.0 111.267 175.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -67.59 -39.03 84.82 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 111.803 -2.453 . . . . 0.0 113.268 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -77.38 61.12 2.14 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 127.13 2.172 . . . . 0.0 110.07 170.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 tttm -49.5 -41.69 41.5 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 112.667 -2.06 . . . . 0.0 115.094 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 44.5 p30 -72.49 -19.43 61.54 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 176.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 64.99 55.01 1.19 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 127.194 2.197 . . . . 0.0 114.433 176.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -104.14 0.24 29.37 Favored 'General case' 0 CA--C 1.549 0.92 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.422 ' HA2' ' NH2' ' A' ' 11' ' ' ARG . . . 76.55 17.78 79.62 Favored Glycine 0 N--CA 1.478 1.472 0 N-CA-C 114.987 0.755 . . . . 0.0 114.987 -173.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -133.96 164.57 27.01 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 122.595 1.188 . . . . 0.0 109.176 178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.409 ' HB ' HG22 ' B' ' 21' ' ' ILE 0.25 5.2 mt -124.08 121.06 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 113.121 -1.854 . . . . 0.0 109.163 165.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -95.7 173.67 7.36 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 113.514 -1.676 . . . . 0.0 114.256 171.361 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.0 tp -48.33 -47.71 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 N-CA-C 117.916 2.561 . . . . 0.0 117.916 -171.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.43 -38.67 87.99 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 175.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 22' ' ' ASP . 82.9 mt-10 -69.41 -43.2 73.9 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 111.836 -2.438 . . . . 0.0 112.776 176.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.613 HD22 ' HD1' ' B' ' 10' ' ' PHE . 4.9 tp -68.18 -36.0 78.91 Favored 'General case' 0 N--CA 1.483 1.19 0 O-C-N 124.165 0.916 . . . . 0.0 111.756 170.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -47.79 -55.31 9.9 Favored Glycine 0 N--CA 1.477 1.427 0 C-N-CA 124.305 0.955 . . . . 0.0 112.087 173.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -62.41 -24.51 67.44 Favored 'General case' 0 CA--C 1.547 0.852 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 177.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.434 HD12 ' HA ' ' A' ' 26' ' ' LEU . 14.3 mt -72.55 -75.59 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 165.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.67 -34.35 71.91 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 118.553 2.797 . . . . 0.0 118.553 -163.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.736 ' HD3' ' HB2' ' B' ' 6' ' ' LEU . 2.4 tpt180 -85.17 137.38 33.05 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -166.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.09 92.66 2.19 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 105.152 -2.166 . . . . 0.0 105.152 154.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 22.5 p -55.95 95.58 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -160.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -176.98 -56.35 0.06 OUTLIER Glycine 0 CA--C 1.535 1.319 0 CA-C-N 110.374 -3.103 . . . . 0.0 108.778 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.739 0 O-C-N 120.076 -1.838 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.538 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . 0.539 ' HE2' ' HG3' ' B' ' 3' ' ' GLU . 75.1 tttt -84.39 121.6 27.77 Favored 'General case' 0 C--N 1.299 -1.63 1 C-N-CA 139.171 6.988 . . . . 0.0 112.767 . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 55.5 p -59.44 -43.98 93.02 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 113.054 -1.884 . . . . 0.0 113.911 179.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.539 ' HG3' ' HE2' ' B' ' 1' ' ' LYS . 15.9 pt-20 -106.27 56.28 0.66 Allowed 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 122.896 1.332 . . . . 0.0 112.235 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -55.42 -58.71 6.63 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 113.462 -1.699 . . . . 0.0 114.778 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . 0.639 ' HB2' HH12 ' A' ' 31' ' ' ARG . 22.6 mm-40 -63.29 -34.47 77.75 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -170.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.736 ' HB2' ' HD3' ' A' ' 31' ' ' ARG . 30.6 tp -42.84 -48.82 5.81 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 168.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.27 -62.56 1.57 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.876 1.27 . . . . 0.0 111.102 -177.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . 0.581 ' H ' ' ND2' ' B' ' 8' ' ' ASN . 5.6 m-80 -46.33 -53.12 11.44 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 167.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.52 -40.68 62.71 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 176.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.613 ' HD1' HD22 ' A' ' 26' ' ' LEU . 4.9 t80 -57.98 -48.85 78.77 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 114.252 -1.34 . . . . 0.0 111.866 175.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.89 -24.28 61.63 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 117.227 2.306 . . . . 0.0 117.227 179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 41.3 mm -70.23 -52.0 33.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 113.67 -1.605 . . . . 0.0 112.283 171.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -71.35 -36.3 71.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 112.63 -2.077 . . . . 0.0 114.918 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -80.38 68.14 6.46 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 127.099 2.16 . . . . 0.0 110.033 171.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -44.12 -55.41 4.77 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 111.69 -2.504 . . . . 0.0 113.724 176.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 22.8 p-10 -85.33 16.19 3.85 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 117.188 2.292 . . . . 0.0 117.188 -172.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 50.82 42.15 27.41 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 166.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 38.8 p30 -98.65 3.52 47.82 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.06 -1.882 . . . . 0.0 114.486 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.07 23.63 69.76 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 125.442 1.496 . . . . 0.0 114.073 -173.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -137.46 171.58 14.25 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.033 0.933 . . . . 0.0 111.563 -175.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.409 HG22 ' HB ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -129.21 133.52 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.635 163.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -115.35 172.92 6.79 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 169.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . 0.264 9.0 tp -43.16 -35.03 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 118.544 2.794 . . . . 0.0 118.544 -170.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . 0.303 0.0 OUTLIER -74.5 -44.03 53.26 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 117.658 2.466 . . . . 0.0 117.658 174.252 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' B' ' 22' ' ' ASP . 49.9 mt-10 -58.03 -46.23 85.65 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 128.074 2.55 . . . . 0.0 110.404 169.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -68.32 -38.58 81.7 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.675 1.59 . . . . 0.0 112.425 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.19 -62.44 5.7 Favored Glycine 0 N--CA 1.476 1.304 0 C-N-CA 125.745 1.64 . . . . 0.0 110.953 170.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -47.98 -41.14 24.42 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.407 HG13 ' O ' ' B' ' 25' ' ' GLU . 12.2 mt -66.23 -72.36 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 172.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 4.0 mt -60.87 -34.12 74.12 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 119.124 3.009 . . . . 0.0 119.124 -168.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . 0.799 ' HE ' HD13 ' A' ' 6' ' ' LEU . 2.9 mmp_? -66.81 -13.61 61.72 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.3 -38.91 71.89 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.358 0.663 . . . . 0.0 111.643 166.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 44.8 p -107.77 58.83 0.62 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.763 1.225 . . . . 0.0 109.434 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . 157.7 59.44 0.01 OUTLIER Glycine 0 CA--C 1.539 1.559 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.617 176.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.144 0 O-C-N 120.463 -1.61 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.886 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . 0.432 ' HB3' HD21 ' A' ' 8' ' ' ASN . 31.8 mmtp -53.6 139.56 31.42 Favored 'General case' 0 C--N 1.299 -1.608 1 C-N-CA 142.179 8.192 . . . . 0.0 113.219 . . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.7 t -120.97 94.64 4.41 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.028 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . 0.309 0.2 OUTLIER 42.94 -98.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 125.787 1.635 . . . . 0.0 115.006 -175.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -78.29 -22.53 48.08 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 176.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -87.8 92.2 9.03 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.952 2.101 . . . . 0.0 116.504 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.537 HD22 ' HE ' ' A' ' 11' ' ' ARG . 6.6 tt -85.72 151.54 23.77 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 129.298 3.039 . . . . 0.0 108.593 -20.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.555 ' O ' ' HB3' ' A' ' 10' ' ' PHE 0.761 . . -40.28 99.97 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 119.812 3.264 . . . . 0.0 119.812 174.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.432 HD21 ' HB3' ' A' ' 1' ' ' LYS . 4.6 m-80 -56.11 -45.8 79.34 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 111.038 -2.801 . . . . 0.0 112.293 169.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -53.36 -37.98 62.9 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 169.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.555 ' HB3' ' O ' ' A' ' 7' ' ' ALA . 14.7 t80 -53.47 -51.37 62.93 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 112.781 -2.009 . . . . 0.0 112.056 173.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.537 ' HE ' HD22 ' A' ' 6' ' ' LEU . 21.1 mmt85 -66.85 -42.68 85.33 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 111.759 -2.473 . . . . 0.0 115.303 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 44.0 mt -60.43 -42.91 92.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 113.331 -1.758 . . . . 0.0 112.168 178.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 6.7 m-30 -78.88 -32.48 45.91 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 111.969 -2.378 . . . . 0.0 115.388 -177.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -69.45 52.27 0.1 Allowed 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 126.725 2.01 . . . . 0.0 113.325 178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.463 ' HD2' ' HG2' ' A' ' 25' ' ' GLU . 33.1 mttm -49.55 -52.54 29.25 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 112.222 -2.263 . . . . 0.0 112.219 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -85.21 20.26 2.0 Favored 'General case' 0 CA--C 1.553 1.094 0 N-CA-C 116.955 2.205 . . . . 0.0 116.955 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 52.83 34.93 17.52 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 163.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -96.09 -3.1 45.28 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 178.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.95 31.72 81.78 Favored Glycine 0 CA--C 1.538 1.471 0 O-C-N 124.164 0.915 . . . . 0.0 112.107 -168.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -146.7 169.69 18.52 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.563 1.145 . . . . 0.0 110.456 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.441 ' HA ' ' OE1' ' A' ' 25' ' ' GLU . 2.3 mp -120.33 128.02 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 CA-C-N 113.79 -1.55 . . . . 0.0 108.647 169.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -109.19 172.93 6.56 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 113.929 -1.487 . . . . 0.0 114.752 178.121 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.284 10.0 tt -52.47 -44.06 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.116 0 N-CA-C 116.442 2.016 . . . . 0.0 116.442 -171.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.09 -43.52 82.33 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 175.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 29' ' ' ILE . 38.8 mt-10 -56.59 -43.79 80.42 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.205 1.802 . . . . 0.0 110.917 169.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.416 ' O ' HG13 ' A' ' 29' ' ' ILE . 3.4 tp -59.96 -44.67 94.28 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.425 ' HA2' HD11 ' B' ' 6' ' ' LEU . . . -52.67 -55.81 21.18 Favored Glycine 0 N--CA 1.48 1.613 0 O-C-N 124.057 0.848 . . . . 0.0 111.965 170.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -55.9 -41.65 74.84 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.48 HG23 ' O ' ' A' ' 25' ' ' GLU . 1.6 pp -72.96 -42.12 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.377 0.671 . . . . 0.0 110.573 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.3 mt -66.77 -27.14 67.36 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 116.218 1.932 . . . . 0.0 116.218 176.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -50.87 -32.5 20.63 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.882 1.673 . . . . 0.0 113.638 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.65 17.79 0.11 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 -173.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.1 t -97.95 67.92 1.98 Allowed 'General case' 0 N--CA 1.495 1.777 0 CA-C-O 122.177 0.989 . . . . 0.0 113.308 -178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -178.57 148.48 8.42 Favored Glycine 0 CA--C 1.54 1.654 0 CA-C-O 122.957 1.31 . . . . 0.0 111.248 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.823 0 O-C-N 120.279 -1.718 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.206 -1.236 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . . . . . . . . . 53.8 tttt -72.32 128.58 36.06 Favored 'General case' 0 C--N 1.301 -1.54 1 C-N-CA 138.945 6.898 . . . . 0.0 111.411 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 90.5 p -82.83 153.67 25.07 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-N 113.8 -1.546 . . . . 0.0 111.878 176.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -50.51 -39.87 49.87 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.704 1.202 . . . . 0.0 113.396 178.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -65.23 -45.53 84.29 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 113.788 1.032 . . . . 0.0 113.788 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -56.92 -42.08 79.32 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 123.657 0.598 . . . . 0.0 112.561 174.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.425 HD11 ' HA2' ' A' ' 27' ' ' GLY . 20.6 tp -56.07 -51.22 68.63 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 173.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . . . . . . . . . . . -53.55 -41.59 66.61 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 124.275 1.03 . . . . 0.0 113.056 175.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -66.34 -45.5 80.0 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 174.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.03 -36.21 65.27 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . . . . . . . . . 24.2 t80 -56.69 -58.76 6.71 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.836 -1.529 . . . . 0.0 110.881 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -68.12 -18.83 64.74 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 111.657 -2.52 . . . . 0.0 116.739 -178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 55.4 mt -72.86 -49.19 41.56 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 114.319 -1.31 . . . . 0.0 112.809 171.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -77.03 -36.93 55.79 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 112.823 -1.99 . . . . 0.0 113.9 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . . . . . . . . . 37.2 t0 -72.8 51.92 0.29 Allowed 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 128.093 2.557 . . . . 0.0 110.501 169.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . 0.576 ' HE3' ' HG2' ' B' ' 25' ' ' GLU . 44.5 mtmt -47.33 -47.53 25.7 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 112.34 -2.209 . . . . 0.0 112.93 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -85.27 19.86 2.14 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 116.751 2.13 . . . . 0.0 116.751 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 52.29 31.27 9.09 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 163.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 51.8 p-10 -98.4 8.62 44.61 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 115.491 1.664 . . . . 0.0 115.491 -174.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 63.92 19.8 63.75 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.419 1.009 . . . . 0.0 113.413 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -136.57 169.53 17.55 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 124.676 1.19 . . . . 0.0 109.209 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 8.3 mt -123.07 127.02 74.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 113.73 -1.577 . . . . 0.0 107.241 162.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.48 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -107.88 176.19 5.22 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 113.269 -1.787 . . . . 0.0 113.521 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.45 HD11 ' H ' ' A' ' 7' ' ' ALA 0.303 5.9 tp -49.08 -54.37 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 113.056 -1.884 . . . . 0.0 116.035 -174.226 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.91 -41.5 95.53 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 -174.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.576 ' HG2' ' HE3' ' B' ' 15' ' ' LYS . 62.8 mt-10 -51.63 -59.72 3.96 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 110.998 -2.819 . . . . 0.0 110.721 164.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.502 ' HA ' HD12 ' B' ' 29' ' ' ILE . 0.9 OUTLIER -66.16 -37.81 86.58 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 117.513 -1.232 . . . . 0.0 114.243 -178.087 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.29 -56.44 17.19 Favored Glycine 0 N--CA 1.482 1.747 0 CA-C-N 118.951 0.796 . . . . 0.0 112.273 166.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -56.62 -42.68 79.23 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 176.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.502 HD12 ' HA ' ' B' ' 26' ' ' LEU . 32.9 mt -58.86 -76.09 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.242 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 173.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 5.4 mp -87.1 65.41 8.88 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 125.94 2.781 . . . . 0.0 115.346 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -63.68 -41.82 98.11 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 110.489 -3.05 . . . . 0.0 111.913 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -81.18 91.77 6.21 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.164 167.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.15 154.75 44.37 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -176.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -101.28 -156.8 27.0 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-N 112.164 -2.289 . . . . 0.0 108.07 164.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.312 -1.047 0 O-C-N 120.723 -1.457 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.215 -0.76 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -85.85 108.15 18.0 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 118.432 -2.668 . . . . 0.0 112.895 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 91.9 p -126.94 -136.38 0.25 Allowed 'General case' 0 CA--C 1.553 1.069 0 CA-C-N 113.384 -1.735 . . . . 0.0 108.464 171.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -80.08 68.96 6.37 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 123.197 1.475 . . . . 0.0 111.493 175.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -54.66 -42.54 71.45 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 112.824 -1.989 . . . . 0.0 113.669 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 6' ' ' LEU . 1.2 mt-10 -85.74 127.68 34.59 Favored 'General case' 0 CA--C 1.547 0.842 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 166.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 5' ' ' GLU 0.281 3.6 pp -87.23 10.29 17.47 Favored 'General case' 0 CA--C 1.551 1.011 0 N-CA-C 117.465 2.394 . . . . 0.0 117.465 -14.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -44.71 -42.42 7.61 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 116.52 2.045 . . . . 0.0 116.52 -173.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 32.3 m-20 -53.18 -47.88 68.48 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 174.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.47 -40.2 71.34 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 176.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -57.47 -50.98 71.28 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 113.524 -1.671 . . . . 0.0 112.254 174.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.7 mmt85 -63.06 -35.16 79.32 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 112.496 -2.138 . . . . 0.0 114.267 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 56.7 mt -61.16 -43.29 96.07 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 CA-C-N 113.039 -1.891 . . . . 0.0 112.191 176.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 22.7 m-30 -77.02 -40.82 45.08 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.833 2.053 . . . . 0.0 114.929 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -69.2 51.72 0.09 Allowed 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 128.535 2.734 . . . . 0.0 114.738 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -44.44 -59.09 2.59 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 112.221 -2.263 . . . . 0.0 113.804 175.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -80.29 24.44 0.44 Allowed 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 117.148 2.277 . . . . 0.0 117.148 -176.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 50.75 33.98 9.29 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 161.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.9 p-10 -100.07 4.56 44.72 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 112.927 -1.942 . . . . 0.0 114.181 179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 60.26 26.11 63.43 Favored Glycine 0 N--CA 1.479 1.529 0 C-N-CA 124.772 1.177 . . . . 0.0 112.382 -171.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.557 ' HB3' ' HB3' ' B' ' 20' ' ' TYR . 13.3 m-85 -139.02 167.03 22.96 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.572 1.149 . . . . 0.0 110.296 -178.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -112.68 127.33 69.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 113.232 -1.803 . . . . 0.0 109.036 168.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.08 179.27 4.67 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 114.862 -1.063 . . . . 0.0 112.384 169.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . 0.277 5.0 tt -55.14 -40.56 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 117.071 2.248 . . . . 0.0 117.071 -171.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -67.65 -39.54 84.56 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.686 1.736 . . . . 0.0 115.686 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 71.0 mt-10 -65.27 -43.21 91.95 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 127.208 2.203 . . . . 0.0 111.979 174.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.569 ' HA ' HD12 ' A' ' 29' ' ' ILE . 1.4 tp -61.58 -45.38 94.35 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.561 0.744 . . . . 0.0 111.191 168.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -47.01 -50.24 16.03 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 125.684 1.611 . . . . 0.0 112.404 170.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -52.86 -52.35 57.66 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.691 0.796 . . . . 0.0 112.55 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.569 HD12 ' HA ' ' A' ' 26' ' ' LEU . 10.8 mt -58.17 -50.45 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 123.881 0.872 . . . . 0.0 109.362 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -74.51 -3.71 32.44 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -73.86 108.99 7.01 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -170.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -75.97 81.67 2.85 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 113.202 -1.817 . . . . 0.0 111.507 172.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 41.7 p -80.01 75.68 6.75 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 113.45 -1.705 . . . . 0.0 110.065 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.07 -144.08 22.48 Favored Glycine 0 N--CA 1.482 1.733 0 CA-C-N 112.495 -2.139 . . . . 0.0 111.117 -175.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.8 0 O-C-N 120.182 -1.775 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.206 -1.23 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' LYS . . . . . 0.623 ' HD3' ' H ' ' B' ' 3' ' ' GLU . 12.0 tmtt? -76.49 137.5 39.68 Favored 'General case' 0 C--N 1.302 -1.472 1 C-N-CA 143.47 8.708 . . . . 0.0 110.447 . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 38.8 p -48.38 -37.29 16.47 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 -173.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.623 ' H ' ' HD3' ' B' ' 1' ' ' LYS . 0.2 OUTLIER -127.53 88.83 2.85 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.593 0.711 . . . . 0.0 110.875 169.17 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 36.1 mp0 -51.88 -38.03 54.58 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 113.989 -1.46 . . . . 0.0 112.547 171.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -85.78 142.89 28.63 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 124.648 1.179 . . . . 0.0 111.932 169.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . . . . . . . . . 65.7 mt -85.33 12.14 8.79 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 116.693 2.108 . . . . 0.0 116.693 -7.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' B' ' 11' ' ' ARG . . . -48.72 -57.11 6.81 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.584 1.153 . . . . 0.0 112.113 -178.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ASN . . . . . . . . . . . . 0.277 13.5 m-80 -85.26 149.67 25.32 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 147.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . . . . . . . . . . . -72.87 4.34 4.26 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 118.849 2.907 . . . . 0.0 118.849 -13.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' PHE . . . . . 0.528 ' HD1' HD22 ' A' ' 26' ' ' LEU . 33.4 t80 -49.93 -53.26 27.28 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 122.218 1.009 . . . . 0.0 112.662 -179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ARG . . . . . 0.535 ' HA ' ' HB3' ' B' ' 14' ' ' ASP . 0.0 OUTLIER -64.81 -31.17 72.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 110.863 -2.88 . . . . 0.0 114.623 -178.066 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ILE . . . . . . . . . . . . . 22.0 mt -69.51 -39.54 78.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-N 113.919 -1.491 . . . . 0.0 111.897 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -74.18 -39.96 62.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 112.513 -2.131 . . . . 0.0 113.066 171.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' ASP . . . . . 0.535 ' HB3' ' HA ' ' B' ' 11' ' ' ARG . 12.1 t0 -70.13 47.91 0.09 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 128.682 2.793 . . . . 0.0 114.099 176.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -46.04 -47.09 17.03 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 113.375 -1.739 . . . . 0.0 114.126 175.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -82.15 27.99 0.46 Allowed 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ALA . . . . . . . . . . . . . . . 51.71 34.74 13.52 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 118.077 2.621 . . . . 0.0 118.077 156.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ASP . . . . . . . . . . . . . 47.8 p-10 -107.9 -1.32 20.83 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -178.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.03 28.9 74.04 Favored Glycine 0 N--CA 1.475 1.241 0 C-N-CA 123.617 0.627 . . . . 0.0 112.678 -170.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' TYR . . . . . 0.557 ' HB3' ' HB3' ' A' ' 20' ' ' TYR . 39.2 m-85 -142.35 168.31 20.04 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.209 1.003 . . . . 0.0 111.065 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mp -117.11 129.76 73.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 125.492 1.517 . . . . 0.0 109.956 170.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' B' ' 25' ' ' GLU . 0.0 OUTLIER -101.93 176.85 5.07 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.056 -1.429 . . . . 0.0 113.674 172.386 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 8.9 tp -48.56 -48.86 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 -175.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -67.23 -41.05 86.33 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' B' ' 22' ' ' ASP . 79.5 mt-10 -59.33 -42.41 91.41 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 112.477 -2.147 . . . . 0.0 112.306 171.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.416 ' HA ' HD12 ' B' ' 29' ' ' ILE . 1.8 tp -64.2 -43.99 93.36 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.007 0.523 . . . . 0.0 111.804 172.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -52.08 -45.67 56.68 Favored Glycine 0 N--CA 1.483 1.806 0 C-N-CA 124.093 0.854 . . . . 0.0 112.453 170.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -56.88 -38.04 72.2 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.909 1.283 . . . . 0.0 113.647 173.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' B' ' 26' ' ' LEU . 12.8 mt -69.58 -63.21 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 172.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 3.7 mp -72.58 17.24 0.11 Allowed 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 118.34 2.719 . . . . 0.0 118.34 -173.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ARG . . . . . . . . . . . . . 56.2 ttp85 -43.4 -36.67 2.02 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 128.398 2.679 . . . . 0.0 115.601 -172.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.16 -12.74 9.31 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 117.127 2.269 . . . . 0.0 117.127 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' THR . . . . . . . . . . . . . 36.4 p -65.0 89.88 0.08 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.672 1.189 . . . . 0.0 113.259 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLY . . . . . . . . . . . . . . . -70.06 93.45 0.42 Allowed Glycine 0 CA--C 1.535 1.312 0 CA-C-O 123.118 1.399 . . . . 0.0 112.233 173.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' NH2 . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.967 0 O-C-N 120.192 -1.769 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_